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ABSTRACT 
Cells of the Schwann cell lineage are derived from the cells of the neural crest. 
Schwann cell development, including factors controlling myelination have been 
studied extensively, but little is known about the development of the glial cells found 
in early nerves. This work describes an intermediate cell type in the development of 
Schwann cells from the neural crest, the Schwarm cell precursor. 
Using immunocytochemistry, the molecular phenotype of these cells has been 
investigated. A study has been made of S100 expression and survival in vitro in 
defined medium, on cells isolated from E14 to newborn nerves. These experiments 
show that glial cells isolated from E14-E15 nerves are not neural crest cells. The 
transition from precursor to Schwann cell occurs rapidly between E15 and E17 in 
vivo. 
Death of precursors in defined medium in vitro has been examined using DNA 
staining and studies of DNA fragmentation. The results indicate that death is by 
apoptosis, which can be delayed by addition of protein synthesis inhibitors or 
elevation of cyclic AMP (CAMP). Culture in neurone-conditioned medium 
suppresses apoptosis. 
A large number of growth factors have been investigated for survival effects. Three 
members of the fibroblast growth factor family have been found to promote short- 
term precursor survival when used in combination with a member of the insulin 
growth factor family. An extensive investigation has been made of the combinations 
required for precursor survival, both in the presence and absence of elevated cAMP. 
Two families of growth factors, Neu differentiation factors (NDFs) and endothelins 
are shown to promote long-term survival of the precursors. Precursor maturation in 
these factors has been followed using immunocytochemistry and assays for survival 
and proliferation. NDFß-2, but not endothelin, promotes maturation of precursors to 
Schwann cells with a time course similar to that seen in vivo. Addition of endothelin 
in the presence of NDFß-2 delays maturation. These results indicate that there is 
likely to be a complex interplay of growth factors controlling Schwann cell precursor 
survival and generation of Schwann cells during nerve development. 
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The glial cells of the peripheral nervous system 
Glia are the cells of the nervous system that surround and support the neurones and 
their axons. Originally their function was believed to be purely structural, acting as a 
glue to hold the nerve tissue together, but a century and a half of research has revealed 
that they have important functions within the nervous system. In the peripheral 
nervous system (PNS), the neurones and glia are mainly derived from the transient 
population of the neural crest. These rapidly migrating cells populate the sensory and 
autonomic ganglia and the peripheral nerves, as well as contributing to other cell types 
that will be described in detail later on. The glial cells that are derived from the neural 
crest fall into four distinct types that will be described below. Unless stated otherwise, 
the antigenic phenotype described is that of the rat. 
Satellite cells 
Satellite cells are the major glial cells found in sensory and autonomic ganglia other 
than those of the enteric nervous system (see below). Many of these cells together 
ensheath the neuronal cell bodies within the ganglia. This cover is continuous and in 
some places may consist of several overlapping processes of the satellite cells 
(Pannese, 1960; 1968). During development of the ganglia, these cells differentiate 
after the neurones and their numbers are closely regulated to the number and size of 
the neuronal cell bodies within the ganglia. After neuronal differentiation, the 
neurones no longer divide but the volume of each cell body increases, expanding the 
area of the neuronal cell membrane. Satellite cells undergo mitosis even after they 
have differentiated in terms of position and morphology. This increase in number is 
directly correlated with the increase in the area of the neuronal perikaryon. Thus, the 
total ensheathment of the neurones is maintained during development (Pannese, 1968; 
Hall and Landis, 1991; 1992). Basal lamina made by the satellite cells covers the 
glial cells and ensheathed neurones separating them from other elements of the 
extracellular matrix that are present in both sensory and sympathetic ganglia (Pannese, 
1968; Baluk et al, 1985; Bannerman et al., 1986). 
The satellite cell-neuronal association is not static; when cells of a mouse 
parasympathetic ganglion were studied in vivo over several weeks the positions of the 
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satellite cells relative to the neuronal cell bodies changed (Pomeroy and Purves, 1988). 
Preganglionic synaptic terminals were found to be more prevalent in the regions of the 
neurone closest to the satellite cell nucleus. It was suggested that the changes in 
satellite cell position were associated with synaptic remodelling. Satellite cells of 
dorsal root sensory ganglia (DRG) of adult rats have been shown to respond to 
axotomy or a localized inflammatory reaction by proliferating. The response of the 
satellite cells is rapid, with the peak of proliferation occuring during the first week 
after injury (Lu and Richardson, 1991). 
Satellite cells from both sympathetic and sensory ganglia express some proteins found 
in common with all peripheral glia (shown in Table 1.1). In addition to these proteins, 
four monoclonal antibodies, GL1, GL2, G1 and G2, raised against undifferentiated 
embryonic chick DRG, show strong expression in sensory ganglion satellite cells but 
are absent from sympathetic ganglion satellite cells. Culture of sympathetic ganglion 
satellite cells resulted in the cells acquiring expression of all four epitopes, suggesting 
that lack of expression in vivo is due to environmental factors (Rudel and Rohrer, 
1992). 
Enteric glia 
The enteric nervous system (ENS) is unlike other areas of the PNS, and in structure 
more closely resembles the central nervous system (CNS). It contains a large number 
of neurones, calculated to be comparable to the number of neurones present in the 
spinal cord. These neurones are organised into two interconnected plexuses, the outer 
myenteric plexus and the inner submucosal plexus (reviewed by Gabella, 1979). 
Sensory-, motor- and inter-neurones are all represented within the ENS and the 
majority of the neurones do not receive extrinsic input from the CNS. Surrounding 
these neurones are the enteric glia. These cells have an irregular morphology, and 
have been compared to the astrocytes of the CNS. 
The enteric glia exhibit extensive branching and irregular processes which mingle with 
the neuronal processes forming a dense neuropil. They form a sheath around the 
neurones and axons of the enteric plexuses. The sheath is incomplete, however, and 
both axonal varicosities and neuronal cell bodies extend through the sheath in places, 
contacting the extracellular connective tissue (reviewed in Gershon and Rothman, 
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1991). The association of enteric glia with axons involves communal ensheathment of 
axon bundles. Since individual glial-neuronal units are not formed in enteric ganglia, 
basal lamina is found covering the whole enteric ganglion rather than individual 
enteric glia (Bannerman et al., 1986); elements of the basal lamina and extracellular 
matrix are not found within the enteric ganglia. 
Absence of fibrillar collagen within the enteric ganglia and the presence of high 
concentrations of the intermediate filament glial fibrillary acidic protein (GFAP) 
within the enteric glia (also found in large amounts in astrocytes of the CNS, as well 
as in Schwann cells) has suggested to some authors that they play a major role in 
structural support of the ENS (reviewed in Gershon and Rothman, 1991, Jessen and 
Mirsky, 1980). Another morphological feature that is comparable to the environment 
of the CNS is the absence of blood capillaries within the nerve plexuses. 
When placed in culture, guinea pig enteric glia have a higher basal level of 
proliferation than Schwann cells under the same conditions (Eccleston et al., 1987a). 
When cultured with enteric neurones, however, the level of proliferation is reduced, 
suggesting that enteric neurones exhibit an inhibitory effect on enteric glial division 
(Eccleston et al., 1989). 
In common with other glial cells of the PNS, enteric glia express S100 (Bannerman et 
al., 1988) but, unlike most other non-myelinating glial cells, they do not express the 
low affinity nerve growth factor receptor (p75LNGFr) (Bannerman et al., 1986,1988). 
Expression of p75LNGFr is upregulated in cultures of rat enteric glia indicating that 
suppression is regulated by the enteric environment (Jessen and Mirsky, 1983). 
Another molecule that displays this property is the avian Schwann cell myelin protein 
(SMP). Expressed on all avian Schwann cells, it is absent from enteric glia and 
satellite cells in vivo (Le Douarin and Ziller, 1993), but culture of these cells leads to 
SMP expression, showing that repressive elements found in the ENS or peripheral 
ganglia control some aspects of the glial phenotype. 
Some of the antigens expressed by non-myelin-forming Schwann cells are also found 
on rat enteric glia (see Table 1.1), but unlike non-myelin-forming Schwann cells, 
enteric glia, in vivo and in vitro do not express the myelin-associated glycolipid, 
galactocerebroside (Ga1C) (Jessen and Mirsky, 1983) or the growth-associated protein 
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GAP-43 (Stewart et al., 1992). Unlike Schwann cells, enteric glia express cell surface 
gangliosides recognised by the antibodies A2B5 (100% of cells) and LB1 (on 95% of 
cells) (Bannerman et al., 1988). 
Teloglia / perisynaptic Schwann cells 
Teloglia are the specialised Schwann cells found surrounding the neuromuscular 
junctions (NMJ) where they appear to play an important role in maintenance and 
regeneration of NMJs. These cells send out fine processes enclosing the nerve 
terminal to within 50nm of the sites of neurotransmitter release (Georgiou et al., 
1994). 
These cells respond to secretion of neurotransmitters by elevating intracellular levels 
of Ca2+ and are thus active participants during synaptic transmission (Jahromi et al., 
1992). Myelin-forming Schwann cells, in the last segment of nerve before the NMJ, 
showed no changes in Ca2+ levels under the same conditions suggesting that they do 
not express receptors for the neurotransmitters. There is evidence that both muscarinic 
and purinergic receptors are present on the teloglia (Georgiou et al., 1994; Robitaille, 
1995). The functional consequence of the rise in teloglial intracellular Ca2+ is 
unknown, but it is possible that it has a role in maintenance of the teloglial phenotype 
(Georgiou et al., 1994). 
Unlike non-myelin-forming Schwann cells in other areas of the peripheral nerves, 
these cells do not normally express GFAP or the growth associated protein GAP-43 
(Georgiou, 1994; Woolf et al., 1992). If the motor endplate is denervated, teloglia 
elaborate extensive processes beyond the NMJ, which are retracted on reinnervation 
(Reynolds and Woolf, 1992). Denervation or blockade of nerve activity upregulates 
the expression of GFAP and GAP-43 in these cells (Woolf et al, 1992; Georgiou et al., 
1994). Inhibition of GFAP expression in normal teloglia appears to be brought about 
by release of neurotransmitters from the nerve terminal: exogenous muscarine has 
been shown to reduce the number of teloglia expressing GFAP in denervated NMJ. It 
is possible that the increase in teloglial intracellular Ca2+ plays a role in inhibiting 
GFAP expression (Georgiou et al., 1994). 
The processes elaborated by teloglia after denervation appear to guide regrowing 
axons to the denervated endplates, and in cases of partial denervation, to guide sprouts 
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from neighbouring innervated endplates to form endplates on the denervated muscle 
(reviewed in Son et al., 1996). 
Schwann cells 
Schwann cells are the glial cells that ensheath axons of peripheral nerves. Two 
differentiated types of Schwann cell exist in the adult nerve: non-myelin-forming 
Schwarm cells that ensheath numerous small diameter axons, and myelin-foming 
Schwarm cells that ensheath a single large diameter axon. Both cell types display 
characteristic morphologies and molecular phenotypes that will be described below. 
They are derived from a common progenitor cell that populates the nerve before birth. 
When cells of either type are removed from axonal contact and cultured in vitro, they 
revert to a cell with a protein phenotype similar to the Schwann cells found in 
embryonic nerves prior to differentiation (Table 1.1; Jessen and Mirsky, 1991). These 
de-differentiated cells can be made to re-express markers of either phenotype given the 
correct culture conditions or by reassociation with axons (Jessen and Mirsky, 1991; 
Guenard et al., 1995). 
Non-myelin-forming Schwann cells 
Non-myelinated nerve fibres, first observed by Remak in 1838, are covered by a 
continuous row of non-myelin-forming Schwann cells. Each of these cells ensheaths 
many small diameter axons. The axons either lie in troughs of Schwann cell 
cytoplasm or are entirely wrapped by thin processes cytoplasm, preventing contact 
between axons (reviewed by Thomas and Ochoa, 1984). The axon bundles within the 
non-myelin-forming Schwann cell change along the length of the cell: a Schwann cell 
may ensheath a particular group of axons at its proximal end but ensheath a different 
group at its distal end. In the places where the axons are incompletely wrapped they 
are separated from the surrounding extracellular matrix of the endoneurium by the 
basal lamina made by the Schwann cells. This basal lamina is continuous along the 
length of the non-myelinated fibre (Gould et al, 1992). 
Some of the antigens expressed by the non-myelin-forming Schwann cells in the rat 
are shown in Table 1.1. In common with the other glial cells of the PNS, non-myelin- 
forming Schwann cells express S 100, (Holton and Weston, 1982a). The 
glycosphingolipid galactocerebroside (GaIC) is a major component of the myelin 
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sheath but is also found in the membrane of the non-myelin-forming Schwann cell 
(Jessen et al., 1985; Eccleston et at, 1987b). Loss of axonal contact downregulates the 
expression of this lipid, but re-association of these cells with axons leads to its re- 
expression (Jessen et at., 1987a, 1987b). Other lipid antigens that are associated with 
both non-myelin-forming and myelin-forming Schwann cells are 04,08 and 09. The 
expression of the 04 antigen on Schwann cells precedes the differentiation of the two 
mature Schwann cell phenotypes (see below; Mirsky et at., 1990), while 08 and 09 
antigens are not expressed on the majority of non-myelin-forming Schwann cells until 
several weeks after they are found on myelin-forming Schwann cells. Expression of 
these lipid antigens is also regulated by axonal contact (Eccleston et al., 1987b). 
Myelin-forming Schwann cells 
The myelin-forming Schwann cell is associated with a single, large diameter axon, 
elaborating a spiralling sheath around the axon (Peters and Muir, 1959; reviewed in 
Thomas and Ochoa, 1984). Each Schwann cell-axon unit is referred to as an 
internode, each internode is separated from the next by the node of Ranvier, a region 
of the axon not covered by myelin but by finger-like processes of Schwann cell 
cytoplasm forming the nodal collar (Thomas and Ochoa, 1984). The internodes of a 
given axon are of similar dimensions, with the distance between each node of Ranvier 
and the thickness of the myelin sheath being remarkably constant, both being 
proportional to the diameter of the axon (reviewed in Bray et al., 1981). The whole 
myelinated fibre, including the nodes of Ranvier is covered by a continuous basal 
lamina produced by the Schwann cells (Gould et al., 1992). 
The Schwann cell myelin sheath is a remarkable specialisation of the cell membrane. 
During myelin formation, the membrane expands and wraps spirally around the axon 
forming the multilamellar sheath (Bunge et al., 1989). Compaction of the myelin 
follows with extrusion of most of the cytoplasm from the myelin sheath. Cytoplasm is 
found in specific regions of the Schwann cell. It is found in the region of the nucleus 
which is situated on the outside of the sheath, and also in the innermost section of the 
sheath adjacent to the axon: the adaxonal cytoplasm. Narrow clefts of cytoplasm, the 
Schmidt-Lanterman incisures, traverse the myelin from the outer to the inner surfaces, 
and extensions of cytoplasm are found at the edges of the Schwann cells at the nodes 
of Ranvier, the perinodal loops (Thomas and Ochoa, 1984). 
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The membrane composition is lipid-rich which enables the myelin sheath to act as an 
insulator around the nerve. In the electron microscope, a cross-section of myelin 
appears as a series of concentric circles. The intraperiod line is formed where the 
external surfaces of the plasma membrane are apposed, and the major dense line is 
formed by apposed cytoplasmic surfaces of the membrane. A high density of sodium 
channels are present in the axonal membrane at the node which, on depolarization, 
allows an inward current in this region (Dugandzija-Novakovic et al., 1995). The 
depolarization `jumps' from node to node, and results in rapid conduction of the nerve 
impulse; this is known as saltatory conduction (Bray et al., 1981). 
The molecular phenotype of the myelin-forming Schwann cell reflects the 
specialization of the membrane; many proteins are found exclusively in these cells or 
are restricted to myelin-forming Schwann cells and oligodendrocytes, the myelin- 
forming cells of the CNS. In contrast, many proteins found on other glial cells of the 
PNS are absent from or expressed at very low levels in myelin-forming cells (Table 
1.1). In most cases, the expression of these proteins is rapidly upregulated if the cells 
are removed from axonal contact (Mirsky and Jessen, 1990), but GAP-43 shows a 
longer time course for re-expression (Curtis et al., 1992). The Cat+- binding protein 
S 100 is present in myelin-forming Schwann cells and the level of expression is higher 
than that found in non-myelin-forming Schwann cells (Holton and Weston, 1982a; 
Mata et al., 1990). As stated earlier, Ga1C, the lipid antigens 08 and 09, as well as 04 
and sulfatide A007 are expressed by myelin-forming Schwann cells, but expression is 
rapidly down-regulated if the cells are removed from axonal contact (Jessen et al., 
1985,1987a; Eccleston et al., 1987b; Mirsky et al., 1990). 
Similarly, other proteins and lipids associated with the mature myelin-forming 
phenotype are lost if the cell is removed from axonal contact. Major myelin proteins 
expressed by the cells are Po, myelin basic protein (MBP), the cell adhesion molecule 
myelin associated protein (MAG), peripheral myelin protein (PMP) 22, and the small 
basic protein P2 (Mirsky et al., 1980; Trapp et al., 1981,1984,1988; Winter et al., 
1982; Trapp and Quarles, 1984; Lemke and Axel, 1985; Griffiths et al., 1989; Pedraza, 
et al., 1991; Welcher et al., 1991). 
Po is the major protein in PNS myelin, accounting for 50% of the total protein 
(reviewed by Hudson, 1990). It is a glycosylated protein with an extracellular domain 
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homologous to the Ig superfamily. Evidence suggests that it functions as a homophilic 
adhesion molecule, holding the wrapped membranes together in the myelin sheath 
(D'Urso et al., 1990; Filbin et al., 1990; Filbin and Tennekoon, 1993). In mutant mice 
lacking Po, the axons are hypomyelinated, with varying levels of myelination; some 
axons are myelinated, and a few exhibit quite thick myelin sheaths, but there is a lack 
of compaction; other large diameter axons are ensheathed by Schwann cells but lack 
any myelin spirals (Giese et al., 1992). Point mutations in the human Po protein are 
associated with the hereditary sensory neuropathy Charcot-Marie-Tooth (CMT) type 
113 disease (Hayasaka et al., 1993). 
Although associated with myelin-formation, the mRNA for Po is expressed very early 
in nerve development, and in migrating neural crest cells in both chick and rat 
(Bhattacharyya et at., 1991; Lee, Brennan et at., in preparation). Low levels of protein 
expression can be detected early in rat development and these continue to be expressed 
on non-myelin-forming Schwann cells even in the adult (Lee, Brennan et at., in 
preparation). Recently, a case has been made for high level Po expression being the 
developmental default state for Schwann cells, with active down-regulation of Po 
protein prior to myelination by axonal signals (Cheng and Mudge, 1996). However, it 
appears that the experiments have used sensitive detection of basal levels of Po protein, 
and evidence from this laboratory has shown that high levels of Po protein found in 
myelinating Schwann cells are not detected in culture, and high levels of mRNA for 
Po, such as those associated with myelination, are down-regulated in the absence of 
axonal contact (Lee, Brennan et at., in preparation). 
Proteolipid protein, (PLP) and the alternatively spliced variant DM20 are expressed by 
Schwann cells but are not incorporated into myelin. This is in contrast to the CNS 
where PLP is one of the most abundant myelin proteins, constituting 50% of the 
membrane protein of oligodendrocytes (reviewed by Mikoshiba et al., 1991). 
Expression of PLP mRNA in the PNS is not regulated by axonal contact, unlike the 
other myelin proteins (Gupta et at., 1991). 
PMP22 is an integral membrane protein expressed mainly by myelin-forming 
Schwann cells, (Snipes et al., 1992). It has been found to be homologous to the 
growth arrest-specific gene Gas-3, one of a group of genes of unknown function found 
in quiescent cells (Welcher et al., 1991). Duplication of the human PMP22 gene 
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results in CMT type IA disease. Rats over-expressing PMP22 exhibit symptoms 
similar to that seen in CMTIA, with PNS hypomyelination, Schwann cell hypertrophy 
and muscle weakness indicating that this protein is important in normal PNS 
myelination (Sereda et al., 1996). It has been suggested that PMP22 and PLP/DM20 
play analogous roles in the PNS and CNS respectively (reviewed in Snipes et al., 
1993). 
MBP is another structural protein found in myelin with many isoforms due to alternate 
splicing (reviewed in Hudson, 1990; Mikoshiba et al., 1991). MBP is a component of 
the major dense line of the myelin sheath (Omlin et al., 1982) but is expressed in the 
PNS at much lower levels than that seen in the CNS (Hudson, 1990). It is not 
essential for normal myelin sheath formation in the PNS, but in mutant mice that lack 
MBP (shiverer) there is an increase in the number of Schmidt-Lanterman incisures 
(Gould et al., 1995). 
MAG is a heavily glycosylated protein that is found in myelin-forming Schwann cells 
on the periaxonal membrane and non-compacted surfaces (reviewed in Colman, 1991). 
It is a member of the immunoglobulin superfamily and, like Po, has adhesive 
properties. It is localized at the axon-Schwann cell interface and first appears at the 
start of myelination, (reviewed in Jessen and Mirsky, 1993). In mice lacking MAG, 
myelin sheaths are essentially normal, but some nerves exhibit an absence of 
cytoplasm from the periaxonal collar and separation of the axon from the surrounding 
sheath (Li et al., 1994). These results indicate that MAG is important for the adhesion 
or spacing of myelin in the periaxonal region. 
P2 is found in compact myelin in a proportion of the myelin-forming cells, mainly 
those with thicker myelin sheaths (Winter et al., 1982). It has been cloned in mouse, 
rabbit and human and shown to belong to the family of fatty acid binding proteins 
(Narayanan et al., 1988,1991,1994). It is thought to be involved with assembly and 
maintenance of the myelin lipids (Gould et al., 1992). In the same manner, the lipid 
antigen Oll is expressed on some myelin-forming Schwann cells that have thicker 
myelin sheaths (Eccleston et al., 1987b); it is not clear whether P2 and 011 are present 
on the same population of Schwann cells. 
20 
Expression of the enzyme 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNP) in 
uncompacted myelin and colocalization of this molecule with the cytoskeleton have 
suggested that CNP is involved in myelin assembly (Hudson, 1990). However, it is 
found on all Schwann cells in culture and is therefore likely to be expressed by non- 
myelin-forming Schwann cells (Jessen and Mirsky, 1993). 
Periaxin (also known as Schwann cell membrane glycoprotein (SAG; Dieperink et at., 
1992) and p170k (Shuman et al., 1983)) is a membrane protein found in myelin- 
forming Schwann cells. It is thought to be involved in axon-glial interactions and in 
the early stages of myelin formation (Gillespie et al., 1994). This protein is found in 
the first uncompacted layers of Schwann cell membrane that ensheath the axon at the 
start of myelination. Subsequently, it is excluded from compacted myelin and is found 
in the periaxonal cytoplasm, where it colocalizes with MAG. It is thought to have a 
role in cytoskeletal interactions during myelination, possibly involving interactions 
with MAG (Gillespie et al., 1994; Scherer et al., 1996). 
Appearance of Schwann cell antigens in development 
The antigenic phenotype described above and in Table 1.1 is that of the mature 
myelin- and non-myelin-forming Schwann cells. Just prior to birth and the start of 
myelination, the cells exhibit a fairly uniform phenotype, with expression of antigens 
that are associated more with the mature non-myelin-forming Schwann cell. A 
diagrammatic representation of Schwann cell development is given in Fig. 1.1. The 
Cat+-binding protein S100 that is found in all mature peripheral glia, is first seen in 
Schwann cells from E16-17 nerves and will be discussed in detail in Chapter 3. The 
lipid antigen 04 is first apparent in S100+ cells from E16, this increases to 40% of the 
cells at E18 and it is expressed by essentially all Schwann cells at E20 (Mirsky et al., 
1990). Interestingly, 04 is thought to be the sulphated form of GaIC which appears 
two days later in development (Mirsky et al., 1990) and is first detected at E19 in cells 
that will become myelin-forming Schwann cells. It is possible that the antibody to 04 
detects antigens other that sulphated Ga1C (R. Mirsky, personal communication). 
Expression of Ga1C is also seen in non-myelin-forming Schwann cells but appears at a 
later stage in development, in the third postnatal week (Jessen et al., 1985). 
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GFAP expression starts to appear at E18 in both myelin- and non-myelin-forming 
Schwann cells but its expression is only transient in myelin-forming cells, being 
downregulated soon after myelination starts. It continues to be expressed in non- 
myelin-forming Schwann cells (Jensen et al., 1990). 
Most recently antibodies recognizing the CD9 antigen on platelets have been found to 
recognize an antigen present on Schwann cells (Hadjiargyrou and Patterson, 1995; 
Kaprelian et al., 1995; Anton et al., 1995). The CD9 antigen is a tetraspan protein 
with similar tertiary structure to PMP22, PLP and gap junction connexins (Mirsky and 
Jessen, 1996). Antibodies to this antigen enhance Schwann cell adhesion and 
migration on DRG neurites (Anton et al., 1995; Hadjiargyrou and Patterson, 1995). 
The CD9 antigen is present on rat Schwann cells from E17 (Tole and Patterson, 1995; 
Anton et al., 1995). 
Schwann cells during nerve degeneration 
Following nerve injury that results in severence of axons, Schwann cells distal to the 
point of injury undergo extensive changes with loss of myelin and massive 
proliferation of the Schwann cells in this region of the nerve. The sequence of events 
following axotomy is referred to as Wallerian degeneration (reviewed in Fawcett and 
Keynes, 1990; Scherer and Salzer, 1996). It is not known what triggers the response 
of the Schwann cells to axotomy. Products released by the damaged axons or invading 
macrophages might promote demyelination and Schwann cell proliferation, in addition 
to changes caused by interruption of axonal signals required for maintenance of the 
mature Schwann cell phenotype (Biachwal et al., 1988; Oaklander and Spencer, 1988; 
Hall, 1989; Perry and Brown, 1992; Scherer and Salzer, 1996). 
Following loss of axonal contact, myelin is actively broken down in the distal region 
of the damaged nerve. Clearance of the axonal and myelin debris is performed by 
Schwann cells and macrophages (Beuche and Friede, 1984; Bigbee et al., 1987; Stoll 
et al., 1989; Brown et al., 1991). Schwann cells can engulf and degrade the debris in 
the absence of macrophages (Fernandez-Valle et al., 1995), but their presence 
enhances the response of the Schwann cells (Clemence et al., 1989; Fernandez-Valle et 
al., 1995). 
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Both myelin- and non-myelin-forming Schwann cells undergo a period of rapid 
division with a peak 3-5 days post-axotomy (Oaklander and Spencer, 1988; Clemence 
et at., 1989; ). The tubes of basal lamina around the Schwann cells are not broken 
down and the proliferating cells are retained by them, forming the bands of Büngner 
(Scherer and Salzer, 1996). 
During this period of degeneration, while myelin proteins are lost from myelin- 
forming Schwann cells, and the lipids Ga1C and 04 are lost from both types of 
Schwann cell (reviewed in Gould et at., 1992), antigens found on the non-myelin- 
forming Schwann cells are re-expressed by the previously myelinating cells. 
Expression of NCAM, L1, GFAP, A5E3, Ran-2 and p75LNGFr is rapidly upregulated 
in de-differentiated cells, harking back to the phenotype found in the nerve prior to 
myelination (Gould et at., 1992). GAP 43, however, is upregulated 4-8 weeks after 
injury indicating that regulation of its expression is controlled differently from these 
proteins (Curtis et al., 1992). 
Since Ll and NCAM are known to play a major role in promoting axonal outgrowth, 
the upregulation of these molecules in damaged nerves is likely to be significant for 
nerve repair (reviewed in Schachner, 1990). Axonal growth into intact nerves is 
extremely limited suggesting that the loss of mature Schwann cell phenotype is 
essential for the regeneration of nerves (Brown et al., 1991). Further evidence for this 
comes from cultures of adult rat DRG neurones which will extend neurites on a 
substrate of predegenerated sciatic nerve but fail to grow on intact nerves (Bedi et al., 
1992). The presence of Schwann cells appears to be necessary for successful axon 
regrowth; in acellular grafts containing only basal lamina, axons grow from the 
proximal stumps of the cut nerve but for limited distances and in the presence of 
accompanying Schwann cells from the proximal stump (reviewed in Fawcett and 
Keynes, 1990; Ide et al., 1983; Feneley et al., 1991). Where Schwann cell migration 
is prevented, little or no axonal outgrowth is observed (Hall, 1986). 
In addition to providing a suitable substrate for axon regeneration, Schwann cells are 
believed to be a source of survival factors for neurones after nerve lesion. The mRNA 
for the neurotrophic factors NGF and brain-derived neurotrophic factor (BDNF) and 
for the neurokine LIF are upregulated in Schwann cells after axotomy (reviewed in 
Scherer and Salzer, 1996; Heumann et al., 1987a, 1987b; Meyer et al., 1992; Curtis et 
23 
al., 1994). These factors are released from the cells and promote neurite sprouting and 
outgrowth as well as acting as survival factors for axotomised neurones (Heumann et 
at., 1987a, 1987b; Acheson et at., 1991; Freidman et al., 1992; Rende et al, 1992; 
Meyer et at., 1992). CNTF is also produced by Schwann cells, but the mRNA 
expression in the distal stump decreases following nerve lesion, although biological 
activity of CNTF is detectable in the distal region for several days after injury 
(Sendtner et al., 1992). As yet, production of NT-3 or NT4/5 has not been reported 
from Schwann cells. Both the neurotrophins and the neurokines can be retrogradely 
transported to the neuronal cell bodies following release from the Schwann cells where 
they can enhance the survival of regenerating neurones (Curtis et al., 1993,1994, 
1995; Scherer and Salzer, 1996). 
Reinnervation of the nerve distal to the point of injury involves regrowth of the axons 
into the basal lamina tubes containing the Schwarm cells. Association of the Schwann 
cells and axons is similar to that seen during late embryonic development, with 
Schwann cells initially surrounding bundles of axons. Eventually, Schwann cells form 
a 1: 1 relationship with the larger diameter axons and start to form myelin. However, 
in these regenerated nerves, the thickness of the myelin sheath is never as great as in 
undamaged nerves, and the length of the internodes are shorter (reviewed in Scherer 
and Salzer, 1996). 
Other Schwann cell functions 
As well as enabling rapid nerve impulse conduction, Schwann cells have been reported 
to perform other important functions in the PNS. Schwann cells actively influence the 
axons they ensheath. Myelination increases the caliber of axons apparently by 
increasing the phosphorylation of neurofilaments within the axons (de Waegh et al., 
1992). The presence of myelin also affects the slow transport mechnism within axons. 
In Trembler mice, a point mutation in the PMP22 protein results in dysmyelination, 
and peripheral axons in these mice exhibit increased density of neurofilament and 
decreased slow axonal transport (de Waegh and Brady, 1990; de Waegh et al., 1992; 
Suter et al., 1992). Schwann cells also control the distribution of ion channels in the 
axolemma, restricting their expression to the paranodal regions. Following 
demyelination, sodium channel expression in the axonal membrane becomes diffuse. 
Subsequent distribution of sodium channels is controlled by the presence of Schwann 
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cells, with clusters of sodium channels becoming focused at the new nodes of Ranvier 
after re-myelination is complete (Dugandzija-Novakovic et al, 1995). 
Schwann cells exhibit ion channels both in vivo and in vitro and neurotransmitter 
receptors in vitro (reviewed in Bevan, 1990; Barres et al, 1990). Several distinct ion 
channels selective for potassium ions have been described both in vivo and in vitro 
(Bevan, 1990; Mi et al., 1995). One of the channels described by Mi et al (1995) is 
selectively distributed in the myelin-forming Schwann cell membrane in the outer 
cytoplasmic loop and in the paranodal loops at the nodes of Ranvier. The localization 
of this type of channel would agree with one of the proposed functions of Schwann 
cells, that of buffering the K+ levels around the axon following axon stimulation. 
Chloride ion and sodium ion channels are also found in Schwann cells although the 
latter is not found in myelin-forming Schwann cells (Bevan, 1990). 
The expression of neurotransmitter receptors in Schwann cells has not been 
demonstrated in vivo. In vitro, however, they express ß1-adrenergic, vasoactive 
intestinal peptide (VIP), and serotonin receptors. Binding of ligands to these receptors 
produces a transient elevation of intracellular cyclic AMP (Yasuda et al., 1988; Yoder 
et al., 1996). ). Purinergic receptor expression has also been reported in Schwann cells, 
and the expression appears to be controlled by axonal contact (Jahromi et al., 1992; 
Lyons et al., 1994,1995). 
Schwann cells can interact with cells of the immune system. The major 
histocompatibility complex (MHC) class II antigens are involved in the presentation of 
foreign antigens to lymphocytes and in initiating an immune response. Schwann cells 
can be made to express these antigens in response to exogenous interferon-y or in the 
presence of mycobacterial antigens and T cells, suggesting that they may play a role in 
the immune response to mycobacterial infection (Samuel et al., 1987; Kingston et al., 
1989). 
Glial cells of the vertebrate central nervous system. 
Four main classes of glia are found in the CNS: astrocytes, oligodendrocytes, 
microglia and ependymal cells. Of these, astrocytes and oligodendrocytes play major 
structural and functional roles within the CNS. The other two classes of cell have 
more restricted roles: microglia, derived from blood monocytes early in development, 
25 
act as macrophages within the CNS, and ependymal cells line the internal cavities of 
the CNS. 
Oligodendrocytes are the myelin-forming cells of the CNS. However, unlike Schwann 
cells of the PNS, each oligodendrocyte can myelinate many axons (reviewed in 
Hudson, 1990). Many myelin proteins expressed by Schwann cells are also expressed 
by oligodendrocytes, but there are also major differences in expression some proteins, 
possibly related to the levels of compaction found in the different myelin sheaths; CNS 
myelin exhibits greater compaction than PNS. For example, the proteins Po and 
PMP22, involved in the compaction of PNS myelin are absent from oligodendrocytes, 
however, PLP, present as a cytoplasmic component within Schwann cells, is a major 
component of CNS myelin and functions in compaction of myelin (Hudson, 1990; 
Snipes et al., 1993). MBP is also expressed in different amount in the two systems, 
making up 30% of the CNS myelin proteins but only 5-15% of PNS myelin; again this 
protein is implicated in myelin compaction (Hudson, 1990). 
Astrocytes are intimately associated with neurones and their processes throughout the 
CNS. During development, astrocytes act as guides for the migration of some 
neurones, providing a scaffold along which neurones can move (reviewed in Hatten et 
al., 1990). These cells contain large quantities of the intermediate filament GFAP, and 
are thought to provide structural support for the CNS which, unlike the PNS, lacks the 
mechanical support of collagen fibres. Astrocytes in the vicinity of blood vessels 
extend end feet that contact and surround the entire external surface of the vessels. By 
an as yet unknown method, these cells induce the endothelial cells lining the blood 
vessels to form tight junctions, forming the blood-brain barrier that restricts the 
transport of molecules into the brain (reviewed in Rubin, 1992; Schlosshauer, 1993). 
Astrocytes also express ion channels and are thought to play a major role in buffering 
the ionic environment (reviewed in Bevan, 1990). They also express neurotransmitter 
receptors, and are thought to control levels of neurotransmitters such as y- 
aminobutyric acid (GABA), serotonin and glutamate by uptake from the external 
environment (Bevan, 1990). 
Astrocytes are not uniform throughout the CNS; cells with different morphology, 
molecular phenotype and function have been found in different areas (reviewed in 
Wilkin et al., 1990; Barres et al., 1990). Extensive studies of the glial cells in the 
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developing optic nerve have been made which have revealed that in vitro, three glial 
cell types can be distinguished, astrocytes type 1 and 2, and oligodendrocytes 
(reviewed in Raff, 1989; Richardson et at., 1990). The type 1 astrocyte forms a 
fibroblast-like cell in culture and does not express the antigen detected by the antibody 
A2B5. This type of astrocyte can be found in situ in the optic nerve. This astrocyte 
develops from a separate lineage to the type 2 astrocyte, which is found as a process- 
bearing, A2B5+ cell in vitro. Whether this latter cell is present in vivo has not been 
clarified (Richardson et al., 1990). 
The type 2 astrocyte develops from a bipotential progenitor, known as the 02A cell , 
found in the rat optic nerve around birth (Raff et al., 1983). This cell also gives rise to 
oligodendrocytes in vivo and in vitro. In the optic nerve, the 02A progenitors 
proliferate, until at the time of birth some cells stop dividing and differentiate into 
oligodendrocytes. Others continue to proliferate and asynchronously stop dividing 
over the next few weeks to generate oligodendrocytes (Raff, 1989; Richardson et al., 
1990). When cells from the optic nerve are placed in culture in low (>0.5%) serum 
concentrations, the cells all cease division and differentiate into oligodendrocytes. 
Addition of astrocyte conditioned medium restores the ability of the progenitors to 
proliferate and prevents premature differentiation into oligodendrocytes (Raff et al., 
1985). It has been shown that platelet-derived growth factor-AA (PDGF-AA) can 
restore the timing of progenitor differentiation in vitro (Raff et al., 1988). PDGF-AA 
and insulin-like growth factor-1 (IGF-1) are survival factors for the progenitors in 
culture (Barres et al., 1992). Addition of NT-3 and PDGF-AA promotes proliferation 
of the progenitors, with differentiation into oligodendrocytes occuring synchronously 
within a clone of cells, suggesting that the number of cell divisions is strictly limited 
(Barres et al., 1994a). Addition of CNTF to the growth factor combination prevents 
differentiation of the progenitors. These cells can also be made to proliferate 
indefinately without oligodendrocyte differentiation in the presence of PDGF and 
bFGF (Bögler et al., 1990). Oligodendrocytes have different growth factor 
requirements to progenitors: after differentiation, PDGF-AA is no longer able to 
prevent the death of the differentiated cells. However, IGF-1, a neurotrophin such as 
NT-3 or a neurokine, such as CNTF support short-term survival of oligodendrocytes. 
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A combination of at least two factors from the different classes is required for long 
term survival (Barres et al., 1993). 
The timing of oligodendrocyte differentiation is believed to depend on an intrinsic 
clock mechanism that counts the number of divisions made by the progeny of a single 
cell (Raff, 1989; Richardson et al., 1990) After a preset number of divisions, 
approximately 8, the clone of cells produced will become unresponsive to mitogens 
and undergo more or less synchronous differentiation into oligodendrocytes (Raff et 
al., 1985; Barres et al., 1994a). The asynchronous production of oligodendrocytes 
within the developing optic nerve is thought to reflect the timing of generation of the 
initial progenitor cell (Barres et al., 1994b). Recently, the processes controlling the 
intrinsic clock have been partly elucidated. There appears to be two parts to the timing 
mechanism: a counting component that involves proliferation driven by mitogens, and 
an effector mechanism that depends on hydrophobic signalling molecules including 
thyroid hormone, retinoic acid and glucocorticoids (Barres et al., 1994b). It has been 
suggested that the susceptibility of progenitors to differentiate in response to the 
effector signals increases with every round of cell division. The intermediary in this 
mechanism may be the transcription factor AP-1 which helps mediate the proliferative 
response to mitogens. The activity of AP-1 can be inhibited by the receptors for the 
above hormones. It is postulated that with every round of cell division the levels of 
AP-1 are decreased and at a particular level of the transcription factor the inhibitory 
effects of the hydrophobic signal receptors are sufficient to block its activity and to 
cause withdrawal of the cell from the cell cycle. It is proposed that this process is 
sufficient to cause oligodendrocyte differentiation (Barres et al., 1994b). 
Growth factors and the nervous system 
Our understanding of the role of growth factors in the development and homeostasis of 
the nervous system has increased enormously in the decades since the first effects of 
NGF on neuronal survival were reported by Levi-Montalcini and Hamburger 
(reviewed in Levi-Montalcini, 1987). Growth factors are required by cells of both the 
developing and mature nervous system for survival and proliferation (reviewed in 
Lemke, 1990; Barres et al., 1992,1993,1994a; Snider, 1994) and now there is 
increasing evidence that growth factors control major developmental decisions. 
Studies on the differentiation of neural crest cells (described in the following section) 
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have revealed that many growth factors can direct crest cell differentiation towards a 
particular fate. Some of the growth factors known to have a role in the PNS, with 
particular reference to Schwann cells, will be described here. The growth factors of 
the fibroblast growth factor (FGF) family, the insulin growth factor (IGF) family and 
the Neu differentiation factor (NDF) family are described in Chapters 5 and 6. 
PGDF-AA and -BB 
PDGF is found in three isoforms that are disulphide-bonded dimers of A and B chains: 
AA, BB and AB (reviewed in Heldin and Westermark, 1990). The receptors for 
PDGF have tyrosine kinase activity and are comprised of a and ß chains that dimerise 
on binding the PDGF ligand; homodimers of as or ßß and the heterodimer of a(3 are 
formed. The a receptors can bind both the A and B chain of PDGF but the ß receptor 
appears to bind the B chain alone (Heldin et at., 1988). Dimerization of the receptors 
leads to autophosphorylation, with subsequent phosphorylation of cytoplasmic 
substrates (Eriksson et al., 1992; Schlessinger and Ullrich, 1992). 
PDGF is a potent mitogen and chemotactic agent for cells derived from the 
mesenchyme (Heldin and Westermark, 1990). It has also been shown to have a major 
role in CNS glial development, acting a mitogen for oligodendrocyte progenitors and 
affecting the timing of oligodendrocyte differentiation as mentioned above (Raff et at., 
1988; Richardson et al., 1988; Pringle et at., 1989; Barres et at., 1993). In the PNS, 
PDGF-BB is a mitogen in the presence of elevated cyclic AMP for rat Schwann cells 
(Davis and Stroobant, 1990; Weinmaster and Lemke, 1990) and can act in an 
autocrine manner (Eccleston et at., 1990). 
In the developing embryo, all three isoforms of PDGF are found within the developing 
CNS and PNS (Yeh et al., 1991; Hutchins and Jefferson, 1992; Reddy and Pleasure, 
1992). Mouse motor neurones are immunoreactive for all three PDGF isoforms at 
E12.5 and immunoreactivity is detected in DRG neurones and peripheral nerve one 
day later (Hutchins and Jefferson, 1992). There is expression of PDGF in neonatal 
and adult rat Schwann cells, with levels peaking shortly after birth (Eccleston et al., 
1993). 
E13.5 mouse nerve fibres express PDGF ß receptor protein (Hutchins and Jefferson, 
1992) and there is immunohistochemical evidence that rat Schwann cells express the 
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both the a and ß receptor at P1 (Eccleston et at., 1993). The detection of a receptor 
protein is in contrast with pharmacological evidence that suggests that a receptors are 
absent or non-functional on Schwann cells, since PDGF-AA, in contrast to PDGF-BB, 
has no known effect on Schwann cells (Davis and Stroobant, 1990). 
Neurotrophic factors - NGF, BDNF, NT-3, NT-4/5 
In addition to the effects of neurotrophins on the neural crest (see below), these factors 
have been shown to support the survival of various neuronal populations in peripheral 
sensory and sympathetic ganglia as well as motor neurones (reviewed in Levi- 
Montalcini, 1987; Thoenen, 1991; Henderson et al., 1993; Klein, 1994; Snider, 1994; 
Snider and Wright, 1996). 
The neurotrophins interact with three high affinity tyrosine kinase receptors, trkA, 
trkB and trkC, and the low affinity p75LNGFr. The neurotrophins bind to the 
receptors in a highly specific manner: the trkA receptor binds primarily NGF but will 
also bind NT-3; the primary ligands for trkB are BDNF and NT-4, with NT-3 also able 
to bind to this receptor; trkC appears to be specific for NT-3 (reviewed in Snider, 
1994). Both trkB and trkC have truncated isoforms lacking the tyrosine kinase 
domain, at least two truncated forms exist for trkB and four for trkC (Snider, 1994). 
The p75LNGF receptor can bind all the neurotrophins with low affinity but the exact 
function of this receptor is not known (Meakin and Shooter, 1992; Curtis et al., 1995). 
The neurotrophins assessed for Schwann cell precursor survival in the present work 
(Chapter 5) are all found within the peripheral nervous system. BDNF and NT-3 are 
expressed by neurones of peripheral ganglia (Ernfors and Persson, 1991; Schecterson 
and Bothwell, 1992) and Schwann cells can produce NGF and BDNF after nerve 
lesion, as described above (reviewed by Scherer and Salzer, 1996). Both trkB and 
trkC are found on migrating crest cells that will form the PNS (Klein et al., 1990; 
Tessarollo et al., 1993). Schwann cells in normal nerves express truncated forms of 
trkB and trkC, as well as full length trkC from E16 (the earliest time point studied) but 
the full-length trkC is down-regulated in the adult (Scherer and Salzer, 1996; 
Offenhäuser et al., 1995). It is not known what function the truncated receptors 
perform in cells but it has been postulated that they may negatively modulate the 
effects of neurotrophins by preventing the interaction with full length receptors 
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(Offenhäuser et at., 1995). As described earlier, p75LNGFr is present on cells of the 
Schwann cell lineage until they differentiate into myelin-forming Schwann cells, with 
expression being maintained on non-myelin-forming Schwann cells. 
Neurokines - CNTF, LIF 
Ciliary neurotrophic factor (CNTF) and leukaemia inhibitory factor (LIF) are related 
cytokines that exhibit trophic effects on cells of the nervous system (reviewed in Rao 
and Landis, 1993). Both factors promote the survival of sensory and motor neurones, 
with CNTF also promoting sympathetic neuronal survival (reviewed in Adler, 1993; 
Sendtner et al., 1990; Murphy et at., 1991; Thoenen, 1991; Rao and Landis, 1993; 
Mitsumoto et al., 1994). CNTF, LIF, and the related cytokine IL-6, promote the long 
term survival of oligodendrocytes in vitro (Barres et al., 1993,1994) and CNTF can 
prevent oligodendrocyte death in vivo (Barres et al., 1993). 
The receptors for these neurokines are integral membrane proteins and share the 
common subunit gp130; the LIF receptor comprises gp130 and the LIF(3 receptor 
subunit; the CNTF receptor has the additional CNTFcL receptor complexed with both 
gp130 and LIFß receptor (Scherer and Salzer, 1996). 
Both CNTF and LIF are expressed by neonatal Schwann cells, CNTF expression is 
low during the first postnatal week and increases thereafter, with high levels of 
expression in myelinating Schwann cells (Rende al., 1992; Curtis et al., 1993,1994). 
SCF/ Steel factor 
Stem cell factor (SCF) is also known as Steel factor, kit ligand or mast cell growth 
factor. Its receptor, c-kit, is a protein tyrosine kinase with homology to the PDGF 
receptor (Qui et al., 1988). SCF and c-kit were discovered to have a role in 
melanogenesis from two mouse mutants, Steel (St)and Dominant White Spotting (YT) 
(reviewed by Williams et al., 1992). These mutations, lacking SCF and c-kit 
respectively, are both lethal in homozygous mice, but heterozygous mice survive and 
display a white spotted coat colour pattern. The pattern of SCF and c-kit expression in 
the normal mouse shows an extensive distribution of transcripts, cells other that those 
derived from the neural crest also express these proteins (Steel et al., 1992). Steel 
factor is normally expressed as two splice-variants, both are membrane bound but the 
larger variant contains an extracellular cleavage site. In the Steel-dickie (Sid) mouse 
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mutant, a deletion of the transmembrane and cytoplasmic regions of the Sl gene 
produce a secreted form of the factor. By analysing neural crest migration in Sid 
mutants, Wehrle-Haller and Weston (1995) have shown that the secreted form of SCF 
is a survival factor for melanocyte precursors in the initial staging area (between the 
neural tube, somite and overlying ectoderm) and during their dispersal on the 
dorsolateral pathway (see below). Survival of the cells once they are in the dermis, 
however, appears to require the presence of the membrane bound form of SCF, but 
this factor does not appear to be required for differentiation into melanocytes (Murphy 
et al., 1992; Steel et al., 1992). 
SCF is found within cells of the mouse embryonic DRG, but there is no apparent 
expression of SCF in the adult DRG (Hirata et al., 1995). The c-kit receptor is 
expressed on melanoblasts and on cells of embryonic and postnatal mouse DRG 
(reviewed by Morrison-Graham and Takahashi, 1993; Hirata et al., 1995). 
Transforming growth factor ßs 
TGFß1 and TGF02 are members of the TGF(3 superfamily of growth factors 
(reviewed by Kingsley, 1994). They are synthesised as precursor proteins each 
containing an amino-terminal signal sequence, a pro-domain and, at the carboxy- 
terminal, the bioactive domain. The precursors form dimers that are then cleaved by 
proteolysis producing mature TGF(3. The cleaved TGFß may remain non-covalently 
linked to the pro-domain, forming a latent complex that can be activated by proteolysis 
or low pH (Kingsley, 1994; Massague et at., 1994). 
The TGFs bind to and signal via two main receptors known as type I and type II TGFß 
receptors, (TGFßR) both are serine/threonine kinases. Although TGF(3 can bind to the 
type II TGF(3R alone, both receptors are required for signalling (Massague et al., 1994; 
Kingsley, 1994). A third receptor has been described, the type III receptor, which is 
the proteoglycan betaglycan. This is believed to regulate the binding of TGFß 
isoforms to the type II receptor (Kingsley, 1994). 
Schwann cells express all three TGF(3 receptors (Einheber et al., 1995). The presence 
of TGFß receptors on cells of the neural crest can be inferred from changes in neural 
crest phenotype after TGFß addition (Stocker et al., 1991; Delannet and Duband, 
1992; Rogers et al., 1992; Leblanc et al., 1995), for example: a novel member of the 
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TGFß family, dorsalin-1, promotes the differentiation and migration of neural crest 
cells from the neural tube (Basler et al., 1993). 
Both Schwann cell precursors and Schwann cells express TGFßs 1-3 in latent form 
(Ridley et al., 1989; Einheber et al., 1995; Scherer and Salzer, 1996; Stewart et al., 
1995). Peripheral neurones in embryonic mice are immunoreactive for TGFßs 2 and 3 
(Flanders et al., 1991), while neonatal rat DRG neurones secrete active TGFI3 in short- 
term cultures (Stewart et al., 1995). 
TGFßs have been shown to have many effects on Schwann cell phenotype and 
behaviour including down-regulation of myelin protein expression (Morgan et al., 
1994; Guernard et al., 1995), upregulation of the cell adhesion molecules N-CAM and 
L1, and stimulation of proliferation in the presence of serum or FGF (Eccleston et al., 
1989; Ridley et al., 1989; Schubert, 1992). 
The neural crest 
As mentioned earlier, the cells of the neural crest give rise to most of the neurones and 
glia in the PNS. In addition, the neural crest generates many other cell types, 
including melanocytes, neurosecretory cells of the adrenal medulla, carotid body and 
parathyroid glands, as well as skeletal and connective tissue of the skull (Le Douarin 
and Smith, 1988; Anderson, 1989). 
Neural crest cells are a transient population that form at the edges of the neural plate as 
a result of inductive events between the neural plate and the presumptive ectoderm 
(reviewed in Selleck et al., 1993; Bronner-Fraser, 1995; Selleck and Bronner-Fraser, 
1995). The neural plate folds to produce the neural tube during neurulation and, at the 
time of closure, the neural crest cells separate from the neural folds to migrate along 
defined pathways within the developing embryo. The migration pathways of these 
cells can be extensive and depend on the rostro-caudal position within the embryo. 
Once migration has ceased, the cells differentiate into appropriate cell types depending 
on the location (Le Douarin and Smith, 1988). 
How the cells of the neural crest generate such a diversity of cell types and at precise 
locations within the developing embryo is not yet fully understood. The timing and 
pathways of migration play a major role in determining the progeny of the neural crest 
(Bronner-Fraser, 1993). Studies of neural crest migration in vivo have revealed some 
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of the environmental cues that control the routes taken by the neural crest cells 
(reviewed in Erickson and Perris, 1993). In vivo studies of labelled single cells have 
revealed that the progeny of a single neural crest cell can generate cells that contribute 
to several lineages within the developing embryo, implying that the original cells are 
multipotent, and the same conclusion has been drawn from experiments on clonal 
cultures of neural crest cells (see below) (reviewed in Bronner-Fraser, 1995; Bronner- 
Fraser and Fraser, 1988,1989; Frank and Sanes, 1991; Fraser and Bronner-Fraser, 
1991). Recent work on the control of developmental decisions in other cell systems 
and in vitro studies of neural crest have provided insights into possible mechanisms for 
directing neural crest cell differentiation towards a particular cell lineage. 
Pathways of migration 
Migration of crest cells in vivo has been studied using a variety of methods. Initial 
studies used transplantation of donor tissue labelled with tritiated thymidine (Weston, 
1963), while later transplantation experiments used chick / quail chimeras, exploiting 
the visible species differences of the cell nucleoli to distinguish the migrating crest 
cells (Le Douarin and Teillet, 1974; Le Douarin and Smith, 1988). Migration of 
neural crest cells in the chick and rat has also been examined using the antibodies 
HNK-1 and NC-1 that recognise a glycosylated epitope present on a variety of cell 
types (Vincent, et al., 1983; Tucker, et al., 1984; Loring and Erickson, 1987; Erickson 
et al., 1989). It is expressed on the surface of most chick neural crest cells and some 
of their derivatives (Vincent, et al., 1983; Tucker, et al., 1984) However, the epitope is 
expressed only transiently on some cells, particularly those that go on to generate 
melanocytes (Vincent, et al., 1983; Tucker, et al., 1984; Bronner-Fraser, 1986; Loring 
and Erickson, 1987; Dupin, et al., 1990; Heath, et al., 1992). It is expressed only on a 
subset of rat neural crest cells (Erickson et al., 1989; Bannerman and Pleasure, 1993). 
More recently, the vital dye DiI has been used to label premigratory crest cells in both 
chick and mouse (Serbedzija et al., 1989,1990,1991,1992). This lipophilic dye is 
incorporated into the cell membranes and labels all cells that are in contact with the 
lumen of the neural tube. Examining embryos at successive stages after injection has 
revealed the migration paths of neural crest cells and by altering the time of injection, 
the chronological order of crest cell contribution to various derivatives has been 
determined (reviewed in Bronner-Fraser, 1995). All these methods have given similar 
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results, with comparable patterns of migration observed in chick, mouse and rat 
(Bronner-Fraser, 1986; Erickson et al., 1989; Serbedzija et al., 1989,1990). 
Migration proceeds in a rostro-caudal manner; the first neural crest cells migrate from 
the neural tube at the level of the most recently formed somite (reviewed in Erickson 
and Perris, 1993). In the trunk region, the neural crest cells follow two main paths of 
migration: ventrally, through the rostral portion of the somites with some cells 
migrating in the intersomitic space, and dorsolaterally, between the ectoderm and the 
dermomyotome (reviewed in Bronner-Fraser, 1993; Bronner-Fraser, 1986; Erickson et 
al., 1989; Serbedzija et al., 1989,1990). 
In the ventral pathway, the caudal half of the somite is non-permissive for neural crest 
migration and also for motor axon outgrowth, resulting in the segmental patterning 
observed in the developing PNS (reviewed in Erickson and Perris, 1993; Keynes and 
Stern, 1984; Rickmann et at., 1985; Bronner-Fraser, 1986; Loring and Erickson, 1987; 
Bronner-Fraser and Stern, 1991). The restriction of crest cell migration to the rostral 
half of the somite results in a temporal delay in migration of cells facing the caudal 
half of the somite. These cells wait at the dorsal surface of the somite before moving 
either in an anterior direction to the migration permissive, rostral half of the somite, or 
caudally to the rostral half of the adjacent somite (reviewed in Le Douarin and Dupin, 
1993). Ventral migration of the neural crest is affected by the notocord which blocks 
the passage of the cells through the sclerotome in the vicinity of the notocord, possibly 
as a result of an inhibitory factor (reviewed in Bronner-Fraser, 1995). 
The neural crest forms derivatives in a ventral-to-dorsal manner within the embryo 
(Serbedzija et al., 1989; 1990; Bronner-Fraser, 1993). In the mouse, two patterns of 
migration are evident in cells following the ventral pathway with early migrating cells 
taking a pathway along the ventrolateral portion of the sclerotome to populate the 
sympathetic ganglia, adrenal medulla and the aortic plexus, while later migrating cells 
take a ventromedial route between the neural tube and the rostral sclerotome, moving 
into the sclerotome to form the DRG (Serbedzija et al., 1989; 1990). In the chick, the 
ventrally migrating neural crest cells appear to follow a single pathway to populate 
both sympthoadrenal derivatives and DRG (Rickmann et al., 1985; Bronner-Fraser, 
1986). 
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Cells migrating on the dorsolateral pathway appear to give rise exclusively to 
melanocytes (Erickson et al., 1992; Erickson and Perris, 1993; Erickson and Goins, 
thAt 
1995). Migration of these cells is observed later thanLof cells following the ventral 
route; the cells delay entering the pathway by up to one day after cells from the same 
axial level have entered the ventral pathway. Conditions generated by the 
dermomyotome appear to be responsible for the failure of the crest cells to migrate 
earlier on this pathway (Erickson et al., 1992). 
The pathways followed by the neural crest during migration provide substrates 
consisting of ECM molecules such as fibronectin, laminin and collagen, that are 
favourable to crest cell motility (Erickson and Perris, 1993). Conversely, areas such as 
the caudal half-somite and around the notocord are not permissive for neural crest 
migration, restricting the movement of these cells (Keynes and Stern, 1984; Rickmann 
et al., 1985; Norris et al., 1989). Thus, neural crest cells are subject to external 
influences on the pathways of migration they can take. In addition, the timing of 
migration can be controlled by cells surrounding the neural crest. Temporally 
expressed prohibitory signals appear to control the migration of cells following the 
dorsolateral pathway, an event that is likely to bias these cells towards a melanocyte 
fate (described below). Recent work has suggested that cells cannot migrate on the 
dorsolateral pathway unless specified as melanocytes (Erickson and Goins, 1995), 
however, studies in vitro have shown that the ability to migrate on the dorsolateral 
pathway does not preclude cells from adopting a non-melanocytic fate (see below) 
(Richardson and Sieber-Blum, 1993). It is probable that the restriction of neural crest 
cell migration plays a major role in controlling the final derivatives produced by crest 
cells, either due to intrinsically timed developmental events, or by exposure to 
extrinsic factors such as growth factors, which may bias the type of cells formed from 
a multipotent progenitor. 
The choice of cell fate 
The cell types generated from the neural crest depend on the axial level of origin of 
the crest cells. Tranplantation studies using chick-quail chimeras have shown that 
mesectodermal derivatives are produced exclusively from crest migrating from the 
cranial region of the embryo and not from crest cells arising in the trunk region 
(reviewed in Le Douarin and Smith, 1988). Similarly, enteric neurones and glia are 
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generated from the most rostral trunk neural crest (with a subpopulation from sacral 
crest) but most of the trunk crest cells do not contribute to the generation of the enteric 
nervous system (Le Douarin and Smith, 1988; Serbedzija et at., 1991; Gershon et at., 
1993). It is possible that these cells are predetermined populations that migrate to 
their final destinations instructed by specific cues in the environment. However, the 
chick-quail chimeric work by Le Douarin and collegues (reviewed in Le Douarin and 
Smith, 1988; Le Douarin and Dupin, 1993; Le Douarin et at., 1993) has shown that 
neural crest cells transplanted to a new position on the rostro-caudal axis will give rise 
to many crest progeny appropriate to this new axial position, suggesting that the cells 
are not predetermined but are influenced by environmental factors in their choice of 
cell fate. However, although cranial neural crest transplanted to the trunk region of 
the embryo can generate the full range of trunk crest derivatives, converse experiments 
show that trunk crest is unable to generate mesectodermal derivatives when 
transplanted to the cranial region (Le Douarin and Smith, 1988; Le Douarin et at., 
1993) suggesting a restriction in the potential fates of the trunk crest. 
The generation of diverse cell types from an homogenous population of cells occurs in 
many different cell systems during development. All cells in a population that have 
the potential to make a cell fate decision with equal probability can be thought of as an 
equivalence group (reviewed in Greenwald and Rubin, 1992). The choice of cell fate 
may be influenced by signals generated outside this group, an event known as 
induction. Alternatively, a stochastic event in one of the cells, such as a minor change 
in cell surface signalling molecules, may generate non-equivalence within the group. 
This alteration of equivalence can produce lateral specification, with the initially non- 
equivalent cell preventing the other cells from differentiating along the same pathway 
and making them adopt an alternative fate (Greenwald and Rubin, 1992). 
In the haemopoietic system, most cells involved in the immune response are generated 
from stem cells in the bone marrow (reviewed in Lydyard and Grossi, 1989). The 
multipotent stem cells give rise to cells that are committed to one of four cell lineages. 
These cells in turn produce more restricted progenitors in the lineages, eventually 
producing terminally differentiated cells. The stem cells can be cultured in vitro in the 
presence of polypeptide growth factors such as the interleukins (IL-) 1 to 11 and the 
haemopoietic colony stimulating factors (CSFs); the cell types generated can be 
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influenced by the growth factors present (Fairbairn et al., 1993). These growth factors 
are known to promote survival and proliferation of the stem cells progeny but it was 
previously unknown whether the growth factors induced differentiation of a particular 
cell type. By suppressing death in the stem cell population using transfection with the 
anti-apoptotic gene bcl-2 (described in Chapter 4), Fairbairn et al. (1993) showed that 
stem cells in vitro generated differentiation of all the normal progeny in the absence of 
exogenous growth factors. This suggests that these cells generate different cell types 
by stochastic events, with growth factors biasing the proportions of each subpopulation 
by subsequent survival and proliferation effects. How cell fate decisions are made in 
the developing PNS is as yet unclear, but studies with neural crest cells in vitro have 
provided insights into factors controlling differentiation of these cells. 
In vitro studies on trunk neural crest cells 
As discussed above, labelling of single cells in vivo, either by transfection with 
retrovirus or by DiI injection, has revealed that at least some cells of the neural crest 
are multipotent (Bronner-Fraser and Fraser, 1988,1989; Frank and Sanes, 1991; 
Fraser and Bronner-Fraser, 1991; Serbedzija et al., 1994). These studies also suggest 
that cells with a more restricted potential can be found within the neural crest, and that 
with time the potential fates of the crest cells becomes increasingly restricted, 
confirming earlier work with chick/quail chimeras using back transplantation (Le 
Douarin and Smith, 1988). Although such work can suggest possible sublineages and 
timing of committment within this cell population, the factors controlling the direction 
of neural crest differentiation cannot be resolved using these methods. Using in vitro 
culture conditions, however, the effects of individual growth factors on crest cell 
development can be studied. 
Several types of study have been performed using cultured neural crest cells (reviewed 
in Stemple and Anderson, 1993). Explants of neural tubes producing mass cultures of 
neural crest have been used to analyse the effects of substrates and growth factors on 
whole populations. An alternative method has been to culture neural crest cells at 
clonal density, thereby controlling more closely the factors affecting crest cell 
development. This method allows the fate of single cells to be followed, and has 
produced evidence for progenitors with variously restricted potentials. 
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Using a clonal culture method, rat neural crest cells capable of undergoing self- 
renewal have been detected (Stemple and Anderson, 1992). It has been argued that 
these cells act as stem cells, capable of producing multipotent progeny even after 
undergoing several rounds of division. Within these cultures, however, cells with a 
more restricted potential are also found, confirming previous work in chick, quail and 
mouse (Cohen and Konigsberg, 1975; Sieber-Blum and Cohen, 1980; Barrofio et al., 
1988; Dupin et al., 1990; Ito and Sieber-Blum, 1991; Ito et al., 1993). In all these 
studies, some clones produced cells of many different lineages, with melanocytes, 
Schwann cells, serotonergic (5-HT) and substance P+ neurones differentiating from a 
single progenitor (Dupin et al., Ito et al., 1993). In contrast, some clones produced 
pigmented cells alone, suggesting that segregation of the melanocyte lineage is an 
early event in crest cell development. However, differences in the proportion of 
colonies giving rise to these pigmented clones occur in mouse (8%; Ito et al., 1993) 
and quail (40-60%; Sieber-Blum and Cohen, 1980) suggesting that timing or control 
of these lineages differs between species. 
Clones with apparently tri- and bipotential precursors have been detected in quail and 
mouse crest cell cultures. The existence of bi- or tripotent progenitors has been 
inferred from the observation that a certain proportion of clones regularly give rise to 
just two or three cell types. For example, in quail cultures, clones are generated that 
contain only Schwann cells (SMP+) and satellite cells (SMP-); also a bipotential 
progenitor for Schwann cells and melanocytes has been suggested (Ciment, 1990). In 
mouse cultures, clones generating Schwann cells and melanocytes have also been 
found, as well as clones that give rise to only serotonergic and sensory neurones (Ito et 
al., 1993). A proposed tripotential progenitor in quail produces these cells plus 
neurones (Dupin et al., 1990). These studies suggest that, as well as multipotential 
progenitors, some cells of the neural crest exhibit more restricted potentials. 
In two studies where cranial crest was cloned, mixed and single cell type clones of 
connective tissue and muscle derivatives developed, cell types that were not seen in 
cultures of trunk neural crest (Dupin et al., 1990; Ito and Sieber-Blum, 1991; Ito et al., 
1993). These results again confirm data from transplantation studies (Le Douarin and 
Smith, 1988) suggesting that cells derived from the truncal level are already restricted 
in potential compared to cells of cranial crest. 
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Clonal analysis has also been performed on tissues populated by neural crest cells after 
crest cell migration has ceased. In cultures of quail enteric neural crest taken from the 
gizzard and bowel, clones can be generated that express tyrosine hydroxylase, a 
marker for entry into the sympathoadrenal lineage (reviewed in Anderson, 1993b; 
Sextier-Sainte-Claire Deville et al., 1994). Similarly in studies using early DRG and 
sympathetic ganglia, multipotential clones can be generated that give rise to 
melanocytes, sensory and autonomic neurones (Duff et al., 1991). Melanogenic 
potential of the clones is lost with increasing age of the donor embryo, again 
suggesting that commitment to the melanocyte lineage is an early event. Clones 
containing neuronal precursors of either sensory or sympathoadrenal lineages are only 
found in the cultures of the appropriate ganglia. Melanocytes appear to be among the 
first cells to become restricted in vitro, but culture of crest-derived cells from quail 
skin shows that some of these cells are also multipotential. Sensory neurones, 
sympathoadrenal cells and other non-pigmented cells (possibly glia) are produced by 
20% of clones (Richardson and Sieber-Blum, 1993). In all the above cultures, 
production of these multipotential clones decreases with increased age of the embryo 
used to isolate the crest derivatives. These studies confirm the data produced by back 
transplantation studies in the chick, that the developmental potentials of cells derived 
from the neural crest are plastic and can be altered by changes in the environment. 
This plasticity is lost with increasing age as cells appear to become terminally 
committed to a particular cell lineage. 
Effects of growth factors on neural crest development 
In the cultures described above, the culture media contain unknown growth factors that 
are added in the form of serum and chick embryo extract, or factors secreted by 
fibroblast feeder layers. While most of the experiments described below are not 
performed entirely in defined media, addition of known growth factors to the cultures 
can be seen to have profound effects on the development of subsets of neural crest 
derivatives. 
FGFs A role for FGFs in neural crest survival originally came from in vivo studies 
where a silastic membrane was inserted between the neural tube and the developing 
DRG anlage (Kalcheim and Le Douarin, 1986). This lead to death of the cells distal to 
the membrane, but coating the membrane in laminin and bFGF restored the ability of 
40 
these cells to survive. In culture, bFGF has been shown to promote the survival of a 
non-neuronal subset of neural crest cells, but proliferation is unchanged in the 
presence of the growth factor (Kalcheim, 1989; Brill et al., 1992; Bannerman and 
Pleasure, 1993). Another study reports that the use of aFGF or bFGF in the presence 
of serum on mouse neural crest cultures stimulates proliferation of these cells (Murphy 
et al., 1991). 
bFGF is reported to stimulate neuronal differentiation from avian neural crest cultures 
but only in a cell-mediated manner (Brill et al., 1992). Transfection of the baby 
hamster kidney cell line BHK-21 with human bFGF cDNA increases the number of 
neurones differentiating from co-cultured neural crest. Parental cells fail to promote 
neuronal differentiation in the absence of bFGF but addition of exogenous growth 
factor to these cells also increases the numbers of neurones in the cultures. In contrast, 
in rat neural crest cultures addition of aFGF and bFGF are reported to delay the 
maturation of neurones (Bannerman and Pleasure, 1993; Bannerman and Guritzky, 
1994). 
bFGF has also been implicated in the development of melanocytes. Hirobe (1992) 
reported that bFGF in the presence of cAMP analogues increases the proliferation of 
mouse epidermal melanoblasts and prevents the differentiation of melanocytes. 
Addition of bFGF to embryonic DRG or peripheral nerve cultures stimulates the 
production of melanocytes (Stocker et al., 1991). The presence of the protein kinase 
C-activating phorbol, 12-0-tetradecanoyl phorbol-13-acetate (TPA) enhances the 
number of melanocytes produced, but the addition of TGFß-1 reduces the number of 
pigmented cells developing. These results suggest that growth factor interplay may 
control the type of derivative formed in differentiating neural crest. 
The FGFs have been implicated in the development of the sympathoadrenal lineage. 
Both sympathetic neurones and adrenal medulla chromaffin cells are derived from a 
bipotential progenitor (reviewed in Anderson, 1993a, 1993b). The differentiation of 
these cells is dependent on the environment, with the presence of glucocorticoids 
preventing neuronal differentiation while promoting the differentiation of chromaffin 
cells and subsequently acting as a survival factor for these cells (Doupe et al., 1985; 
Anderson, 1993 a, 1993b). These cells can alter their phenotype even if isolated from 
the adult; in the presence of low glucocorticoid levels and NGF, these cells will 
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differentiate into sympathetic neurones (Doupe et al., 1985). The pheochromocytoma 
cell line PC12 resembles chromafiin cells in its response to growth factors and 
glucocorticoids and is often used to study sympathetic neuronal differentiation. Both 
bFGF and aFGF have been shown to mimic NGF effects on adrenal chromaffin cells 
and PC12 cells, by stimulating proliferation of these cells and inducing stable neurite 
outgrowth and neuronal differentiation (Rydel and Greene, 1987; Stemple et al., 1988; 
Claude et al., 1988). However, bFGF does not promote long-term survival of the 
differentiated neurones. After differentiation, the sympathetic neurones become 
dependent on NGF for their survival (Stemple et al., 1988). 
These studies indicate that FGFs have a range of effects on the developing neural crest 
and survival, proliferation or differentiation in response to these factors depends on 
other signals from the environment. 
Neurokines The neurokines LIF and CNTF have been implicated in-neural crest cell 
differentiation along neuronal pathways. Mouse crest cells cultured in bFGF then 
switched to medium containing LIF or CNTF results in the differentiation of sensory 
neurones from these cultures (Murphy et al., 1991,1994). Proliferation of chick 
sympathetic neuroblasts is inhibited by CNTF, which promotes the survival and 
differentiation of neurones from these cells (Ernsberger et al., 1989). In addition, 
CNTF appears to enhance production of neurones expressing vasointestinal peptide 
(VIP), normally only expressed by a subpopulation of sympathetic neurones 
(Ernsberger et al., 1989). It has been known for sometime that environmental factors 
can cause a switch in neuronal neurotransmitter, from a noradrenergic to a cholinergic 
phenotype (reviewed in Patterson, 1990; Doupe et al., 1985; Patterson and Chun, 
1977). LIF and CNTF have also been reported to induce this switch in vitro in older 
sympathetic neurones cultured from neonatal rats (Yamamori et al., 1989; Ludlam et 
al., 1994) suggesting that these neurokines can determine the neurotransmitters 
Expressed by neurones, and probably influence the neurones developing from the 
neural crest (reviewed in Rao and Landis, 1993). 
Neurotrophins The neurotrophins NGF, BDNF and NT-3, have been implicated in 
several aspects of neural crest development (Sieber-Blum, 1991; Wright et al., 1992; 
Sieber-Blum et al., 1993). BDNF and NT-3 have been shown to promote the survival 
of neural crest cells. BDNF coating of silastic membranes implanted between the 
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neural tube and the DRG anlage, as described for FGF, prevents the death of 
developing DRGs suggesting a trophic role for BDNF (Kalcheim et al, 1987). NT-3 
has also been shown to act as a survival factor for early neuroblasts differentiating 
from neural crest (DiCicco-Bloom et al., 1993). As described above, NGF can induce 
sympathetic neuronal differentiation and survival of sympathoadrenal progenitors 
(Anderson, 1993a, 1993b). In clonal cultures of quail trunk neural crest, addition of 
BDNF but not NGF promotes differentiation of sensory neurones (Sieber-Blum, 1991; 
Sieber-Blum et al., 1993). However, BDNF does not promote the proliferation of the 
cells in the clone, indicating that it acts to direct cell differentiation towards a sensory 
neurone fate (Sieber-Blum, 1991; Sieber-Blum et al., 1993). 
NT-3 has been shown to promote the survival of sensory and sympathetic neurones in 
DRG and sympathetic ganglia (reviewed in Snider, 1994; Henderson, 1996). Culture 
of neural crest cells with NT-3 causes an increase in proliferation of these cells 
(Kalcheim et al., 1992). This factor promotes the survival of proliferating sensory 
neurone precursors (ElShamy and Ernfors, 1996); in this study, cultured DRG sensory 
neurone precursors from embryonic mice mutant for NT-3 show enhanced survival 
after the addition of exogenous NT-3. Both NT-3 and BDNF have been reported to 
increase the rate of neuronal maturation in cells from embryonic chick DRG (Wright 
et al., 1992). 
Glial growth factor NT-3 has been shown to be produced by non-neuronal cells of 
sympathetic ganglia (Verdi et al., 1996) and it has been suggested that NT-3 and glial 
growth factor (GGF; Marchionni et al., 1993; described in Chapter 6), another growth 
factor implicated in neural crest differentiation, are both involved in cell fate 
determination within developing ganglia (Verdi et al., 1996). GGF, a member of the 
Neu differentiation factor family (also called neuregulins and heregulins), has been 
shown to bias neural crest differentiation towards a glial fate, suppressing neuronal 
differentiation while allowing glial differentiation to proceed (Shah et al., 1994; 
Mirsky and Jessen, 1996). In cultures of non-neuronal cells from sympathetic ganglia, 
NT-3 mRNA expression is upregulated by the addition of GGF-2, CNTF and at lower 
levels by PDGF. These cells produce a factor, identified as NT-3 by use of blocking 
antibodies, that can promote the survival of a Subpopulation of sympathetic ganglia 
neuroblasts. In addition, NT-3 produced by the non-neuronal cells down-regulates the 
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expression of trkC and upregulates expression of trkA on the neuroblasts, conferring 
the ability to respond to NGF on these cells (Verdi and Anderson, 1994; Verdi et al., 
1996). GGF mRNA can be detected in freshly isolated neuroblasts (Verdi et al., 1996) 
suggesting a possible mechanism for generating both neurones and glia within the 
developing ganglia: since cells differentiating early as neurones produce GGF they 
might then direct as yet uncommitted neighbouring cells towards a glial fate. These 
non-neuronal cells in turn produce NT-3 which can support the survival of the 
neuroblasts and affects the switch for trophic requirements in the differentiating 
neurones, from NT-3 in neuroblasts to NGF in neurones. 
TGF f superfamily The bone morphogenetic proteins (BMPs) are members of the 
TGF1 superfamily and are expressed at sites of autonomic neuronal differentiation 
(Shah et al., 1996). BMP-2 induces stem cell cultures of rat neural crest to 
differentiate into neurones of the sympathetic lineage. Some clones containing only 
neurones develop under these conditions, indicating that BMP-2 is likely to act 
directly on the cells, rather than via a non-neuronal intermediate. Some clones 
produce cells expressing smooth muscle antigens, and in cultures where TGF3I is 
used instead of BMP-2, virtually all cells differentiate into smooth muscle (Shah et al., 
1996). Smooth muscle is not normally associated with derivatives of trunk neural 
crest and although showing that these cells have not lost the potential to differentiate 
along this pathway, may not represent actual cell fate decisions made in vivo. 
Stem cell factor (SCF) As described above, the membrane-bound form of SCF has 
been shown to be a survival factor for melanocyte precursors in vivo (Steel et al., 
1992) and in vitro (Murphy et al., 1992). Addition of soluble SCF acts as a survival 
factor for embryonic mouse sensory neurones in vitro (Hirata et al., 1995). Most 
recently SCF has been shown to be trophic for pluripotent quail neural crest cells in 
vitro. In addition, it enhances the number of sensory neurone precursors developing 
from these cultures, when present on its own, but in combination with NGF or NT-3, 
this effect is lost. However, in combination with a neurotrophin, SCF promotes the 
survival of melanogenic cells, suggesting multiple actions of this factor during neural 
crest cell differentiation (Langtimm-Sedlak et al., 1996). 
In conclusion, the development of a particular cell type from the multipotent cells of 
the neural crest involves a series of complex events, from interaction with the ECM, to 
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cell-cell interactions and the effects of growth factors and hormones in the 
environment. The cell ultimately differentiating in vivo at the end of development is a 
sum of all these events. The work presented here is a study of a cell that is an 
intermediate on the path of development from the neural crest to the Schwarm cell. 
The phenotype of this cell, its survival requirements and the factors involved its 
maturation to a Schwann cell phenotype will be described in the following chapters. 
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Table 1.1 Molecular phenotype of rat peripheral glia 
A comparison of some antigens expressed by glial cells of the adult rat PNS in vivo 
and short-term cultured Schwann cells. (Data from Bannerman et al., 1988; Mirsky 
and Jessen, 1987,1990; Gould et al., 1992; * R. Mirsky, personal communication). 
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Table 1.1 Molecular phenotype of rat peripheral glia 
Antigen Satellite Enteric Non- Myelin- Short- 
cells glia myelin- forming term 
forming Schwann cultured 
Schwann cells Schwann 
cells cells 
............................................................................................................ p75LNGFr +- ............................... + .................................. - 
................................. + 
S100 ++ + + + 
N-CAM ++ + - + 
Ll++ + + 
A5E3 ++ + - + 
Ran-2 -+ + - + 
Laminin ++ + + + 
GAP-43 + + - + 
Vimentin ++ + + + 
GFAP +b + + + + 
04 ++ + + - 
Ga1C +* - + + - 
P0 -o _o _o + _o 
MBP -- - + - 
a expressed mainly at nodes of Ranvier. 
b expressed in 40-60% of rat sympathetic ganglia satellite cells but only present in a 
minority of DRG satellite cells. 
° expressed at basal levels but not at high levels, b asal levels in enteric glia and 
satellite cells not determined. 
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Figure 1.1 Schematic representation of rat Schwann cell development in the 
sciatic nerve. 
The scheme describes the observed stages in development of rat Schwann cells from 
cells of the neural crest. Schwann cell precursors are found in the nerve at E14-15. 
Schwann cells are generated from Schwann cell precursors between E15-17, when 
S100 is first detected and the cells survive culture in defined conditions (Chapter 3). 
At around birth, the first cells adopting the myelin phenotype are seen, with expression 
of Po being observed. By the fifth post-natal day, the first cells to express myelin 
proteins have down-regulated molecules associated with the mature non-myelin- 
forming Schwann cells, such as GFAP, NCAM, A5E3 and p75LNGFr. Mature non- 
myelin-forming Schwann cells, expressing Ga1C are found in the third postnatal week. 
Differentiation of Schwann cells in the nerve is complete by the fifth to sixth postnatal 
week. 
Sch, Schwann cell; N-M Sch in solid frame, non-myelin-forming Schwann cell; N-M 
Sch in stipple frame, cells with a similar molecular phenotype to the mature non- 
myelin-forming Schwann cell that will progress to myelination; M-Sch, myelin- 
forming Schwann cell; Ga1C, galactocerebroside. . indicates molecules that are 
down-regulated during differentiation of Schwann cells along the myelin pathway. 
Myelin proteins are those normally expressed only by myelin-forming Schwann cells, 
such as the proteins Po, MBP, and MAG. Reproduced by the kind permission of R. 


























MATERIALS AND METHODS 
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Animals 
Sprague Dawley rats were used throughout this work. 
Pregnant rats were killed by asphyxiation in C02, and the embryos decapitated and 
kept on ice. Neonates were killed by decapitation. 
Dating of the embryos was as described in Christie, 1965, taking the day of the vaginal 
plug to be embryo day (E) 0. 
Defined Medium 
The defined medium (DM) used in this study was a modification of the medium of 
Bottenstein and Sato (1979). Dulbecco's modified Eagle's medium (DMEM) and 
Ham's F12 medium (both Gibco Life Technologies, Paisley, Scotland) mixed 1: 1 and 
supplemented with (final concentrations in parenthesis) bovine serum albumin (BSA, 
0.03 mg/ml), transferrin (100pg/ml), glucose (7.9mg/ml), putrescine (16pg/ml), 
progesterone (60ng/ml), thyroxine (400ng/ml), triiodothyronine (10.1ng/ml), selenium 
(160ng/ml), dexamethasone (38ng/ml) (all the above were from Sigma Chemical 
Company, Poole, England), glutamine (2mM; ICN Biomedicals, Thame, England ), 
penicillin (100 IU/ml) and streptomycin (100 IU/ml) (both from Gibco Life 
Technologies). Insulin or IGFs were used separately or together at concentrations 
appropriate for the experiment (detailed in the text). 
Defined medium with components omitted (Chapter 5) 
The hormones progesterone, triiodothyronine, thyroxine and dexamethasone were 
omitted from defined medium either singly or all together. Survival experiments in 
these media were performed by plating the cells in deficient medium containing 
100ng/ml IGF-1 and, after 3hr, adding 280µ1 of the same medium containing 
lOOng/ml IGF-1 and 3ng/ml bFGF. 
Preparation of coverslips and substratum coating 
13mm diameter coverslips (BDH, Lutterworth, England) were sterilized by baking at 
140°C for 4 hr. Coverslips were coated with poly-L-lysine (PLL; >300,000 MW, 
Sigma) by incubating with a solution of lmg/ml PLL in deionised H2O for 24 hr at 
room temperature (RT). The coverslips were then washed over 3 days with 8 changes 
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of sterile deionised water and air dried. The coverslips were stored dessicated for at 
least one month prior to use. 
Wells of plastic 4-well multidishes (Nunc, Gibco Life Technologies, Scotland) were 
coated with 250µl of a lower concentration PLL solution, 20pg/ml, and incubated for 
2 hr at RT. The solution was removed and the wells were air dried without washing, 
and kept for a week prior to use. 
For laminin coating, coverslips or wells previously coated with PLL were used. 
Laminin (Gibco Life Technologies) was diluted in DMEM to a final concentration of 
20pg/ml from a 1mg/ml stock solution and incubated on coverslips at RT for 1 hr. 
The volume of laminin used was either 10 or 20pl on coverslips and 50µ1 in wells. 
Fibronectin (Gibco Life Technologies) was diluted from a 1mg/ml stock solution in 
DMEM to a final concentration of 25µg/ml and incubated on PLL coverslips for 1 hr 
at RT, as above. 
Collagen, in the form of acid soluble rat tail collagen (produced by the method 
described in Bergsteinsdottir et al., 1993), was used at an approximate concentration of 
10µg/cm2 on glass coverslips. The collagen was air dried onto the coverslips 
overnight and the coverslips washed three times with sterile distilled water then once 
with medium before use. 
Preparation of Schwann cell precursor cultures 
Schwann cell precursors were prepared essentially as described in Jessen et al. (1990). 
Sciatic nerves were dissected from embryos of varying ages, from E14 to E18. The 
nerves were cut into small pieces and incubated with 6O01il enzyme cocktail solution 
at 37°C in 5% C02/95% air. Enzyme cocktail solution consists of Kreb's solution 
without calcium and magnesium (12mM NaCl, 4.7mM KC1,1.2mM KH2PO4,11mM 
glucose, 1: 50 amino acid solution (Gibco Life Technologies) buffered with NaHCO3), 
with 3mg/ml collagenase (type 2; Worthington Biochemical Co., Freehold, N. J., 
USA), 1.2mg/ml hyaluronidase (Sigma) and 0.3mg/ml chick egg white trypsin 
inhibitor (Sigma). The tissue was incubated for 1 hr, triturated through a lml pipette 
tip then through a 200µ1 pipette tip, before being reincubated for a further 20 min, 
with trituration through a 200µl pipette tip after 10 min and at the end of the 20 min 
reincubation. The cell suspension was transferred to a centrifuge tube, the volume 
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made up to 10ml with DMEM containing 10% FCS (Advanced Protein Products, 
Brierley Hill, England), and centrifuged at 1000rpm for 10 min. In experiments 
described in Chapter 5, this was followed by a further wash with 10ml DM to remove 
any serum present. In Chapter 6, DM alone was used to make the volume to 5ml 
before centrifugation. The cells were resuspended in DM containing growth factors 
appropriate to the experiment (described in the text). After counting, the cells were 
plated out onto glass coverslips or plastic 4-well multidishes depending on the 
experiment. The drop size and number of cells depended on the type of assay to be 
undertaken, these details are given in the text. The cells were incubated for 3 hr at 
37°C in 5% C02/95% air before topping up with medium required by the experiment. 
K. R. Jessen performed the embryonic dissections for chapters 3-5, and many 
dissections for chapter 6. 
Preparation of neonate Schwann cells 
Sciatic nerves of newborn rat pups were dissected and the epineurial sheaths removed 
prior to dissociation in enzyme cocktail solution as detailed above. After digestion in 
enzyme for 1 hr at 37°C in 5% C02/95% air, the tissue was dissociated by sequential 
trituration through a lml pipette tip and a 2O01il pipette tip. No reincubation with 
enzyme was necessary. The cell suspension was made up to 10ml with DM, 
centrifuged and resuspended in DM. The plating medium differed in the growth 
factors added, containing 1µM insulin (Sigma) (Chapters 3 and 4), either 1µM 
recombinant insulin (Sigma) or 100ng/ml IGF-1 (Kabi Pharmacia, Uppsala, Sweden) 
in Chapter 5 (as described in the text), and 1nM recombinant insulin in Chapter 6. 
Cells were counted and plated as described previously. 
Survival assay 
Following incubation of the cells at 37°C in 5% C02/95% air for three hours, 28Oµ1 of 
appropriate medium were added to each well. Three coverslips were incubated for a 
further 5 min, then fixed. Fixation was either for 20 min in 2% paraformaldehyde 
(BDH) with the coverslips mounted unstained on glass slides, or the cells were 
prefixed for 5 min with 2% paraformaldehyde in phosphate buffered saline (PBS) 
followed by labelling for either the p75 low affinity nerve growth factor receptor 
(p75LNGFr; a gift from Dr. E. Johnson Jr. ) or L1 (Sweadner, 1983; a gift from Dr. A. 
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Furley). The remaining coverslips were cultured at 37°C and stained for p75LNGFr 
or L1 at a time point appropriate for the experiment. For the standard survival assay, 
the cells were fixed and labelled at 20 hr post-plating. 
The number of cells that had attached and flattened at 3 hr and were positive for 
p75LNGFr (Chapters 3,4, and 5) or Ll (Chapter 6) were taken to be the original 
starting population, survival was calculated as the proportion of these cells still alive 
after the culture period and expressed as a percentage. 
Long term survival assays (Chapters 5 and 6) 
The medium of long term cultures was replaced using fresh growth factor aliquots 
each day. As before, the number of cells surviving at the end of the culture period was 
calculated relative to the number of cells alive and flattened 3 hr post-plating. 
Subculture and replating of long term cultures (Chapter 6) 
Cells were cultured at an initial density of 12,000 cells per S0µ1 drop on PLL coated, 
laminin-coated plastic culture wells. To subculture the cells, the wells were rinsed 
briefly in versene (0.2% EDTA in PBS) and incubated for 4 min with l00µ1 versene 
and 40µl enzyme cocktail. The cells were triturated and transferred to a centrifuge 
tube that had been coated with defined medium. The cells were centrifuged at 
1000rpm for 10 min at 4°C and resuspended in defined medium with 1nM 
recombinant insulin and 100ng/ml IGF-1. They were then plated at 2000 cells in 20µl 
drops on laminin-coated glass coverslips and incubated for 3 hr at 37°C in 5% C02/ 
95% air. The wells were topped up with 300p1 defined medium containing 1nM 
recombinant insulin and 100ng/ml IGF-1. In assays for the mitogenic effect of bFGF 
with the cAMP elevating agent forskolin, the medium also contained 3ng/ml bFGF 
and 5µM forskolin (Calbiochem-Novabiochem, San Diego, USA). Some coverslips 
were taken at this 3 hr point and stained for L1 or double-labelled for p75LNGFr and 
S100 (see below). 
Growth factors 
Epidermal growth factor (EGF) was supplied as a stock solution of 100µg/ml in 
DMEM with 1% FCS (a gift from Dr. F. Watt, ICRF); recombinant PDGFs AA and 
BB (both PeproTech Inc, NJ, USA) were reconstituted in 4mM acetic acid and further 
diluted in PBS to a stock concentration of 2µg/ml. Recombinant human Neu 
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differentiation factor-02 (NDF-ß2; Amgen, Thousand Oaks, CA, USA) was diluted in 
PBS with 0.5mg/ml BSA to a stock concentration of 5gg/ml. Recombinant human 
transforming growth factor-ß1 (TGF-ß 1; Boehringer Mannheim, Lewes, England) and 
purified porcine TGF-02 (R &D systems, Abingdon, England) were reconstituted in 
4mM HC1 with 10 mg/ml BSA to a stock dilution of 1 pg/m1. Murine stem cell growth 
factor (SCF, mast cell growth factor, steel factor; a gift from Immunex, Seattle, USA) 
was supplied as a stock solution of 100µg/ml in 100mM Tris pH 7.4. Purified nerve 
growth factor (NGF; a gift from Dr. J. Winter, Sandoz Institute, UCL. ) was supplied 
in medium at a concentration of approximately 5gg/ml. Recombinant human acidic 
fibroblast growth factor (aFGF, FGF-1; a gift from Dr M. Jaye, Rohrer 
Biotechnology) was supplied as a stock solution of 800gg/ml and was used from a 
substock of 8.1g/ml made monthly in 1M NaCl in 10mM Tris pH7.4 and kept 
refrigerated. Recombinant human Kaposi's sarcoma fibroblast growth factor (K-FGF, 
FGF-4), stock concentration of 43µg/ml, and a fragment of this molecule, K-140, 
stock concentration of 41.5pg/ml were gifts from Dr. C. Basilico. Recombinant 
human endothelin-1 (ET-1; Cambridge Research Biochemicals) was dissolved in 0.1% 
acetic acid to a concentration of 1mM and then diluted to 10µM in L15 with 0.1% 
BSA. Recombinant endothelin-2 (ET-2) and endothelin-3 (ET-3) were were gifts 
from Dr. P. Milner, UCL, supplied at a concentration of 10µM in PBS. 
Stock solutions of all other growth factors were made in L15 medium with 10mg/ml 
BSA. The sources of the other growth factors are as follows: 
Recombinant human insulin-like growth factors I and II (IGFs I and II) were from 
Kabi Pharmacia, stock concentrations 10mg/ml. Basic fibroblast growth factor 
(bFGF) was from both PeproTech, and R&D systems, with a stock concentration of 2 
pg/ml. Brain derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) were a 
gift from Dr. G. Dechant and Dr. Y. Barde, stock concentrations of 2 µg/ml. Ciliary 
neurotrophic factor (CNTF), stock concentration 100pg/ml, and NT-4, stock 
concentration 2 µg/ml were gifts from Regeneron, Tarrytown, USA. a-melanocyte 
stimulating hormone (a-MSH; Sigma) was at a stock concentration of 10µM. 
Recombinant murine leukaemia inhibitory factor (LIF) was a gift from Drs. L Grey 
and J. Heath, stock concentration 10µg/ml. 
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TPA (12-O-Tetradecanoylphorbol 13-acetate; Sigma) was at a stock of 2.5mM in 
ethanol and calcium ionophore A23187 (Sigma) was at a stock concentration of 
100µM in ethanol. Heparin (Sigma) was kept at a stock concentration of 20µg/ml. 
All growth factors were aliquoted into 10 or 20µl aliquots, (50 and 100µ1 aliquots in 
the case of IGFs 1 and 2), and stored refrigerated or frozen at -70°C as appropriate. 
Fresh aliquots were taken for each experiment and when changing the medium daily 
on long term cultures. 
Neurone culture 
Cultures of dorsal root ganglia neurones were prepared from newborn rats. The 
ganglia were removed, trimmed and incubated with 1.25mg/ml trypsin (Gibco Life 
Technologies) in Kreb's solution without calcium and magnesium, for 20 min at RT. 
An equal volume of DMEM containing 10% donor calf serum (CS; Sigma) was added 
and the ganglia dissociated by drawing the tissue through decreasing diameter needles 
(0.8mm, 0.6mm and 0.5mm) three times through each needle. Leaving the larger 
pieces of tissue behind, the cell suspension was centrifuged at 1000rpm for 10 min and 
the cells resuspended in DMEM containing 5% horse serum (HS, hybrimax; Sigma), 
5% CS and 1µM insulin. The cell suspension was plated out on PLL-coated 35mm 
petri dishes (Nunc, Gibco Life Technologies) and NGF added at a final concentration 
of 50ng/ml. 
To purify the cultures, 10µM cytosine arabinoside (Ara C; Sigma) was added for the 
first three days in culture, the cells were then switched to the same medium without 
Ara C for 2-3 days and back into Ara C containing medium for a further 4-5 days. 
The cells were then pulsed with Ara C in this medium as required to maintain 
optimally pure neuron cultures. These cultures contained between 800,000 and 
1,200,000 neurones per petri dish, calculated by counting cells in a representative field 
and extrapolating this count to the area of the petri dish. 
Neurone conditioned medium 
Cultures of neurones were changed into defined medium containing 2.5% CS and 
2.5% HS with 50ng/ml NGF for one day. They were then washed in defined medium 
and changed into 1.5m1 defined medium, with or without NGF, for conditioning. 
After 2 days, the defined medium was collected and replaced with a further 1.5m1 
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defined medium, to be conditioned for a further 2 days before returning the cultures to 
DMEM 5% HS, 5% CS and 50ng/ml NGF. 
The conditioned medium was either used fresh or stored frozen at -70°C in cryotubes 
(Nunc, Gibco Life Technologies) precoated with heat-treated BSA in PBS, (0.3% 
BSA in PBS heated to 80°C for 3 min), and washed in deionised water prior to use. 
Neural crest culture 
Culture of rat neural crest were carried out essentially as described by Smith-Thomas 
and Fawcett (1989) and Bannerman and Pleasure (1993). Ell embryos of 18-26 
somites were used. The most caudal 6-8 somites and a small piece of contiguous non- 
segmented tail region were excised using fine needles. After trimming off 
accompanying tissue, the neural tubes were incubated in 0.1% collagenase in Kreb's 
solution without calcium and magnesium for 15 min on ice and then for 10 min at 
37°C. The tissue was transferred to L15 medium containing 10% FCS and ing/ml 
bFGF on ice. The neural tubes were cleaned of surrounding somites by pipetting 
through a wide bore glass pipette and by teasing with fine needles. The cleaned tubes 
were transferred to defined medium without dexamethasone, containing 2% FCS, and 
ing/ml bFGF prior to plating in a drop of this medium on PLL-coated, fibronectin- 
coated coverslips. After 2 hr incubation at 37°C, the cultures were flooded with the 
same medium. Outgrowth of neural crest cells could be seen by 20 hr post-plating. 
In some experiments to determine the survival requirements of neural crest, neural 
tubes were dissected in serum-free conditions using L15 medium or DM as described 
above but supplemented with 3ng/ml bFGF and 100ng/m1 IGF-1. After culture for 20 
hr the neural tubes were excised using fine needles and either the medium exchanged 
or the cells replated as described for Chapter 6. The medium used for survival 
contained 100ng/ml IGF-1,1nM insulin and either 3ng/ml bFGF, 1.5ng/ml NDF or 
IOnM ET-1. 
Immunohistochemistry 
Prefixation of coverslips was performed in the culture wells by addition of an equal 
volume of 4% paraformaldehyde (final paraformaldehyde concentration 2%). 
Fixation was for 5 min at RT, after which the coverslips were removed from the 
culture wells, washed and incubated with the relevant antibodies. 
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Antibodies used on live cell cultures or cells prefixed for 5 min with 2% 
paraformaldehyde were diluted in modified Eagle's medium (MEM; Gibco Life 
Technologies) containing 15mM Hepes (N-2-hydroxyethylpiperazine-N'-2- 
ethanesulphonic acid, Sigma) (MEM-H) and 10% CS. Washes between antibody steps 
were in MEM-H. 
Antibodies used on fixed cell cultures were diluted in antibody diluting solution (PBS 
containing 10% CS, 0.1M lysine (Sigma) and 0.02% sodium azide (Sigma)). 
Post-fixing washes were in PBS. 
After antibody labelling and fixation, all cultures were mounted on glass slides in 
Citifluor anti-fade medium (UKC, Canterbury, UK) and sealed. 
Conjugated antibodies 
Fluorescein-conjugated goat anti-mouse and goat anti-rabbit Igs, and tetramethyl 
rhodamine-conjugated goat anti-mouse and goat anti-rabbit Igs were from Cappel, 
Organon Teknika, Durham, USA. These second layers were preabsorbed against 
immobilized rabbit and mouse Igs to remove cross-reacting antibodies as described 
below. Biotin-conjugated sheep anti-mouse and sheep anti-rabbit antibodies, and 
streptavidin-fluorescein were from Amersham Life Sciences, Amersham, England. 
These were used without preabsorption at a dilution of 1: 100. 
Removal of cross-reacting antibodies in second layers 
Sepharose-linked immunoglobulins were packed into two columns of 0.5m1 bed 
volume on nylon wool. The columns were washed in PBS and the relevant conjugated 
antibody was run through the columns in succession, using a small amount of PBS to 
elute the last of the unbound antibody. The columns were regenerated with 15m1 5M 
magnesium chloride followed by 7ml PBS. Sodium azide was added to the purified 
antibody at a final concentration of 0.02% prior to storage. The titre of each batch of 
antibody was tested before use and adjusted so that fluorescein-conjugated anti-mouse 
Igs and rhodamine-conjugated anti-rabbit Igs were used at dilutions of 1: 100, and 
rhodamine-conjugated anti-mouse Igs and fluoresein-conjugated anti-rabbit Igs were 
used at dilutions of 1: 200. 
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BrdU incorporation and visualization 
Cells were exposed to either 20µM BrdU (Boehringer Mannheim) for the last 1.5 hr of 
culture or to 10µM BrdU for the whole culture period. They were then prefixed for 5 
min in 2% paraformaldehyde and stained with either p75LNGFr or L1 as detailed 
below. Fixation in methanol at -20°C for 10 min was followed by incubation with 2N 
hydrochloric acid (HC1) for 20 min at RT. Following extensive washes in PBS, the 
cells were treated with 0.1M sodium borate, pH 8.5, for 10 min to neutralize any 
remaining acid. The coverslips were drained and incubated with anti-BrdU antibody 
(Gratzner, 1982; a gift from Dr D. Mason) diluted 1: 100 in PBS containing 0.1% 
triton-X100 (BDH) for 1 hr at RT. The anti-BrdU antibody was visualized with 
rhodamine-conjugated goat-anti-mouse immunoglobulins diluted 1: 200 in PBS 
containing 0.1% triton-X100 for 30 min before washing and mounting on slides. 
p75LNGFr 
The monoclonal antibody 192-IgG, against the p75LNGFr was a gift from Dr. E 
Johnson Jr. (Taniuchi et al., 1986), was used at 1: 100 from hybridoma supernatant, or 
1: 500 when in the form of ascites. The monoclonal antibody 217c, also recognising 
p75LNGFr (Ferrari et al., 1991) was used in the form of culture supernatant at 1: 200. 
The antibody was incubated on prefixed cultures for 30 min at RT. 
L1 
The monoclonal antibody ASCS4, against L1 (Sweadner, 1983; a gift from Dr. A. 
Furley) was used in the form of neat hybridoma supernatant or at a 1: 1 dilution with 
MEM-H 10%CS on prefixed cells. Incubation was for 1 hr at RT, followed by biotin- 
conjugated anti-mouse Igs for 30 min and streptavidin-fluorescein for 15 min. 
Rabbit anti-L1 (a gift from Dr. M. Schachner; Rathjen and Schachner, 1984) was used 
at a dilution of 1: 200 for 30 min on live cells without prefixation. This polyclonal 
antibody was used exclusively for Chapter 3 and is not the same as that used 
throughout the rest of this thesis. 
S100 
Following labelling for p75LNGFr, the cultures were fixed with 4% paraformaldehyde 
for 20 min and treated with methanol at -20°C for 10 min. To remove non-specific 
background, the coverslips were incubated with 3% gelatin (type 2, bovine skin, 
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Sigma) in PBS for 30 min, then incubated with anti-S100 (Dakopatts, Copenhagen, 
Denmark) diluted 1: 10,000 overnight at RT. The label was visualized using sheep 
anti-rabbit biotin for 30 min, followed by streptavidin-fluorescein for 15 min. Control 
coverslips for this label omitted the anti-S 100 antibody and were incubated in antibody 
diluting solution alone. 
GAP-43 
Cultures were fixed in 4% paraformaldehyde in PBS for 20 min, followed by 
methanol at -20°C for 10 min. Rabbit anti-GAP-43 antibody (Curtis et at., 1991; a 
gift from Dr. R. Curtis) was used at a final dilution of 1: 1000 for 30 min. 
Vimentin 
Cultures were fixed in 95% ethanol, 5% acetic acid (acid alcohol), for 15 min, 
followed by 0.3% triton-X100 in PBS for 20 min. A mouse monoclonal antibody to 
vimentin (Boehringer Mannheim) was used at 1: 100 for 30 min. 
NCAM 
Rabbit anti-NCAM (Gennarini et at., 1984) was used at a dilution of 1: 500 for 30 min 
on cells after prefixation of cultures with 2% paraformaldehyde for 5 min. 
A5E3 
The mouse monoclonal antibody A5E3 in the form of ascites (Mirsky et at., 1985) was 
used at a dilution of 1: 500 on live cells for 30 min. 
Ran-2 
Purified mouse monoclonal antibody Ran-2 (Bartlett et al., 1981) was used at a 
dilution of 1: 50 for 30 min on live cells. 
04 
Mouse monoclonal antibody 04 (Sommer and Schachner, 1981) in the form of 
hybridoma supernatant was used at a dilution of 1: 1 for 30 min on live cells. 
Galactocerebroside 
Mouse anti-GaIC, a monoclonal antibody in the form of ascites (Ranscht et al., 1982), 
was used at a dilution of 1: 100 on live cells for 30 min. 
GFAP 
Cultures were fixed in acid alcohol for 15 min, followed by treatment with 0.3% 
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triton-X100 in PBS for 20 min. Rabbit antiserum to glial fibrillary acidic protein 
(GFAP; Dakopatts) was used at a dilution of 1: 100 for 30 min. 
Laminin 
Rabbit polyclonal anti-laminin (a gift from Dr. R. Timpl) was used at dilution of 1: 500 
on live cells cultured on fibronectin-coated coverslips. 
Rat 401/Nestin 
Mouse monoclonal antibody (Friedman et al., 1990) in the form of hybridoma 
supernatant, was used neat on cells that had been fixed in 4% paraformaldehyde for 20 
min and then treated with methanol for 10 min at -20°C. 
Po 
Rabbit polyclonal anti-Po was generated in the laboratory essentially as described by 
Brockes et al., 1980 (Morgan et al., 1994). The antiserum was purified by incubating 
with chloroform-extracted newborn rat skin for 48 hr, followed by precipitation with 
caprylic acid, then 40% ammonium sulphate. 
Cells were fixed in 2N HCl for 15 min, washed extensively in PBS then further 
neutralized with 0.1M sodium borate solution for 10 min. The cells were then blocked 
for 2 hr with antibody diluting solution, washed and incubated in anti-Po. The 
antibody was used at a dilution of 1: 1000 for 2 hr to detect high levels of protein 
expression found in myelinating Schwann cells, and at 1: 200 overnight at 4°C to 
detect low levels. Both concentrations were visualized using fluorescein-conjugated 
anti-rabbit Igs. 
Myelin basic protein, (MBP) 
Monoclonal antibody to MBP (Boehringer Mannheim) was used at a concentration of 
1: 200 overnight on cells fixed in 4% paraformaldehyde for 20 min. 
Hoechst staining 
A stock solution of lmg/ml Hoechst dye H33258 (bisBenzimide; Sigma) in water, was 
diluted 1: 1000 in PBS and applied to fixed cell cultures for 10 min prior to mounting 
and viewing with Hoechst optics. 
Labelling of dying cells that had detached from the monolayers with Hoechst dye was 
performed as follows: the cells were spun for 10 min at 600rpm, and resuspended in 1 
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volume of PBS. They were then fixed by addition of 2 volumes of 4% 
paraformaldehyde for 10-15 min. The cells were resuspended in this fixing mixture 
and transferred dropwise to a washed nitrocellulose millipore filter (Schleicher and 
Schuell, Dassel, Germany) using absorbant paper to draw the liquid through the filter. 
The filter containing the cells was then washed twice with PBS, transferred to a petri 
dish and stained with Hoechst dye 1: 1000 in PBS for 20 min. 
Quantification 
Most results are based on three separate experiments, using duplicate or triplicate 
coverslips (occasionally quadruplicate coverslips). Where the results are from only 
one or two experiments this is stated in the text. 
At least 300 cells per coverslip were counted for BrdU incorporation, and at least 250 
cells per coverslip were counted for S 100 expression. 
Survival for all experiments is expressed as `percentage survival', referring to the 
number of cells surviving at the experimental timepoint relative to the number of cells 
alive and flattened at 3 hr post-plating. 
Error bars in the graphs indicate SEM, or SD in the case of experiments with only two 
repetitions. 
Microscopy 
All cultures were viewed using a Zeiss microscope and x 20, x 40 dry or x 63 oil 
immersion phase-contrast lenses. Epi-illumination was used with rhodamine, 
fluorescein or Hoechst filters. 
DNA fragmentation assay 
A total of 400,000-500,000 cells were plated at a concentration of 50,000 cells per 
well on PLL coated, laminin-coated culture wells, in defined medium with IW 
insulin. After 3 hr, the medium was removed and replaced with either NCM or 
defined medium with I µM insulin. At 5 hr or 7 hr post-plating, floating cells were 
harvested by centrifugation of the culture medium. Cells still attached to the substrate 
were washed briefly in PBS and lysed in 100µl lysis buffer (total volume), together 
with the cells harvested from the culture medium. The lysis buffer contained 10mM 
Tris (pH 8), 100mM NaCl, 1mM EDTA and 0.5% sodium dodecyl sulphate (SDS). 
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The samples were treated essentially as described by Davis et al (1986). Proteinase K 
(Fluka, Gillingham, England) was added to the lysates to a final concentration of 
200gg/ml which were then incubated for 3-18 hr at 50°C. After cooling to RT, RNase 
A (Gibco Life Technologies) was added to a final concentration of 200gg/ml and 
incubated for 30 min at 37°C. The samples were extracted twice with phenol : 
chloroform (1: 1) (both BDH) and the aqueous layer containing the DNA was taken for 
electrophoresis. 
Gel electrophoresis 
The samples were run on 1.7% agarose gel (Pharmacia, Milton Keynes, England) in 
lx TBE (0.09M Tris borate, 0.002M EDTA) with 0.5pg/ml ethidium bromide (Sigma) 
in the gel and with lx TBE as running buffer. The sample was diluted 1: 6 in loading 
buffer (30% glycerol in water, 0.25% bromophenol blue (Sigma)) and ethidium 
bromide was added to the sample (final concentration 40pg/ml) before loading 20µl 
per lane on the gel which was then run at 1OOmV for 1 hr. The gel was destained by 
soaking in deionised water, with several changes, for 1 hr. The DNA was visualized 
on a transilluminator and photographed using polaroid film at f16 for I second. 
63 
CHAPTER 3 




Rat Schwann cells have been studied in detail both in the perinatal and adult animal 
(Mirsky et al., 1990; Jessen et al., 1990; Morgan et al., 1991; Gould et al., 1992; 
Jessen and Mirsky, 1993; Stewart et al., 1993). Schwann cells from nerves of late 
embryonic rats (E18 and older) have a phenotype similar to that of cultured Schwann 
cells from later animals (reviewed in Mirsky and Jessen, 1990). There are few 
data available, however, about glial cells associated with nerves early in development. 
This chapter is a study of the glial cells associated with the sciatic nerve of early 
embryonic rats (and brachial plexus in the case of E14 rats) and defines the previously 
undescribed phenotype of the glial cells, Schwann cell precursors, associated with the 
nerves at E14-15. To understand the in vivo environment of these cells and the factors 
that may influence their development, there follows a description of the development 
of the peripheral nerve, in particular the rat sciatic nerve. 
Neuronal development and limb innervation 
The sciatic nerve is a mixed nerve with both motor fibres from the ventral spinal cord 
and sensory fibres from the DRG, originating from the lumbar spinal segments L4-L6. 
Neural crest cells that form the rat DRG begin to condense in the anterior half of the 
adjacent somite (or that of the more caudal somite) between Ell and E13 (Angulo, 
1951; Sobkowicz et al., 1973; Lawson et al., 1974). The development of the DRG and 
the differentiation of the neurones within the ganglia proceeds in a rostro-caudal 
manner with the DRG of the cervical region developing ahead of those in the lumbar 
region. In the rat lumbar ganglia, some large neurones stop dividing at El I and start 
to differentiate. The peak of this differentiation is seen at E12 for large ventrolateral 
neurones and E13 for the smaller dorsomedial neurones with most mitosis complete by 
E15 (Lawson et al., 1974). 
At the lumbar level in the rat embryo, the motor neurones start to project axons from 
the ventral spinal cord towards their target tissue at El 1. Axons of the DRG neurones 
start to grow out from the DRG at this time and join the motor axons to form loose 
bundles of nerves at E12 (Reynolds et al., 1991). These spinal nerves grow into the 
base of the hindlimb around E12, where they form a plexus of dense nerve bundles 
with axons projecting out into the surrounding tissue from the growing tip of the nerve 
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(Reynolds et al., 1991). A day later, the nerves are still tightly bundled and only 
e 
project a short way into the dev1loping hindlimb. During this time, the axons in the 
plexus defasciculate and reorganise, a process that has also been described in the chick 
hind limb (reviewed in Scott, 1987; Tosney and Landmesser, 1985). The nerve enters 
the proximal hindlimb at early E14; most axons at this time are still bundled in a 
plexus but the first branches are apparent, directed outward toward the skin (Reynolds 
et al., 1991). By E15 the nerves extend into two thirds of the developing limb and 
have started to branch into the developing muscles in the proximal limb. Increased 
branching of the nerve bundles is observed over the next few days and innervation of 
the most distal part of the hindlimb is detected by E19. Nerve terminals within the 
muscles are first apparent at E17, the branching of the terminals increases with time 
until fine sprays of immature terminals are apparent in all muscle nerves by E21. 
Mature endplates are seen in the muscle from the second postnatal day (P2), although 
they are associated with polyinnervation. Over the next two weeks, the terminals 
mature and synapses are eliminated so that a single axon is associated with each 
endplate (Reynolds et al, 1991). 
Intitiation of electrical activity 
In the rat embryo, spontaneous electrical activity can be detected in the lumbar DRG 
neurones from E16, peaking between E18 and E19 (Fitzgerald, 1987). The first action 
potentials to be recorded in the dorsal horn neurones, in response to stimulation of the 
skin of the hind limb, occur at E19, although electrical stimulation can produce a 
response as early as E17 (Fitzgerald, 1990). The peripheral nerves innervating the rat 
intercostal muscles have been shown to be excitable from E13 onward, a day earlier 
than the formation of nerve-muscle contacts in this region (Ziskind-Conheim, 1988). 
Action potentials can be recorded in these nerves prior to myelination, with the 
conduction velocity increasing as the axon diameter increases. The initiation of 
electrical activity in the developing nerves correlates with development of spontaneous 
movement (E15 forelimb and E16 hindlimb) and reflexes (E16 forelimb and E17-18 
hindlimb) (Narayanan et al., 1970). 
Neural crest origin of peripheral nerve glial cells 
In an early experiment on neural crest, Harrison (1924) showed in Rana (frog) that 
removal of the dorsal part of the neural tube prior to the migration of neural crest 
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resulted in a lack of DRG formation and an absence of sheath cells from the motor 
axons that projected into the periphery. He observed that, in normal embryos, the 
most distal sections of the axons are devoid of associated cells but, in the proximal 
sections, spindle-shaped sheath cells are closely associated with the axons. These cells 
migrate in a proximo-distal direction along the axons, except when they encounter the 
ventral roots, where migration appears to be directed along the roots toward the 
developing spinal cord. 
This close association of sheath (or glial) cells with developing axons and their 
migration along the nerves has been confirmed in more recent studies in the tadpole 
tail fin (Billings-Gagliardi et al., 1974), and chick limb (Weston, 1963; Loring and 
Erickson, 1987; Dahm and Landmesser, 1988; Carpenter and Hollyday, 1992a, 
1992b). In the chick, neural crest cells comigrate with developing spinal nerves, 
always in close association with the axons, but are absent from the most distal portion 
of the growing axons (Dahm and Landmesser, 1988; Carpenter and Hollyday, 1992b) 
a result confirmed in mouse (Bogusch, 1992). These cells are initially distributed in 
uneven groups along the axons, but with increased developmental age, the entire 
surface of the nerve bundles is ensheathed (Dahm and Landmesser, 1988). A few 
studies have indicated that Schwann cell precursors migrate ahead of the axons and 
may act as pathfinding glia (Noakes and Bennett, 1987; Serbedzija et al., 1990; 
Haninec and Dubovy, 1992), but in Splotch mutant mice, where Schwann cells and 
DRG neurones are absent from lumbar regions due to failure of neurulation, motor 
neurones grow into the periphery with normal patterns of innervation, albeit at slower 
rates (Grim et al., 1992). 
There is some evidence in the chick embryo that cells associated with the proximal 
ventral roots are derived from the ventral neural tube and are not neural crest in origin 
(Weston, 1963; Loring and Erickson, 1987; Lunn et al., 1987). Other studies have 
shown that the glial cells that populate the ventral roots are of neural crest origin 
(Carpenter and Hollyday, 1992a; Bhattacharyya et al., 1994) and it is possible that the 
cells in this region of the developing nerve are a mixture of neural tube and neural 
crest cells. 
In the chick, removal of the ventral neural tube just prior to motor axon outgrowth and 
neural crest migration does not prevent neural crest migration to the ventral root 
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region of the embryo (Bhattacharyya et al., 1994). The loss of axons, however, 
prevents the arrest of the neural crest cells in this area, and results in the complete 
absence of Schwann cells in this region at later developmental stages. No increase in 
cell death is observed in this region in the absence of motor axons suggesting that the 
cells continue to migrate, possibly to associate with the axons of the developing 
sensory neurones. 
Glial-axonal relationships in the developing nerve 
Ultrastructural studies reveal that, in the rat, the glial cells associated with early 
developing nerves, at E14, are found around the perimeter of nerve axon bundles, 
separating the axons from the surrounding mesenchyme (Peters and Muir, 1959; 
Jessen et al., 1994), and many nuclei are present within the bundles in the larger 
branches of the nerve (Jessen et al., 1994; Hashimoto and * Jessen, personal 
communication). These cells have fine processes that extend into the bundles of 
tightly packed, small diameter axons, each glial cell being in contact with many axons; 
the slender processes of the glial cells separate the axons into domains. No basal 
lamina is found in the nerve at this time. 
Although there is extensive proliferation of the glial cells in the nerve at E14, there is a 
dramatic peak of proliferation of Schwann cells, between E17 and E21, the day of 
birth (Peters and Muir, 1959; Stewart et al., 1993). As a result of glial cell 
proliferation and neuronal death, the number of glial cells within the nerve increases 
with concommitant decrease in the number of axons associated with each glial cell 
(Peters and Muir, 1959). Basal lamina is first detected in the nerve at E16-17 
(Bignami et al., 1984). 
By birth, some Schwann cells are associated with single, large diameter axons, but 
many Schwann cells enfold several smaller diameter axons. Maturation of the nerve 
takes place over the next five to six weeks, by which time single, large diameter axons 
are found in association with myelin-forming Schwann cells and groups of small 
diameter axons are ensheathed by non-myelin-forming Schwann cells (Webster and 
Favilla, 1984; Jessen and Mirsky, 1990). Myelination of axons in a 1: 1 relationship 
with Schwann cells begins at birth and is preceeded by withdrawal of the cells from 
the cell cycle (Stewart et al., 1993). 
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This chapter describes the first stages of the characterization of the rat Schwann cell 
precursor, a cell that can be isolated from the embryonic sciatic nerve at E14. Using 
embryonic nerves from different ages, the changes in morphology, expression of the 
Schwann cell marker SlOO and survival ability in the absence exogenous growth 
factors of these cells during embryonic development will be described. 
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RESULTS 
Glial cells isolated from early embryonic nerve exhibit morphological and 
phenotypic differences from perinatal Schwann cells 
Schwann cells isolated from perinatal nerves (E17 to newborn) expressed both the low 
affinity p75 nerve growth factor receptor (p75LNGFr) and the calcium-binding protein 
S100 (Fig 3.1, D, E, F). When limb nerves from E14 and E15 embryos were 
dissociated and the cell suspension plated on laminin-coated coverslips, 95% ±4 
(SEM, n=4) of the cells were found to express p75LNGFr, as determined by the 
antibodies 192-IgG (Fig 3.1 B) and 217c (Ran-1) (not shown). However, the C2'- 
binding protein S100 that is ubiquitously expressed in perinatal and adult peripheral 
glia was not detected in the embryonic Schwann cells (Fig 3.1 C) using 
immunohistochemical techniques that stained cells from E17 and older nerves (Fig 3.1 
F). 
Morphological differences between cells isolated from E14 nerves and perinatal nerves 
were obvious from about 3 hr in culture. The early glial cells, plated onto laminin- 
coated coverslips, exhibited an epithelial morphology, forming flattened groups of 
cells with extensive contacts between the cells (Fig 3.2 A). In contrast, cells from 
newborn nerves under the same conditions exhibited an elongated bi- or tripolar 
morphology with little contact between the cells (Fig 3.2 B). An intermediate 
morphology was seen in cells from late embryonic nerves (E17 and E18, Fig. 3.2 C). 
Expression of S100 is developmentally regulated in peripheral nerve glial cells 
Limb nerves from embryonic rats of different developmental ages, E14-E18 and 
newborn, were dissociated and plated out on laminin-coated coverslips. At 3 hr post- 
plating, the cells were stained for p75LNGFr and S 100. The percentage of 
p75LNGFr+ cells that also expressed S 100 is shown in Fig. 3.3. 
No S100 expression could be detected in cultures from E14 and E15 nerves. The 
expression of S 100 was first seen in the nucleus and rapidly spread to the surrounding 
cytoplasm at E16. By E17 the majority of p75LNGFr+ cells also expressed 
cytoplasmic SlOO. The level of SlOO immunolabelling seen in the cytoplasm 
increased from E17 through to birth, suggesting that the level of S100 protein 
continued to increase in these cells. 
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Culture in defined medium distinguishes embryonic glia from newborn Schwann 
cells 
Dissociated nerves from E14 rats were plated out in defined medium with 1µM 
insulin, 4000 cells per 20pl drop, on laminin-coated coverslips. At 3 hr, the coverslips 
were either fixed and stained for p75LNGFr or topped up with defined medium 
containing insulin and cultured for a further 17 hr before staining for p75LNGFr. 
Parallel experiments with nerves from newborn rats were performed under the same 
conditions. 
At 3 hr, cultures from both E14 and newborn nerves showed similar numbers of cells 
that had attached and flattened, and appeared to be healthy; for newborn cultures this 
was 2095 ± 125 cells (SEM, n=4) and for E14 cultures 2523 ± 230 cells (SEM, n=10) 
(Fig 3.5 A). 
A dramatic difference was observed at 20 hr: the cultures of newborn Schwann cells 
contained bi- and tripolar cells with almost all cells present at 3 hr surviving to 20 hr 
under these culture conditions (Fig 3.4). In the cultures of E14 cells, however, there 
were very few cells left alive (Fig 3.4). These cultures contained mainly cell debris 
and rounded, dead or dying cells (Fig 3.5 B). The manner of this death will be the 
subject of Chapter 4. 
When tissue from the surrounding mesenchyme was cultured in the same way as the 
embryonic nerves, many cells survived cultured in defined medium. The surviving 
cells looked like early fibroblasts, with short bi- or tripolar processes; cell-cell contact 
was limited (not shown). Of these cells, less than 5% expressed levels of p75LNGFr 
seen in the cultures of E14 nerve. 
Developmental age determines survival ability in defined medium 
Using similar procedures to those described above, limb nerves from newborn rats and 
embryonic rats of different ages (E14-E18) were dissociated and cultured for 3 hr and 
20 hr in defined medium with 1µM insulin. The number of p75LNGFr cells 
surviving at 20 hr was plotted as a percentage of the cells that had flattened at 3 hr 
(Fig 3.6). 
At E14 and E15, less than five percent of the p75LNGFr+ cells survived to 20 hr. The 
ability to survive in defined medium began to appear in cells isolated from E16 nerves; 
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about 15% of the cells survived to 20 hr. By E17, this number had risen to 
approximately 90%. At E18, the number of cells surviving at 20 hr was equal to that 
seen with Schwann cells isolated from newborn rat nerves. 
Plating density does not affect survival of glial cells from E14 cultures 
To determine whether the plating density affected the survival of E14 cells, cells were 
dissociated and plated at different densities in defined medium containing 1µM 
insulin. 1,000,4,000 and 16,000 cells were plated in 20gl drops on laminin-coated 
coverslips and the number of p75LNGFr+ cells surviving at 20 hr were counted (Table 
3.1). 
No difference in survival was detected in the different plating densities; essentially the 
same proportion of cells died even at the highest density. Thus, it appears that these 
early glial cells do not produce autocrine growth factor(s) that promote their survival. 
Cell division does not account for the increased number of cells surviving with 
increased developmental age 
To determine whether division of a subpopulation of the cells in culture was 
contributing to the number of cells surviving at 20 hr, cells were dissociated from E17 
and newborn nerves and plated, as described previously, in defined medium with 1 µM 
insulin. 20µM BrdU was added for the last 1.5 hr of the 20 hr culture and the cultures 
were then stained for p75LNGFr and BrdU incorporation. 
In three separate experiments, with triplicate coverslips, the percentage of p75LNGFr+ 
cells that had incorporated BrdU into their DNA in E17 cultures was 1.0,0.5 and 0, 
and in newborn cultures, 1.0,0.6 and 0.9 (both averages less than 1%). 
Neurone-conditioned medium can prevent the death of E14 glial cells 
Since the E14 glial cells do not appear to produce an autocrine growth factor under 
defined conditions in vitro, and since in vivo they are in intimate contact with axons of 
the growing nerve, defined medium conditioned by DRG neurones was used to see if it 
could support the early glial cells in culture. 
Defined medium containing 1 µM insulin was conditioned by purified cultures of DRG 
neurones for 2 days. E14 cells, plated in defined medium with insulin, were topped up 
at 3 hr with neurone-conditioned medium (NCM) and cultured for a further 17 hr. 
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At 20 hr, approximately 80% of the p75LNGFr cells were still alive (Fig 3.5 Q. The 
presence or absence of 50ng/ml of NGF in the medium prior to conditioning made 
only a small difference to the ability of the conditioned medium to promote survival: 
NCM without NGF produced survival that was 90% ±2 (SEM, n=2) of that seen in 
the presence of NGF. Defined medium with 1µM insulin and 50ng/ml NGF did not 
rescue E14 cells when not conditioned by neurones (see Chapter 5, table 5.1). 
To determine whether the NCM stimulated DNA synthesis in the rescued cells, 20µM 
BrdU was added to the E14 cells for the last 1.5 hr of culture. The cells labelled for 
both p75LNGFr+ and BrdU at 20 hr were counted. Using triplicate coverslips, the 
percentage of p75LNGFr+ cells that had incorporated BrdU was 1.0% ±1 (SEM, n=3). 
The molecular phenotype of E14 glial cells 
As described previously, the molecular phenotype of Schwann cells from late 
embryonic nerves is well known (reviewed in Mirsky and Jessen, 1990). 
Immunohistochemistry was used to establish the similarities and differences between 
the glial cells from E14 nerves and perinatal Schwann cells. 
Cultures of E14 cells were established on laminin-coated coverslips (except for 
staining for laminin expression where fibronectin was used as a substrate). 
Immunolabelling was performed at 3 hr and after 18 hr in NCM. No difference was 
seen between cells under the different conditions indicating that the phenotype was 
essentially unchanged after short-term culture. 
More than 90% of cells expressed the adhesion molecules N-CAM and L1, the surface 
antigens A5E3 and Ran-2, , and the 
intermediate filament protein vimentin (Fig 3.7). 
Both 192-IgG and 217c antibodies against p75LNGFr were bound by 95% of the cells. 
Using the rat 401 antibody to nestin, 95% of the cells were positive; weak surface 
labelling for the ECM molecule laminin could also be detected. 
As described earlier, S100 protein was undetectable in these cells, as was the 
intermediate filament glial fibrillary acidic protein (GFAP). The surface antigen 04 
and the lipid galactocerebroside (GaIC) were absent from the cells and the major 
Schwann cell myelin protein MBP was not detected. (Table 3.2). High levels of Po, 
comparable to those found in myelinating cells were not observed in the E14 cells. 
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However, low levels of Po expression could be detected specifically in the E14 glial 
cells when high levels of antibody were used (not shown). 
Are E14 glial cells migrating neural crest cells? 
The morphology of the E14 cells is strikingly similar to that of rat neural crest cells in 
culture To determine whether these cells were in fact neural crest cells, cultures of rat 
Ell neural tubes were made and the migrating crest cells stained after 2 days in 
culture, in parallel with cells from E14 nerve after 20 hr culture in NCM. 
Both cultures were double-labelled with antibodies to p75LNGFr and one of the 
following antibodies: N-CAM, L1, A5E3 or Ran-2. Both E14 glial cells and 
p75LNGFr+ neural crest cells expressed N-CAM, L1, A5E3 and Ran-2 (Table 3.2). 
However, a difference between precursors and neural crest cells was observed when 
the cells were labelled for the membrane phosphoprotein GAP-43. More than 95% of 
the E14 glial cells were positive for this antigen but it was undetectable on 
p75LNGFr neural crest cells. To confirm that GAP-43 expression was not due to 
differences in culture conditions, both neural crest cells and E14 glial cells were 
cultured in identical conditions (defined medium without dexamethasone, with 2% 
FCS and ing/ml bFGF). Again, GAP-43 was observed in E14 cells but not in neural 
crest cells (Fig 3.8). 
To determine whether there were differences in survival requirements for the neural 
crest and precursors, neural tubes were explanted as described in Chapter 2, but using 
3ng/ml bFGF and l00ng/ml IGF-1 instead of bFGF and serum. After 20 hr the neural 
tubes were excised and the neural crest either transferred into medium containing the 
growth factors to be tested, or the cells were replated as for Chapter 6, with addition of 
the same growth factors. Combinations of growth factors that support long-term 
precursor survival, namely 1.5ng/ml NDFß-2 and 100ng. m1 IGF-1, and 1nM ET-1 
with 100ng/ml IGF-1 (see Chapter 6) failed to support neural crest survival beyond 20 
hr after tube removal (data not shown). 
*(Smith-Thomas and Fawcett, 1989) 
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Table 3.1 The effect of density on cell survival 
Cells were plated in DM containing 1µM insulin in 20µl drops on laminin-coated 
coverslips. The cells were stained for p75LNGFr at 20 hr post-plating. Increasing the 
cell density from 1,000 cells/ 2Oµ1 to 16,000 cells/ 20µ1 did not increase the proportion 
of cells surviving 
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Table 3.1 Effect of density on cell survival 










Number of cells Mean survival at 
plated 20 hr 




SEM % of total cells 
(n=3) plated 
..................................... ............... 2 >1 
4000 20 10 >1 
16000 64 28 >1 
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Table 3.2 The molecular phenotype of E14 glial cells 
Cells isolated from E14 nerves were immunolabelled after 3 hr and 18-20 hr in culture 
in NCM as described in Chapter 2. Neural crest cells were immunolabelled after 20 hr 
in culture with bFGF and 2%FCS. In all cases where cells were positive, more than 
90% of the cells were labelled. 
77 
Table 3.2. Molecular phenotype of E14 glial cells 
Antigen E14 glialcells El I neural crest cells 
................................................. 5100 .................................................................... - 
............................................................... 
- 
p75LNGFr (192 Ig) + + 
p75LNGFr (217c) + + 
N-CAM + + 
L1 + + 
A5E3 + + 
Ran-2 + + 
Laminin + n. d. 
GAP-43 + - 
Vimentin + n. d. 
Nestin + n. d. 
GFAP - n. d. 
04 - n. d. 
GaIC - n. d. 
Po - n. d. 
MBP - n. d. 
(n. d. = not determined. ) The phenotypical analysis was performed on two sets 
of cultures for both E14 and neural crest cells. 
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Table 3.3 The molecular phenotype of Schwann cells 
The antigen expression for myelinating, non-myelinating and short term cultured 
Schwann cells is as reported in Gould et al., 1992 (also described in Table 1.1). 
Antigens in section 1) are expressed by mainly non-myelinating cells, 2) expressed by 
both myelinating and non-myelinating cells and 3) by myelinating cells. Antigen 
expression for precursors is as described in table 3.2 
a Present mainly at nodes of Ranvier. 
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Table 3.3 The molecular phenotype of Schwann cells 
.............................................................................................................................................................................................................................. Antigen Myelinating Non- Short term Schwann cell 
Schwann cells myelinating cultured precursors 
Schwann cells Schwann cells 
1) p75LNGFr - + + + 
N-CAM - + + + 
Ll ±a + + + 
A5E3 - + + + 
Ran-2 - + + + 
GAP-43 - + f + 
GFAP - + + + 
2) Vimentin + +++ 
Nestin + +++ 
s100 + ++- 
04 + +-- 
Ga1C + +-- 
3) Po + --- 
MBP + --- 
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Figure 3.1 Comparison of p75LNGFr and S100 expression between E14 and 
perinatal Schwann cells 
Schwann cells isolated from E17 rats and cultured for 3 hr in defined medium are 
shown in phase contrast in (D) and express the p75LNGFr as recognised by the 
antibody 192 Ig (E); these cells also express S100 (F). Nerves from E14 rats cultured 
under the same conditions are shown in phase contrast in (A). They also express 











Figure 3.2 Morphology of cells isolated from E14 nerves and perinatal nerves 
(A) At 3 hr post-plating, cells from E14 nerves exhibit a flattened, epithelial 
morphology, forming groups of cells with extensive cell-cell contacts. (C) Schwann 
cells from newborn nerves cultured under the same conditions exhibit an elongated bi- 
and tri-polar morphology. Cells cultured from E18 (B) nerves show an intermediate 
morphology, with some flattening of the cell body and more cell contacts than those 
seen in (C). (D), (E) and (F) show p75LNGFr expression on the cells shown in (A), 
(B) and (C) respectively. Bar = 40µm. 
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Figure 3.3 The developmental appearance of S100 immunoreactivity 
Cells freshly isolated from nerves of different developmental ages were double 
immunolabelled for p75LNGFr and S100. The change in the percentage of 
p75LNGFr+ cells that express S 100 immunoreactivity with increased developmental 
age is shown. Each point represents the average from three experiments, error bars 
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Figure 3.4 Comparison of survival in defined medium between E14 and newborn 
cells 
In a 20 hr survival assay, essentially all p75LNGFr' cells from E14 nerves die, 
whereas p75LNGFr+ cells from newborn nerves live. The percentage survival is the 
number of p75LNGFr+ surviving at 20 hr post-plating; expressed as a percentage of 
flattened p75LNGFr+ cells 3 hr after plating. The survival is an average from three 














Figure 3.5 Precursors cultured under different conditions - morphology and 
cellular relationships 
Three hours after plating in non-conditioned defined medium (A, 3H DM), E14 
precursors have flattened and formed small groups of cells. Seventeen hours later in 
the same medium (B, 20 H DM), the cells have died, leaving debris and rounded cells 
in the culture medium. If the cells are changed into NCM at 3 hr, they survive and 
appear 17 hr later (C, 20 H NCM) as extended, flattened cells, forming large cellular 
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Figure 3.6 Developmental regulation of survival ability in the Schwann cell 
lineage 
Using the 20 hr survival assay (described in legend to Fig 3.4), cells from nerves of 
different age rats show varied abilities to survive culture in defined medium. The 
ability to survive in this assay is acquired rapidly between E16 and E17. Each point 
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Figure 3.7 The antigenic phenotype of E14 precursors 
The cells were immunolabelled after culture in NCM for 18 hr with antibodies as 
indicated and photographed using fluorescence optics (upper panels) and phase 
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Figure 3.8 GAP-43 expression distinguishes precursors from neural crest cells 
E14 precursors (E14) and neural crest (('RI: ST) %ýere double immunolabelled for 
p75LNGFr and GAP-43. The photographs show a group of 10-15 E14 cells and the 
edge of a flattened sheet of crest cells migrating away frone the neural tube, both after 
20hr in culture. The p75LNGFr labelling is similar in both cases, whereas only the 
E14 cells are strongly immunolabelled with GAP-43 antibodies. Exposure times for 




Identification of the rat E14 glial cell in culture 
Cells isolated from the nerve at E14 expressed the low affinity p75LNGFr, as 
determined by the antibodies 192-IgG and 217c. These antibodies have been shown to 
label rat neural crest cells and Schwann cells in culture (Smith-Thomas and Fawcett, 
1989; Jessen et al., 1990; Bannerman and Pleasure, 1993). Unlike perinatal Schwann 
cells, however, the early glial cells did not express, or expressed at very low levels, the 
Cat+-binding protein S 100. This protein is a marker for all perinatal and adult 
peripheral glia and its absence could indicate that these cells are not of the Schwann 
cell lineage. Indeed, the developing muscle found in the limb at this time strongly 
expresses p75LNGFr (Yan and Johnson, 1988; Wheeler and Bothwell, 1992). 
However, the distinct pavement-like morphology, combined with the expression of 
other markers found in peripheral nerve, for example NCAM, L1, A5E3 and nestin, 
indicated that the cells isolated at E14 were not mesenchymal in origin. 
E14 glia can be distinguished from perinatal Schwann cells by morphology, S100 
expression and survival ability 
Schwann cells isolated from perinatal nerves can be cultured in defined medium where 
they exhibit a typical spindle-shaped morphology and can be identified by their 
expression of the Cat+-binding protein S 100. It was surprising, therefore, to find that 
glial cells from E14 and E15 nerves were strikingly different, with a squamous 
morphology, an absence of S 100 protein and a requirement for additional factors to 
enable the cells to survive culture in defined medium. 
Morphology 
Schwann cells taken from E18 and newborn (or older) nerves assumed an elongated 
bi- or tripolar morphology in culture, with few cell-cell contacts (Fig 3.2 B, Q. Cells 
from E14 and E15 nerves adopted a more epithelial morphology: flattened pavements 
of cells were formed, with extensive cell-cell contact and few elongated processes (Fig 
3.2 A). An intermediate morphology was seen at E16 and E17 (not shown), the cells 
having elongated processes but with more extensive cell-cell contacts than those seen 
at E18. 
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The morphology of the E14 cells was reminiscent of neural crest cells in culture, 
although the E14 cells appeared to have lamellar processes that were absent from the 
neural crest cells (compare Fig 3.2 A and 3.8) and the cell-cell. contacts were not as 
continuous as those seen in areas of crest cell outgrowth from cultured neural tubes. 
As described previously, E14 cells in vivo ensheath large numbers of small diameter 
axons with fine lamellar processes extending into the developing axonal bundles 
(Jessen et al,. 1994), these processes appear to be retained to some degree in vitro. 
With increased developmental age, the numbers of axons associated with each glial 
cell decreases (Peters and Muir, 1959; Webster et al., 1973). The change in 
morphology between the early glial cells and those found in the nerve from E17 
onward is likely to reflect the maturation of these cells, enabling them to assume the 
appropriate relationships with the growing axons that will eventually lead to the 
formation of myelin sheaths or non-myelinated fibres. 
S100 expression 
When cells of different developmental ages were dissociated, plated in very short term 
cultures, and immunolabelled with anti-S100 antibodies, a change in S 100 expression 
was seen with increasing developmental age. The expression of this Cat+-binding 
protein was first seen faintly in the nucleus at E15-E16 and appeared in the cytoplasm 
between E16 and 17. The level of expression, judged by the intensity of 
immunolabelling, increased with increasing developmental age up to birth. This 
appearance of S100 protein in cultured cells between E16 and E17 was also seen in 
sections of nerve from these ages (Jessen et al., 1994) indicating that S 100 expression 
is developmentally regulated in vivo. 
The appearance of S100 in peripheral glial cells during development has been 
documented in quail DRG (Holton and Weston, 1982a) and in chick DRG and sciatic 
nerve (Bhattacharyya et at., 1992). Holton and Weston (1982a) observed that glia 
isolated from embryonic quail DRG acquire low levels of S 100 expression when 
cultured in the absence of neurones. This expression is upregulated in the presence of 
neurones and appears to require cell-cell contact. The promotion by neurones of S 100 
expression in early glia has also been reported in co-cultures of rat embryonic retinal 
neurones and neural crest cells (Smith-Thomas et al., 1990). In these co-cultures, the 
differentiation of neural crest cells into Schwann cells, as determined by bipolar 
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morphology and S 100 expression, was enhanced by the presence of the neurones, both 
temporally and quantitatively. 
Since 5100 expression appears to be intimately associated with the Schwann cell 
precursor to Schwann cell transition, it is interesting to speculate on the role of this 
protein in this transition. S 100 belongs to the calmodulin-S 100-troponin C 
superfamily of proteins that contain EF-hand Cat+-binding sites (Donato, 1986; 
Zimmer et al., 1995). Three isoforms of S 100 have been described, dimers of a or ß 
subunits: S 100ao (a(x), S 100a (aß) and S 100b (ßß) (reviewed in Donato, 1991). Each 
subunit is a small acidic protein (approximately 10.5 kD) with two binding sites for 
calcium. The S l00ß subunit can also bind Zn 2+ with high affinity, which in turn 
increases the S 100 binding affinity for Ca2+ (Donato, 1991). 
Originally S100 was considered to be specific to the nervous system, in particular to 
glial cells, and has been used extensively as a marker for glia within the PNS. More 
recently, however, the different isoforms have been found in many cell types, but 
S 100b is very highly expressed in peripheral glial, and both S 100a and S 100b are 
found in glial cells of the CNS. The antibody used in these studies recognises both the 
a and ß subunits (technical information from Dakopatts) but Schwann cells have been 
reported to express only ß subunits (Spreca et al., 1989). Currently, there are 16 
proteins identified as members of the S100 family that show amino acid sequence 
homology and structural similarities; the expression of these proteins is cell-type 
specific (reviewed in Zimmer et al., 1995). The amino acid sequences of the S100 
proteins have been highly conserved between species suggesting an important 
biological role. 
There is increasing evidence that the S100 proteins are multifunctional and that they 
play an important role in modulating the response of cells to extracellular stimuli. The 
S 100 proteins are themselves modulated by calcium: binding of Ca2+ results in a 
conformational change which exposes amphipathic amino acids that are believed to 
bind to target proteins (reviewed in Zimmer et al., 1995). Some of the putative target 
proteins have been described in several cell types, but as yet there is an incomplete 
picture of the role of S 100 in the nervous system. 
An obvious function for S 100 is to control intracellular Ca2+ levels. The presence of 
high levels of Ca2+ have been reported to induce or prevent cell death depending on 
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the system under study. For example, treatment of thymocytes with glucocorticoids 
results in Ca2+-influx and apoptosis; this effect can be mimicked using the Cat+- 
ionophore A23187 and inhibited by removal of Ca2+ from the medium (Ellis et al., 
1991; Compton and Cidlowski, 1992). However, an increase in intracellular Ca2+ as a 
result of membrane depolarization of cultured sympathetic neurones acts to suppress 
death of these cells (Edwards et al., 1991). In Chapter 5, addition of Cat+-ionophore 
to precursors does not prevent death, and it may be that high intracellular levels of 
Ca2+ cause death in these cells. Because of the multiple binding sites for Cat+, 
expression of S100 could act as a buffer of Cat+-levels within Schwann cells. 
However, reports from work in skeletal muscle with S 100ao suggest that this form of 
S100 releases Ca2+ from sarcoplasmic reticulum (Zimmer et al., 1995) suggesting that 
simple control of Ca2+ levels is unlikely to be the prime function of S 100 in Schwann 
cells. 
S100 has been reported to act as a mitogen for C6 glioma cells and primary astrocytes 
(Selinfreund et al., 1991). Expression of S100 begins at a time when glial cell division 
starts to increase in the nerve, therefore it is possible that it is acting to control the 
response of the Schwann cell precursors to mitogens. It is expressed highly, however, 
in mature myelin-forming Schwann cells (Mata et al., 1990); these cell do not divide 
under normal conditions but will divide in the distal nerve after axotomy, a region 
where the level of expression of S 100 has been reported to decrease post-lesion (De 
Leon et al., 1991). 
There is some evidence for S 100 as a neurotrophic factor since it maintains embryonic 
chick cortical neurones in vitro (Winningham-Major et al., 1989) and promotes chick 
motor neurone survival in vivo (Bhattacharyya et al., 1992). It also stimulates neurite 
extension from cultured embryonic chick cortical neurones (Winningham-Major et al., 
1989) and sensory neurones from embryonic chick and rat DRG (Van Eldik et al., 
1991). These effects depend on disulphide linked dimers of S100ß and are blocked by 
the use of anti-S100 antisera. Treatment of the PC 12 cell line with S 100, however, 
results in an increased intracellular Ca2+ level and does not produce neurite extension, 
inducing the cells to die by apoptosis (Fano et at., 1993). Since S 100b expression 
appears to be coincident with the transition from the survival factor-dependent 
Schwann cell precursor to the Schwann cell that can be maintained with out additional 
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growth factors, it could be postulated that S 100 is a survival factor for Schwann cells. 
However, two observations from later work with Schwann cell precursors suggest that 
S 100 is not an absolute requirement for growth factor-independent Schwann cell 
survival: i) addition of exogenous S l00ß does not promote the survival of precursors 
(data not shown) and ii) when precursors are cultured in the presence of 
survival-promoting growth factors that allow progression to a Schwann cell 
phenotype, most cells become S 100+ and survive culture in defined medium, but a 
small proportion of cells survive under these conditions and do not express S 100 
protein (described in Chapter 6). 
S100 can act as a modulator of enzyme activity and has been shown to prevent the 
phosphorylation of several substrates of protein kinase C (PKC) such as GAP-43 and 
neurogranin (Sheu et al., 1994,1995; Lin et al., 1994). Perhaps more importantly, 
5100 has also been shown to affect proteins involved in the cytoskelton by inhibition 
of protein phosphorylation (Baudier and Cole, 1988). S 100 has both inhibitory and 
stimulatory effects on tubulin polymerization, increasing the microtubule disassembly 
rate in the presence of Cat+, possibly by sequestering tubulin, and decreasing the 
phosphorylation of the microtubule-associated -r protein leading to an increase in 
tubulin polymerization (Donato, 1985; Zimmer et al., 1995). 
Other cytoskeletal proteins are targets of S100: GFAP assembly into intermediate 
filaments is inhibited by binding of S100 to GFAP (Bianchi et al., 1993) and 
decreased S 100b expression in C6 gliomas results in promotion of the actin filament 
network (although this latter action is unlikely to be a direct effect of S100 on actin 
since there is no apparent binding of S100 to actin; Selinfreund et al., 1990). It is 
possible, therefore, that in the Schwann cell lineage S100 has a role in cell 
morphology. Normal C6 gliomas are bipolar, stellate cells that express S 100b, but if 
the level of S100b expression is decreased using antisense methods the cells assume a 
flattened fried-egg morphology (Selinfreund et al., 1990). It is intriguing in this 
context that the increase of expression of S100 in the Schwann cell precursors 
coincides with the change from a flattened squamous morphology to a bi-or tripolar 
one. Thus S100 maybe involved in the cytoskeletal changes associated with the 
precursor to Schwann cell transition, possibly by altering microfilament and 
intermediate filament assembly. 
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Most recently, MyoD, a member of the myogenic basic helix-loop-helix (bHLH) 
transciption factor family that activate muscle-specific genes, has been shown to 
contain a consensus sequence that binds calmodulin, S 100a and S 100b in a calcium- 
dependent manner (Baudier et al., 1995). The binding of calmodulin and S100a 
results in an inhibition of MyoD phosphorylation by PKC. Although the binding sites 
for calmodulin/ S 100 are distinct from the DNA binding domain of MyoD, binding of 
these proteins results in an inhibition of MyoD DNA binding activity. This study 
looked mainly at the S 100 protein found in high levels in developing muscle, S 100a, 
since this is most likely to be available for interaction with the MyoD transcription 
factor, but it raises another possible function of S100 within glial cells, that of 
transcription factor regulation. As yet, however, no bHLH transcription factors have 
been found in perinatal Schwann cells, and transcription factors that are known to play 
a role in Schwann cell development, such as those of the zinc finger family (Krox 20 
and Krox 24), the leucine zipper family (CREB, jun, C/EBPa) and the POU domain 
family (OCT 6/ SCIP/ tst-1, OCT 1) (reviewed in Stewart et al., 1996a) have not been 
shown to have S100 consensus binding sites. Therefore, the regulation of transcription 
factors by S 100 in the developing Schwann cell is purely speculative. 
Survival in defined medium 
In these studies, the appearance of S 100 expression and change in morphology closely 
paralled the ability of the embryonic glial cells to survive culture in defined medium. 
While at E14 and E15, less than 5% of the cells that attached and flattened at 3 hr 
survived culture in defined medium to 20 hr post-plating , this 
increased to 15% at 
E16, and to 90% of the cells at E17 (Fig 3.6). These results suggest that the 
embryonic glial cells that can be isolated at E14 differentiate into Schwann cells in the 
nerve between E15 and E17. 
The ability of the E17 and older Schwann cells to survive culture in defined medium 
without exogenous growth factors may be due to the autocrine production of such 
factors by these cells. Schwann cells from perinatal and adult nerves are known to 
produce growth factors that can act as autocrine factors. For example they produce all 
three major isoforms of TGFI (mitogenic for Schwann cells; Ridley et at., 1989; 
Schubert, 1992; Einheber et al. 1995; Stewart et at., 1995), and PDGF-BB (acts as a 
Schwann cell mitogen in the presence of elevated cAMP or TGFf3; Davis and 
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Stroobant, 1990; Eccleston et al., 1990,1993). Schwann cells also produce 
neurotrophic factors namely NGF, BDNF, NT-3, NT-4/5, CNTF, LIF and glial 
derived neurotrophic factor (GDNF) (reviewed in Scherer and Salzer, 1996) and 
possess receptors for some of these factors. The low affinity p75LNGFr is expressed 
in undifferentiated and non-myelin-forming Schwann cells and NGF is reported to 
increase the level of L1 expression on cultured mouse Schwann cells (Seilheimer and 
Schachner, 1988). Schwann cells also express mRNA of full length trkC, and the 
truncated forms of 1rkB and irkC lacking tyrosine kinase domains (Offenhäuser et al., 
1995). It is possible that the lack of survival ability by early embryonic glial cells is 
due to lower levels of autocrine growth factor(s) being produced by these cells. 
Plating the E14 cells at high density did not increase the proportion of cells surviving 
at 20 hr (Table 3.1). This may indicate that the cells cannot produce the growth 
factor(s) that promotes their survival at E17, or that they lack the receptors for the 
factor(s), or both of these. In earlier studies (Jessen et al., 1994), medium conditioned 
by neonatal Schwann cells could not rescue the E14 cells, suggesting that they lack the 
receptors for the survival factors that might be produced by older Schwann cells. 
Moreover, the exogenous addition of growth factors known to be produced by 
Schwann cells, namely NGF, BDNF, NT3, NT4, TGFO and PDGF-AA and -BB, to 
cultures of E14 cells did not promote survival. These results will be described in 
detail in Chapter 5. These results suggest that the factors necessary for E14 cell 
survival must be produced by other cells in the early nerve or the surrounding 
environment. 
The increased survival in defined medium seen at E17 could be due to proliferation of 
a subpopulation of cells rather than increased survival. When E17 and newborn cells 
were pulsed with BrdU for the last 1.5 hr of the 20 hr assay, it was found that less than 
1% of cells incorporated the label, indicating they were undergoing division. These 
levels of division are too low to account for the numbers of cells seen at 20 hr. 
Neurone-conditioned medium promotes survival of E14 glial cells 
As described earlier, at all stages of nerve development the glial cells are seen in close 
association with the growing axons (Peters and Muir, 1959; Loring and Erickson, 
1987; Dahm and Landmesser, 1988; Carpenter and Hollyday, 1992a, 1992b; Jessen et 
al., 1994; Y. Hashimoto and K. R. Jessen, personal communication). This close 
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association with neurones is known to directly influence Schwann cell gene and 
protein expression (reviewed in Mirsky and Jessen, 1990; Gould et al., 1992; Scherer 
and Salzer, 1996), upregulating expression of proteins such as S 100 (Holton and 
Weston, 1982b), galactocerebroside (Jessen et al., 1987a), 04 (Mirsky, et al., 1990) 
and, in myelin-forming Schwann cells, the myelin proteins including Po, MBP, MAG 
and PLP (reviewed in Gould et al., 1992; Lemke and Chao, 1988). It has also been 
reported that diffusible molecules from neurones can influence Schwann cell genes, 
downregulating p75LNGFr and inducing SCIP and Po in cultured adult rat Schwann 
cells (Bolin and Shooter, 1993). Axons are, therefore, a potential source of survival 
factor(s) for embryonic glia. 
When defined medium was conditioned by purified DRG sensory neurones, either in 
the presence or absence of NGF, it promoted the survival of E14 glial cells. At 20 hr, 
in NCM, 80% of the E14 cells were still alive (Figure 3.5 Q. 
Purified axonal membrane has been shown to stimulate proliferation in Schwann cells 
from neonatal rats (Salzer et al., 1980a, b; Sobue and Pleasure, 1985). It was possible, 
therefore, that the conditioned medium was having a mitogenic effect on a small 
proportion of the cells and not acting as a survival factor. Pulsing the cultures with 
BrdU for the last 1.5 hr of culture, however, revealed that, in NCM, the level of cell 
division was low at less than 1%, and could not account for the numbers of cells 
surviving. 
It is possible that the survival factor(s) found in the NCM are produced by other cells 
in the neuronal cultures, these are fibroblasts, satellite cells and Schwann cells. 
However, the levels of E14 survival seen in conditioned media from different cultures 
of purified DRG neurones were directly related to the purity of the neuronal cultures: 
the best survival was seen in medium from the purest cultures of neurones (not 
shown), indicating that the source of survival factor(s) was unlikely to be the 
contaminating cells. This has since been confirmed in similar survival experiments 
using immunopanned DRG neurones to condition the medium (Dong et al., 1995). 
Since the survival ability of the medium decreased with increasing numbers of non- 
neuronal cells, it is possible that these contaminating cells were either degrading the 
survival factors produced by the neurones, or selectively binding them and removing 
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them from the conditioned medium. These results indicate that neurones are likely to 
be the source of survival factors for early embryonic glial cells. 
The molecular phenotype of the E14 glial cell 
Dissociated cells cultured from E14 nerves for either 3 hr (in defined medium) or for 
20 hr (in NCM) were probed with a panel of antibodies that have been shown to label 
Schwann cells at later stages of development (reviewed in Mirsky and Jessen, 1990; 
Jessen et al., 1990; Mirsky et al., 1990). The labelling after the different times in 
culture was the same, indicating that the short time in culture did not alter the 
molecular phenotype of the cells. 
Table 3.2 describes the phenotype of the E14 cells compared to similar cultures of rat 
neural crest cells. These results are compared to those seen in myelin- and 
non-myelin-forming Schwann cells in Table 3.3. 
These early cells express three proteins that label both myelin- and non-myelin- 
forming Schwann cells, the extracellular matrix molecule laminin (although this 
expression was weak) and the intermediate filament proteins vimentin and nestin. As 
described earlier, they fail to express S100, found in all Schwann cells. The majority 
of the early glial cells express markers that are normally associated with 
non-myelin-forming Schwann cells, namely p75LNGFr, the cell adhesion molecules 
NCAM and L1, and the cell surface molecules of unknown function A5E3 and Ran 2. 
However, unlike the non-myelin-forming Schwann cells, these cells do not express the 
intermediate filament protein GFAP. 
Late embryonic Schwann cells express the lipids galactocerebroside and 04 (Mirsky et 
at., 1980,1990) but these are absent from the glial cells found at E14. The appearance 
of these lipids preceeds the expression of high levels of the myelin protein Po and 
expression of MBP in myelin-forming cells, normally seen in the nerve from birth 
onwards (reviewed in Gould et al., 1992). In accordance with the absence of lipids, 
the myelin protein MBP and high levels of Po are also not expressed in the Schwann 
cell precursors. Thus these cells more closely resemble the phenotype of the 
non-myelin-forming Schwann cells. 
The low level of Po expression specifically in the precursors is in agreement with 
observations made in the chick, where expression of this protein can be detected in a 
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sub-population of neural crest cells (Bhattacharrya et al., 1991). Studies of the mRNA 
expression in the rat have confirmed that, as in chick, Po mRNA can be detected in a 
sub-population of migrating neural crest cells (Lee, Brennan et al., in preparation). 
Since this protein exhibits homotypic binding, it may be involved in adhesion of the 
neural crest cells to one another during migration. It is not known whether expression 
of the protein indicates commitment to a glial lineage. 
The phenotype of these cells suggests that these are early cells of the Schwann cell 
lineage and not cells of mesenchymal origin despite their lack of S 100 expression. 
The expression of L1 is not detected on cells isolated from the mesenchyme (not 
shown) and appears to be very specific for the Schwann cell precursors in tissue 
derived from the embryonic limb. In later studies such as those described in Chapter 
6, L1 has been used as a specific marker for precursors: approximately 3-5% of cells 
labelled by p75LNGFr are negative for L1, suggesting that some of the p75LNGFr+ 
cells are not of the Schwann cell lineage (Z. Dong, personal communication). 
E14 cells are not migrating neural crest cells 
Neural crest cells are highly motile cells, migrating long distances within the 
developing embryo and forming most cell types of the peripheral nervous system. 
Much evidence points to these cells giving rise to Schwann cells, although there is no 
in vivo evidence for this in the rat. It is possible that the cells seen associated with the 
developing nerve at E14 are migrating crest cells, capable of differentiating into 
several cell types, with no commitment to the Schwann cell lineage at this stage. 
Although there is no evidence from this work that the cells of the early nerves cannot 
assume other developmental fates, this study shows that there are differences between 
neural crest cells and E14 glial cells cultured under the same conditions. Thus the 
cells have advanced from the neural crest stage of development. 
In culture, rat neural crest cells have a subtly different morphology from the E14 cells, 
with fewer lamella sheets and more intimate cell-cell contacts (Fig 3.8). However, 
they express several antigens that are found on the E14 glial cells, namely p75LNGFr, 
N-CAM, L1, A5E3 and Ran-2. The major antigenic difference that can be detected 
between these cells is the expression of the membrane-associated phosphoprotein 
GAP-43: this antigen is very weakly expressed or entirely absent from neural crest 
cells but is highly expressed in cells from E14 nerves. Although not quantitatively 
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measured, the level of immuofluorescence seen in the E14 cells is equivalent to the 
level observed in growing neurites of cultured neurones (not shown). 
GAP-43 was first identified as a membrane phosphoprotein in neurones (reviewed in 
Skene, 1989) and is associated with the membrane of growth cones in development or 
regeneration (Skene et al., 1986). This protein is likely to have a role in membrane- 
cytoskeleton interactions, particularly where the membrane is undergoing changes or 
process formation (Zuber et al., 1989; Meiri and Gordon-Weeks, 1990). It is also 
expressed in non-myelin-forming Schwann cells, but not myelin-forming cells in the 
normal nerve (Curtis et al., 1992). Unmyelinated axons undergo changes in diameter 
associated with transport of membranous organelles (Greenberg et al., 1990) and it has 
been postulated that non-myelin-forming Schwann cells need to be able to alter cell 
shape to accommodate these alterations in axonal caliber (Curtis et al., 1992). 
The presence of GAP-43 in Schwann cell precursors possibly relates to process 
formation, since these cells elaborate lamellar sheets and tapering processes in culture 
and extend fine processes into the bundles of axons in the E14 nerve (Jessen et al., 
1994). They must be able to undergo extensive cytoplasmic changes at this time, 
accompanying the growing axons as they extend into the surrounding tissue. Neural 
crest cells, however, show little process formation and migrate rapidly within 
extracellular matrix, not forming close associations with surrounding tissue. The 
absence of GAP-43 within these cells may reflect the lack of cell membrane extension. 
A further difference between neural crest cells and E14 precursors was the ability of 
IGF-1 and either NDF or ET-1 to promote long-term survival of these cells in the 
absence of the neural tube. In these studies, bFGF in the presence of IGF-1 acted as a 
short-term survival factor both for neural crest cells and for precursors (see Chapter 5); 
this effect of bFGF with high levels of insulin on rat neural crest cells has been 
reported previously (Bannerman and Pleasure, 1993). The lack of effect of NDF and 
ET-1 on neural crest cells may indicate that a complex combination of factors is 
required for neural crest survival, since crest cells express receptors for NDF 
(Marchionni et al., 1993) and can respond to GGF, a member of the NDF family (Shah 
et al., 1994; Verdi et al., 1996; described in detail in Chapter 6). Trunk neural crest 
cells are also influenced by ETs (described in detail in Chapter 6). These results 
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suggest that the maturation of neural crest cells to the glial cells found in E14 nerve 
involves changes in survival requirements. 
Thus E14 glial cells are not migrating neural crest cells, although they share 
similarities such as a flattened morphology in vitro, an inability to survive in defined 
medium and high motility. 
The results presented here show that the glial cells that can be isolated from the 
embryonic nerve at E14, the Schwann cell precursors, are intermediates in the 
Schwann cell lineage, lying between the neural crest cells and perinatal Schwann cells. 
Transition to a perinatal phenotype is rapid and involve changes in morphology, 
molecular phenotype and dependence on survival factors. This developmental step is 
tightly controlled and takes place between E15 and E17. 
The following chapter will explore the cellular events that occur when E14 precursors 
are removed from neuronal contact and cultured without exogenous growth factors 
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CHAPTER 4 
SCHWANN CELL PRECURSORS DIE BY APOPTOSIS IN THE 
ABSENCE OF GROWTH FACTORS 
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INTRODUCTION 
Cell death has long been known to play an important role in normal animal 
development (Glücksmann, 1951; Snow, 1987; Ellis et al., 1991). Cell death is also 
vital in homeostasis; cell renewal must carefully balance cell proliferation and death. 
It is during embryogenesis, however, that normal cell death is involved in generating 
the final body plan of the animal and is responsible for regulating both the cell 
numbers and phenotypes within a tissue (Snow, 1987). Most tissues have been found 
to undergo periods of cell death connected with morphological changes or elimination 
of unwanted cells (Glücksmann, 1951). For example, neural tube closure requires cell 
death as does palatine fusion in mammals, formation of digits from the limb primordia 
and loss of transitory structures such as the tadpole tail (Snow, 1987). In the immune 
system, normal cell death is responsible for the elimination of self-reactive T cells 
(Cohen, 1991). Cell death is also an essential component in generation of both central 
and peripheral nervous systems where excess cells and those forming inappropriate 
connections must be eliminated. 
The morphology of apoptosis 
Normal cell death is referred to as apoptosis or programmed cell death (Wyllie et al., 
1980; Kerr et al., 1987). The process of apoptosis follows similar patterns in many 
different cell types with these patterns appearing to be conserved between species 
(Ellis et al., 1991). It was thought to differ from necrotic death in morphological 
detail and in the response of the surrounding cells to the products of cell death (Wyllie 
et al., 1980; Kerr et al., 1987). In apoptosis, the cell cytoplasm and nucleus condense 
and the cell is fragmented into many small discrete vesicles which are rapidly 
phagocytosed by surrounding cells, preventing any inflammatory reaction and 
maintaining the integrity of the surrounding tissue (Wyllie et al., 1980). Necrotic 
death, however, results in swelling of the endoplasmic reticulum and mitochondria, 
followed by rupture of the plasma and organelle membranes. The resulting release of 
cell contents produces in an inflammatory reponse within the surrounding tissue 
(Wyllie et al., 1980). The two modes of cell death may activate some of the same 
pathways: recently, DNA fragmentation that has been thought to be a characteristic of 
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apoptosis has been detected within cells exhibiting morphological changes associated 
with necrosis (reviewed in Bortner et al., 1995). In addition, not all types of cell 
undergoing apoptosis will exhibit all of the changes classically associated with this 
form of cell death (Bortner et al., 1995). 
An early event in apoptosis is the condensation of chromatin to the outside edges of 
the nucleus which may assume an irregular outline (Wyllie et al., 1980). This 
condensation is thought to involve a domain nuclease that cleaves the DNA into 
50-300 kb fragments (Bortner et al., 1995; Earnshaw, 1995a). The nuclear membrane 
remains intact but the nuclear pores are redistributed to accumulate between the areas 
of condensed chromatin as a result of nuclear lamina disassembly by proteolysis 
(Earnshaw, 1995b). The nucleus may then fragment into small, highly condensed 
(pyknotic) chromatin bodies, only some of which are bounded by nuclear membrane 
(Wyllie et al., 1980; Kerr et al., 1987). 
Cytoplasmic condensation accompanies the nuclear changes, associated with varying 
degrees of membrane blebbing and vacuole formation (Kerr et al., 1987). Organelles 
remain intact throughout the process of apoptosis (Wyllie et al., 1980). Eventually the 
cytoplasm separates into many apoptotic bodies, some containing the condensed 
chromatin, all of which are sealed by a plasma membrane (Wyllie et al., 1980; Kerr et 
al., 1987). Changes in the cell membrane must occur that allow these apoptotic bodies 
to be rapidly phagocytosed and degraded by neighbouring cells (Cohen, 1991). The 
time taken to completely eliminate a cell by apoptosis varies according to cell type 
(Earnshaw, 1995b) but can be extremely rapid, a matter of a few hours for cells of the 
immune system (Cohen and Duke, 1984). 
Control of apoptosis 
Apoptosis is an active process requiring the action of nucleases and proteases 
(reviewed in Earnshaw, 1995a). Various conditions have been identified as a trigger 
for apoptosis, with different cell types being sensitive to different conditions. The 
most common signals in vivo appear to be variation in hormonal or growth factor 
levels, for example immature thymocytes die when exposed to glucocorticoids (Cohen, 
1991), sympathetic neurones will die in vitro if deprived of NGF (Martin et al., 1988). 
Apoptosis is also induced in many cell types by exposure to radiation. Recently two 
factors have been identified that actively induce cell death when bound to their 
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appropriate receptors: tumour necrosis factor (TNF) and Fas ligand (FasL) (reviewed 
in Cleveland and Ihle, 1995). The latter is thought to be responsible for the 
elimination of self-reactive T cells and to play a role in T cell-mediated cytotoxicity. 
Some of the genes involved in the apoptotic process were originally determined in 
mutations of C. elegans (reviewed in Ellis et al., 1991; Ellis, 1992; Freeman et al., 
1993). Two genes are required to be active for death to occur: ced 3 and ced 4 (Ellis 
and Horvitz, 1986; Yuan and Horvitz, 1990). Mutation of either gene results in the 
survival of cells that normally die. The action of these genes appears to be blocked by 
the product of the ced-9 gene. This gene acts to prevent death: mutations that activate 
ced-9 prevent cell death and mutations that delete the gene are fatal, resulting in loss 
of cells that would normally survive. These studies indicate that cell death is 
suppressed in all cells that normally survive (Ellis et al., 1991). Determination of 
which cell should undergo cell death seems to be controlled by separate genes 
according to cell type in steps that occur before the activation of ced-3 and ced-4 (Ellis 
et al., 1991). At least 7 different genes are responsible for engulfment of the dead 
cells. 
Cell death genes in mammalian systems 
Cell death genes have been sought in vertebrates and several homologues of the C. 
elegans genes have been identified. A homologue of the death repressor ced-9 is the 
mammalian gene bcl-2. This was originally isolated from a human B cell lymphoma 
(Tsujimoto et al., 1985) and encodes a membrane protein that appears to be associated 
with the inner mitochondrial membrane, nuclear envelope and parts of the 
endoplasmic reticulum (Hockenbery, et al., 1990; reviewed in Wang et al., 1995). 
Introduction of the human bcl-2 gene reduces the number of cell deaths when 
introduced into C. elegans (Vaux et al., 1992). Overexpression of the gene protects 
various mammalian cells from cell death, for example PC12 cells transfected with bcl- 
2 can survive in the absence of NGF (Mah et al., 1993), and in transgenic mice the 
numbers of neurones dying during the period of normal cell death is reduced 
(Martinou et al., 1994). There are some situations, such as neurones after CNTF 
withdrawal, where bc1-2 does not seem to prevent apoptosis (Allsopp et al., 1993). 
Several homologues of bcl-2 have now been identified including bcl-x (Boise et al., 
1993), bax (Oltvai et al., 1993), bad (Yang et al., 1995) and bak (Chittenden et al., 
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1995; Farrow et al., 1995; Kiefer et at., 1995). The Bax protein has been shown to 
dimerise with Bcl-2 and both proteins can form homodimers (Oltvai et al., 1993; 
Middleton et al., 1996). The formation of heterodimers of Bax with Bcl-2 reduces the 
ability of the latter protein to prevent apoptosis and thus the two proteins are thought 
to act as regulators of the cell death process, with the outcome dependent on the ratio 
of the two proteins (Oltvai et al., 1993; Middleton et al., 1996). Overexpression of 
Bax in various neuronal types can prevent some neuronal death after growth factor 
withdrawal but actively suppresses survival of these neurones in the presence of 
growth factors, implying a complex interaction between these proteins and the process 
of cell survival (Middleton et al., 1996). 
The product of ced-3 has been found to be 28% homologous in DNA sequence to the 
mammalian cysteine protease interleukin-Iß-converting enzyme (ICE) (Yuan et al., 
1993). This enzyme cleaves the precursor of interleukin-10 (IL-10) to give the mature 
cytokine (reviewed in Kumar, 1995). It was thought that ICE might be an essential 
protein for apoptosis, but transgenic mice deficient in ICE still exhibit normal cell 
death (Li et al., 1995). A family of cysteine proteases related to ICE have been found 
that include Nedd2/ Ich-1 (Wang et al., 1994; Kumar, 1995), and CPP32 (Lazebnik et 
al., 1994; Nicholson et al., 1995). All of these proteases are homologous to ced-3 and 
all have been reported to induce apoptosis when overexpressed in various cell types 
(reviewed by Kumar, 1995; Fraser and Evan, 1996; Wang et al., 1994; Nicholson et 
al., 1995). Although the members of this protease family share an unusual substrate 
specificity, cleaving peptides at an Asp-X bond (where X is any amino acid), each 
protease appears to be active on a specific substrate (Kumar, 1995). One of the first 
events detectable in cell-free apoptosis systems is the cleavage of the enzyme poly 
(ADP-ribose) polymerase (PARP) responsible for DNA repair; PARP has been shown 
to be a substrate for CPP32 (also known as prICE and apopain) (Lazebnik et al., 1994; 
Nicholson et al., 1995). This is the first description of an activity for aced-3-like gene, 
and it is possible that different genes in the protease family have roles in degrading 
different substrates or act in different cell types. 
The Drosophila gene reaper appears to control apoptosis; its deletion blocks almost all 
death in embryos (White et al., 1994). Irradiation-induced apoptosis is also blocked 
by deletion of this gene and it is possible that several pathways to apoptosis converge 
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at this point (White et al., 1994; Steller, 1995). The action of reaper is not known but 
it has been suggested cell death effectors, present in most or all cells, are activated by 
reaper (White et al., 1994), or that it inhibits negative regulators of apoptosis such as 
bcl-2. So far, there are no homologues of this gene in the mammalian system. 
Apoptosis in the mammalian nervous system 
Extensive cell death of neurones within the developing central and peripheral nervous 
systems has been well documented (reviewed by Oppenheim, 1991; Hamburger and 
Levi-Montalcini, 1949; Cowan et al., 1984). In the developing PNS, it is known that 
neurones undergo a period of cell death, thought to be associated with limiting amount 
of growth factors, neurotrophins, essential for neuronal survival (Davies, 1988; Barde, 
1989). The restriction of neuronal numbers by such means is thought to eliminate 
defective cells and aberrant connections between neurones and their targets, and to 
adjust the size of the neuronal population to that appropriate for the organism 
(Oppenheim, 1991). Neurones can be cultured in vitro in the presence of appropriate 
neurotrophins but undergo apoptosis if deprived of these growth factors (Davies, 1988; 
Barde, 1989). 
Cell death by apoptosis during development has also been reported in glia of the CNS 
in vivo (Pannese and Ferrannini, 1967; Knapp et al., 1986; Barres et al., 1992) and as 
many as half of all oligodendrocytes within the optic nerve are thought to die during 
development (Barres et at., 1992). Barres et al. (1992) also showed that 
oligodendrocytes will undergo apoptosis if deprived of growth factors in culture. 
Recently, glial cell death during normal development of the PNS has been studied in 
the ventral roots of the embryonic chick (Ciutat et at., 1996). Cells identified as 
Schwann cell precursors by use of a monoclonal antibody that recognises chick Po 
(Bhattacharyya, et at., 1991) have been observed to die, in two waves during normal 
development: the first wave is early, peaking at E5-6; the second wave peaks at E8.5, 
and is thought to relate to the period of normal motor neurone death in the chick 
(Ciutat et al., 1996). 
The genes responsible for the death or survival of cells within the nervous system have 
yet to be fully elucidated. The protein bcl-2 has been found extensively in the nervous 
system during development, and continues to be expressed in the adult (Merry et al., 
1994). Examination of peripheral ganglia with anti-bcl-2 antibodies show expression 
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of this protein in both neurones and glia (Merry et al., 1994). As described above, bcl- 
2 can protect neurones from apoptosis both in vivo (Martinou et al., 1994) and in vitro 
(Allsopp et al., 1993; Mah et al., 1993). 
Homologues of bcl-2 have also been detected in the nervous system; bax has been 
detected at the mRNA level in peripheral ganglia of both young and adult rats 
(Gillardon et al., 1994); and bcl-x-deficient mice exhibit extensive neuronal death 
during neuronal differentiation (Motoyama et al., 1995). 
Most recently, a gene encoding neuronal apoptosis inhibitor protein (NAIP) has been 
isolated and found to be expressed in motor but not sensory neurones (Liston et al., 
1996). Like the bcl homologues, it appears to be part of a family of genes; detection 
of a Drosophila homologue would suggest that these genes may be a conserved family 
of apoptosis supressors (Liston et al., 1996) 
The initial studies on the Schwann cell precursors showed rapid death of these cells in 
the absence of their normal environment and without addition of exogenous growth 
factors. The manner of death in vitro has been investigated and this Chapter describes 
the evidence for apoptotic death of these cells in the absence of growth factors. 
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RESULTS 
Removal from axonal contact results in rapid death of E14 precursors 
It was observed that when E14 Schwann cell precursors were removed from axonal 
contact and placed in culture in defined medium, almost all did not survive to 20 hr 
post-plating. As described in Chapter 3, these cells were healthy and flattened at 3 hr 
post-plating, but by 20 hr only cell debris remained (Figs 3.4,3.5 A, B). A time 
course of death was plotted by fixing and immunolabelling cells with p75LNGFr 
antibodies at 3 hr, 4.5 hr, 6 hr, 7 hr, 9 hr, 11 hr and 20 hr after plating. Survival was 
calculated as before: the number of flattened p75LNGFr+ cells surviving at a given 
time was plotted as a percentage of similar cells that had flattened at 3 hr (Fig 4.1). 
Cell numbers remained constant until approximately 5 hr after plating. There then 
followed a period of rapid death, the majority of cells in the cultures were dead by 9 hr 
after plating and almost all cells were dead after 20 hr in culture. At the end of this 
time very little cell debris was associated with the coverslip (Fig 3.5 B), unlike the 
situation found when these cells were killed by toxicity (not shown). 
Dying cells exhibit morphological changes and pyknotic nuclei 
During the period of cell death in culture, it was observed that the dying cells rounded 
up and assumed a phase-bright appearance, and often these cells associated with the 
surface of flattened groups of precursor cells (Fig 4.2 A). The cytoplasm of these cells 
appeared granular, some cells having vacuoles within the cytoplasm. These shrunken 
cells stained intensely for p75LNGFr (not shown). 
When these cells were stained with the Hoechst nuclear stain H33258 that chelates 
with the DNA of the cells, the nuclei of the rounded cells appeared to be very small, 
very intensely stained and were often fragmented into two or more separate (pyknotic) 
bodies (Fig 4.2 B, arrows). Such nuclear changes indicate nuclear shrinkage, DNA 
condensation and nuclear fragmentation. 
To see whether the cells that were lost from the precursor monolayer during the period 
of cell death could be detected in the culture medium, cell supernatant from a single 
experiment at 8 hr post-plating was centrifuged and the pellet fixed before transferring 
to a nitrocellulose filter. This was then stained with Hoechst dye and viewed using 
Hoechst optics. Despite the thickness of the filter, the fragmented cell nuclei could be 
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determined and counted. Approximately 80% of cells that were lost from the 
monolayer could be recovered in this way. 
Dying precursors have fragmented DNA 
To further study the fragmentation of the DNA observed with Hoechst dye staining, 
E14 precursors were cultured in non-conditioned defined medium for 5 and 7 hr, and 
in NCM for 20 hr. Newborn Schwann cells were cultured in non-conditioned defined 
medium for 20 hr for a comparison. At the end of the culture time, both floating cells 
and cells still attached to the culture substrate were lysed, digested and extracted, and 
the DNA run on a 1.7% agarose gel; with E14 cells cultured in NCM for 20 hr the 
floating cells and adherent cells were lysed separately. Ethidium bromide was used to 
detect the DNA under UV light (Fig 4.3). Each treatment of the precursors represents 
a separate dissection. The number of cells in the starting populations of all the 
treatments was similar, 400,000- 500,000 cells. The samples were all treated 
identically to prepare the cell lysates and the volumes loaded onto the gel were 
identical in all cases. 
Fragmentation of the DNA into repeated nucleosome lengths was observed in 
precursors as early as 5 hr after plating in defined medium (Fig 4.3, lane 1). This 
laddering was more pronounced by 7 hr (Fig 4.3, lane 2). Precursors cultured in 
NCM, however, showed no laddering even after 20 hr in culture (Fig 4.3, lane 3), 
although extremely faint laddering could be detected if the small proportion of floating 
cells were removed and lysed separately (Fig 4.3, lane 4). Newborn Schwann cells 
cultured for 20 hr in defined medium showed no laddering of the DNA (Fig 4.3, lane 
5). 
Protein synthesis inhibitors delay precursor death 
The protein synthesis inhibitors cycloheximide and emetine were used to see whether 
new proteins were required for the death of precursors in defined medium. 
Cycloheximide at a concentration of 0.5µg/ml or emetine at a concentration of 
1.5µg/ml were included in the defined medium added to the cells 3 hr after plating. 
These concentrations had been determined to be the most effective at prolonging 
precursor survival (dose response curves not shown here). The survival of cells was 
determined at 9 hr and 20 hr post-plating by fixing and immunolabelling the cells for 
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p75LNGFr, and calculating survival as a percentage of the cells at 3 hr as described 
previously. 
Figure 4.4 shows the survival at 3 hr, 9 hr and 20 hr after plating. At 9 hr, only 23% t 
3 (SEM, n=3) of cells were alive without protein synthesis inhibitors. In the presence 
of 0.5pg/ml cycloheximide, 82% ± 13 (SEM, n=3) were alive, flattened and 
p75LNGFr at this time. Emetine was less effective at preventing precursor death: in 
defined medium with I. 5pg/ml emetine only 54% ±7 (SEM, n=3) survived at 9 hr. 
By 20 hr, only 2% ±I (SEh4, n=3) of the cells flattened and labelled at 3 hr remained 
in defined medium alone. The number of cells surviving in cycloheximide decreased 
to 25% ±6 (SEM, n=3) and only 7% ±2 (SEM, n=3) of cells remained in cultures that 
included emetine. The cells surviving in cycloheximide continued to die over the next 
12 hr. These results indicate that, although protein synthesis inhibitors can delay 
precursor death in defined medium, ultimately these cells will die in the absence of 
trophic factors. 
Single experiments with the protein synthesis inhibitors anisomycin (at 0.5µg/ml) and 
puromycin (at 1 pg/ml) produced 18% and 13% precursor survival respectively, at 9 hr 
(not shown). By 20 hr, however, less than 1% of cells survived. 
Addition of forskolin delays precursor death in a dose-dependent manner 
Elevation of cyclic AMP in cultures of post-natal Schwann cells upregulates the 
expression of the myelin protein Po (Morgan et al., 1991) and has been thought to 
mimic in vivo signals from axons to Schwann cells. To see whether elevation of cAMP 
would promote the surivival of the precursors in culture, two concentrations, 2µM and 
20µM, of the cAMP-elevating agent forskolin were used in defined medium and the 
survival of precursor cells determined at 4.5 hr, 6 hr, 10 hr and 20 hr (Fig 4.5). 
Both concentrations of forskolin delayed the death of the precursors with 20µM more 
effective than 2 it t (Fig 4.5). The delay was first obvious at 6 hr post-plating, when 
56% ±7 (SD, n=2) of cells were alive in defined medium but 82% ± 14 (SD, n=4) of 
cells remained in 2µ1'I forskolin and 92% ±8 (SD, n=2) of cells were alive in 20µM. 
By 10 hr, only 11% ± 10 (SD, n=2) of cells survived in defined medium but 36% ±7 
and 68% ±13 (SD, n=2) of cells were alive in 2p M and 20µM forskolin respectively. 
Only 20µM forskolin had an effect at 20 hr, where 16% ± 16 (SD, n=2) of cells 
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remained alive, suggesting that elevating cAMP can delay but not prevent precursor 
death. 
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Figure 4.1 Time course of precursor death in vitro 
E14 precursors were fixed and immunolabelled with p75LNGFr after various times in 
culture, in the presence of nonconditioned defined medium. Survival is expressed as a 
percentage of flattened p75LNGFr+ cells remaining at each timepoint relative to the 
number of these cells at 3 hr. There is an initial delay of approximately 4-5 hr before 
loss of cells is apparent. Death then proceeds rapidly, with most cells dying by 9 hr 
after plating. Each point represents the average from three experiments, error bars 
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Figure 4.2 Morphological changes in cultured precursors indicative of apoptosis 
(A). Phase-contrast micrograph of precursors cultured for 7 hr in nonconditioned 
defined medium. Numerous rounded, phase-bright cells are found in association with 
an area of apparently normal flattened cells. The cytoplasm of these phase-bright cells 
appears granular, with evidence of vacuoles. Bar = 20ýrm 
(B). The cells shown in (A) stained with Hoechst H33258 dye and viewed with 
Hoechst fluorscence optics. The rounded cells visible in (A) have small, intensely 
stained nuclei. In many of these cells the nuclei have fragmented (arrows). 
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Figure 4.3 Dying precursors exhibit I)NA laddering 
A DNA fragmentation assay of E14 precursors (lanes 1-4) and newborn Schwarm cells 
(lane 5). The DNA extracts were run on a 1.7% agarose gel with ethidium bromide 
and visualized using UV illumination. Laddering of DNA is detectable in precursors 
cultured in defined medium as early as 5 hr after plating (lane 1). This laddering is 
intensified after 7 hr culture of these cells in defined medium (lane 2). Culture of E14 
precursors in defined medium conditioned by DRG neurones prevents DNA 
fragmentation even 20 hr after plating (lane 3); floating cells from the same culture 
exhibit faint DNA laddering (lane 4). Newborn Schwarm cells do not exhibit 
fragmentation when cultured for 20 hr in defined medium alone (lane 5). 
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Figure 4.4 Inhibitors of protein synthesis delay precursor death in defined 
medium 
Addition of 0.5µg/ml cycloheximide (hatched colummn) or I_5ýtýgýml emetine (grey 
column) delayed the death of E14 precursors cultured in defined medium Survival of 
cells cultured in defined medium alone is represented by the black columns. 
Cycloheximide is more effective than emetine at delaying precursor death at both 9 hr 
and 20 hr after plating. Cells were stained with p75LNGFr and counted at the 
timepoints indicated. Survival is calculated relative to cells at 3 hr as described 
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Figure 4.5 Forskolin causes a dose-dependent delay in precursor death 
Treatment of cells with 2µM forskolin (diamonds) or 20µM forskolin (open triangles) 
delays the death of E14 precursors. Open squares represent the survival of E14 cells 
cultured in defined medium alone. 20µM forskolin is more effective and delaying the 
onset of precursor death. Cells were stained with p75LNGFr at the timepoints 
indicated and survival calculated as described previously. Each point represents the 
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DISCUSSION 
Although there is no in vivo evidence in the rat for Schwann cell apoptosis during 
development, it is believed that many, if not all cells will undergo apoptosis when 
cultured in conditions that deprive them of factors essential to their continued survival 
(Raff, 1992). The recent observation that chick Schwann cells undergo apoptosis in 
vivo during normal development (Ciutat et al., 1996), suggests that Schwann cell death 
is a normal event in peripheral nerve development. This chapter provides evidence 
that Schwann cell precursors exhibit characteristic changes associated with apoptotic 
death when they are removed from axonal contact and cultured in vitro in defined 
medium. 
Morphological changes and the timecourse associated with precursor death in 
vitro 
As described earlier, withdrawal of essential growth factors from many cell types 
results in the initiation of death by apoptosis (Collins et al., 1994). When Schwann 
cell precursors are removed from axonal contact and placed in culture in defined 
medium containing high levels (1µM) of insulin, death is rapid. Despite the cells 
flattening and appearing healthy at 3 hr post-plating (Fig 3.5 A), evidence of cell death 
is apparent from five hours in culture onwards (Fig 4.1). Rapid cell loss follows until, 
by 20 hr post-plating, very few p75LNGFr+ cells remain. 
On its own, the rapidity of death of these cells is not indicative of apoptosis. Different 
cell types appear to have varying times of response to apoptotic stimuli: thymocytes 
subjected to the glucocorticoid dexamethasone show signs of apoptosis by 2 hr after 
treatment (Cohen and Duke, 1984) while hepatocytes treated with TGF3I do not 
exhibit any significant changes until 20-24 hr after treatment (Oberhammer et al., 
1992). 
Morphological changes associated with death by apoptosis were observed in the 
precursors during the period of cell death in culture. The cells withdrew their short 
cytoplasmic processes and rounded up, appearing as phase-bright images often in 
association with the precursor monolayers (Fig 4.2 A, arrows). Such cytoplasmic 
condensation is consistent with apoptosis (Wyllie et al., 1980; Kerr et al., 1987). 
Granular cytoplasm and the presence of vacuoles within some of these phase-bright 
130 
cells are also indicators of apoptosis (Wyllie et al., 1980; Kerr et al., 1987). During 
these cytoplasmic changes, the nuclei of the precursors could be seen to condense and, 
in some cases, were observed to be fragmented. Despite the extensive death in these 
cultures, no cells were observed that exhibited any signs of necrosis: there was no 
membrane swelling or visible lysis of the cells during the period of cell death. 
As described earlier, the earliest morphological event of apoptosis at the nuclear level 
is chromatin condensation which can only be observed in the electron microscope 
(Kerr et al., 1987). Chromatin is sharply defined and condensed to the edges of the 
nucleus (Wyllie et at., 1980). Electron microscopic studies of dying Schwann cell 
precursors have revealed such nuclear changes, with chromatin condensed into 
crescents around around the margin of the nucleus (Jessen et al., 1994). 
By staining the dying cells with the nuclear dye Hoechst H33258, nuclear 
condensation and fragmentation was most apparent (Fig 4.2 B). Intensely stained 
nuclei were observed in all the phase-bright cells, with some of the nuclei having 
fragmented (Fig 4.2 B arrows). Such changes in nuclear structure are consistent with 
the process of apoptosis (Wyllie et al., 1980; Kerr et al., 1987). 
Apoptosis of cells in vivo is followed by rapid phagocytosis of these cells by their 
neighbours (Wyllie et al., 1980; Kerr et al., 1987). The timecourse of precursor death 
revealed that cells rapidly disappeared from the coverslips after assuming apoptotic 
characteristics. Examination of the supernatant revealed that the majority (80%) of 
these cells could be recovered from the medium, suggesting that phagocytosis was not 
responsible for their apparent loss, rather that they had lost the ability to adhere to the 
coverslip or their neighbouring cells. Changes affecting cell adhesion during apoptosis 
have been reported in vivo where cells separate from the surrounding tissue at the time 
of cytoplasmic condensation, for example: epithelial cells lose desmosomal 
connections (Wyllie et al., 1980). 
DNA fragmentation as a signature of apoptotic death 
As the morphological changes described above strongly suggested that the Schwann 
cell precursors died by apoptosis, an investigation was made of one of the most 
characteristic events of apoptosis, double stranded DNA fragmentation. Separation of 
fragmented DNA on agarose gels produces a DNA ladder, first observed in apoptosing 
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thymocytes by Wyllie (1980). Although not all cells undergoing apoptosis exhibit 
DNA fragmentation, where fragmentation is present and is associated with other 
characteristics such as cytoplasmic condensation, it is indicative of apoptosis 
(reviewed in Bortner et at., 1995). 
DNA fragmentation, or laddering, could be detected in Schwann cell precursors as 
early as 5 hr after plating in defined medium (Fig 4.3, lane 1), with an increase in 
intensity of the bands by 7 hr post-plating (Fig 4.3, lane 2). Conditioning of the 
medium by neurones abrogated this effect, with no laddering being detected in 
adherent cells at 20 hr post-plating (Fig 4.3, lane 3). Laddering, however, was 
detected in the floating cells found in the NCM-treated cultures (Fig 4.3, lane 4). 
Schwann cells from newborn nerves cultured in defined conditions showed no 
laddering at 20 hr post-plating (Fig 4.3, lane 4). 
The timing of the appearance of DNA fragmentation in the precursors cultured in 
defined medium correlates well with the first morphological changes associated with 
the death of these cells, just preceding the loss of cells from the coverslips (first 
apparent five hours post-plating). Cell loss in the cultures reaches about 50% of the 
starting population at 7 hr after plating and this is reflected by an increase in intensity 
of the DNA bands. 
The absence of DNA laddering in adherent precursors cultured in NCM is consistent 
with the survival of these cells in culture to 20 hr post-plating and beyond. This shows 
that factors in the NCM can suppress apoptosis in these cells. As reported in Chapter 
3, NCM promotes the survival of 80% of precursors at 20 hr post-plating. When 
floating cells from the precursor cultures were examined for DNA fragmentation faint 
bands could be detected, suggesting that the 20% of cells that are not rescued by NCM 
die by apoptosis. These cells may be unable to respond to the survival factors present 
in the NCM either because they lack sufficient receptors for the factors (Collins et al., 
1994), or because they have already irreversibly committed to the apoptotic pathway 
prior to addition of NCM to the cultures. 
The absence of DNA laddering in newborn Schwann cells cultured under the same 
conditions that produced laddering in E14 precursors, would indicate that these older 
cells are capable of producing their own survival factors, either acting in a paracrine or 
an autocrine fashion (discussed in Chapter 3). 
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The DNA ladder seen on the agarose gel indicates internucleosomal cleavage of the 
DNA. It is thought that an endogenous endonuclease cleaves the DNA in the linker 
region between the histones on the chromosomes (Wyllie, 1980; reviewed in Bortner 
et al., 1995). The DNA wrapped around each histone is approximately 180-200 base 
pairs, thus the ladder represents multiples of this unit (Wyllie, 1980; Bortner et at., 
1995, Earnshaw, 1995a). This fragmentation of the DNA is an early event in the 
process of apoptosis and is irreversible, once DNA has been cleaved in this manner the 
cell will die (Bortner et at., 1995). 
The enzyme responsible for the DNA fragmentation has yet to be clearly identified, 
and it is possible that a different nuclease is responsible for this phenomenon in 
different cell types (Earnshaw, 1995a). Early studies on thymocyte apoptosis point to 
the action of a calcium-dependent endonuclease in DNA fragmentation (Wyllie, 1980; 
Cohen and Duke, 1984). But other enzymes have been identified as fragmentation 
nucleases including DNase I, DNase II and cyclophilin A (reviewed by Bortner et al., 
1995; Earnshaw, 1995a). 
Although no studies have been performed on the nature of the nuclease involved in 
Schwann cell precursor apoptosis, the timing of the appearance of the calcium-binding 
protein S 100 is closely correlated with the ability of the Schwann cell precursors to 
survive culture in defined medium (as discussed in Chapter 3) and it is interesting to 
speculate that modulation of calcium in these cells could reduce endogenous activity 
of a calcium-dependent endonuclease. As described in Chapter 6, however, 
maturation of the Schwann cell precursors in growth factors produces some cells that 
appear to live in defined medium without detectable S100 which would suggest either 
that modulation of calcium levels within these cells is not the sole factor controlling 
apoptosis. 
Protein synthesis inhibitors can delay precursor death 
As described earlier, death by apoptosis is an active process. Both RNA and protein 
synthesis inhibitors have been shown to suppress apoptosis in many cells including 
thymocytes (Cohen and Duke, 1984; Wyllie et al., 1984), oligodendrocytes (Barres et 
al., 1992) and neurones both in vivo (Oppenheim et al., 1990) and in vitro (Martin et 
at., 1988; Scott and Davies, 1990; Edwards et al., 1991). 
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Delay of apoptosis in the Schwann cell precursors by the protein synthesis inhibitors 
cycloheximide and emetine suggests that the process of death in these cells requires de 
novo protein synthesis. However, the protein synthesis inhibitors did not promote long 
term survival. 
Although RNA and protein synthesis inhibitors have been shown to delay or block the 
death of many cell types as mentioned above, the reverse of this situation is true in 
other cells. For example, protein synthesis inhibitors initiate apoptosis in 
metamyelocytes (Cohen, 1991), the promyelocytic leukaemia cell line HL-60 (Martin 
et al., 1990) and macrophages (Waring, 1990). The induction of apoptosis in such 
cells has been put forward as evidence for the ubiquitous presence of proteins that 
initate the process of apoptosis (see below) (Raff, 1992; Steller, 1995). Support for 
this idea comes from a system where enucleated cells can still undergo apoptosis 
following growth factor withdrawal (Jacobsen et al., 1994). 
As described above, cells appear to contain both repressors (bcl-2, bcl-x, bax, NAIP) 
and activators (ICE, Ich-1, CPP32, reaper) of apoptosis (Hockenbery et al., 1990; 
Kumar et at., 1994; Merry et al., 1994; Wang et at., 1994; White et al., 1994; 
Motoyama et at., 1995; Nicholson et al., 1995; Liston et at., 1996; Middleton et at., 
1996). The relative levels of these apoptotic modulators and the rate of their turnover 
may influence what happens to a cell when it is exposed to adverse conditons such as 
growth factor withdrawal. It has been suggested that RNA and protein synthesis may 
be required to produce derepressors of the cell death pathway rather than molecules 
directly involved in the death process (Steller, 1995). In cells where inhibition of 
macromolecular synthesis induces apoptosis, however, it may be that the repressors are 
found at low levels and are continuously turned over; blocking synthesis of new 
repressors may alter the balance of the apoptotic proteins towards activation of the 
death pathway. 
Protein synthesis inhibitors delay Schwann cell precursor death but do not prevent 
these cells from ultimately dying by apoptosis. A similar situation is found in 
oligodendrocytes (Barres et al., 1992) but neurones exhibit long term survival after 
inhibition of macromolecular synthesis (Martin et al., 1988; Scott and Davies, 1990; 
Oppenheim et at., 1990; Edwards et al., 1991). This would suggest that the control of 
apoptosis within neurones and glia is different. 
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The different effects of protein synthesis inhibitors on preventing apoptosis have been 
reported in other cells, for example rat thymocytes (Chow et al., 1995). Treatment of 
these cells with methylprednisolone, ionomycin or thapsigargin results in DNA 
fragmentation which is inhibited by cycloheximide and partially inhibited by emetine. 
Puromycin, however, actively induces DNA fragmentation even at concentrations that 
greatly inhibited protein synthesis (Chow et al., 1995). 
The protein synthesis inhibitors used in the current study all have different modes of 
action (Pestka, 1971) but it is possible that they have other activities that are also able 
to interfere with apoptosis. Cycloheximide and anisomycin are reported to 
superinduce immediate-early genes (Edwards and Mahadevan, 1992; Zinck et al., 
1995) and to activate intracellular signalling pathways involving mitogen-activated 
protein kinase (MAPK) and stress-activated protein kinase (SAPK) (Zinck et al., 
1995). However, emetine and puromycin do not produce the same effects (Edwards 
and Mahadevan, 1992). It is unlikely that the action of protein synthesis inhibitors in 
delaying or preventing cell death occurs via superinduction of immediate-early genes: 
the immediate-early genes c-fos and c-jun have been implicated in postive regulation 
of apoptosis (Smeyne et al., 1993; Ham et al., 1995). However, transgenic mice have 
been described that lack c jun, c-fos, and both c-jun and c-fos (Roffier-Tarlov et al., 
1996); the mice do not exhibit unusual patterns of cell death suggesting that these 
immediate early genes are not essential for apoptosis. 
The cAMP-elevating agent forskolin delays precursor death in a dose-dependent 
manner. 
Elevation of intracellular cAMP in vitro can to some extent mimic the action of axon- 
associated signals on Schwann cells inducing either proliferation or myelination 
depending on the conditions (Sobue et al., 1986; Lemke and Chao, 1988, Monuki et 
al., 1989; Mirsky et al., 1990; Weinmaster and Lemke, 1990; Morgan et al., 1991). In 
other culture systems, cAMP analogues have been reported to act as survival factors 
for rat sympathetic and sensory neurones in the absence of NGF (Rydel and Greene, 
1988; Edwards et al., 1991). In these systems, the cAMP analogues mimicked NGF, 
promoting long term survival of the neurones. Sympathetic neurones could be rescued 
even after initiation of the death program with both cAMP analogues and NGF 
(Edwards et al., 1991). This rescue did not require de novo protein synthesis and it 
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was suggested that both cAMP elevation and NGF may act on a common target or 
related targets, possibly by post-translationally modifying proteins involved in the 
death pathway (Edwards et at., 1991). 
cAMP elevation, like protein synthesis inhibition, did not promote long term survival 
in the Schwann cell precursors, again revealing differences between neurones and glia 
in the control of apoptosis. 
Unlike differentiated neurones, the Schwann cell precursor is a highly motile cell 
(Jessen et at., 1994). The presence of a sensitive mechanism for killing these cells 
should they stray from their normal environment might therefore be important. If it is 
assumed that the axons are the source of precursor survival factors in vivo, the ability 
of these cells to undergo apoptosis rapidly after growth factor withdrawal would 
constitute an essential control in normal peripheral nerve development. 
In conclusion, Schwann cell precursors undergo death when removed from axonal 
contact. This process is rapid, with half the cells dying 7 hr after plating in defined 
medium and essentially all cells dying by 20 hr in culture. Morphological and nuclear 
changes indicate that death is by apoptosis. Death of these cells can be delayed but not 




FGFS AND IGFS ARE REQUIRED FOR SHORT TERM 
SCHWANN CELL PRECURSOR SURVIVAL 
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INTRODUCTION 
The requirement of cells in culture for exogenous growth factors has been well 
documented in many systems, including oligodendrocytes (Barres et al., 1993) and 
neurones of the peripheral nervous system (Thoenen, 1991; Snider, 1994). The 
Schwann cell precursors are able to survive in culture if the medium has been 
conditioned by DRG neurones, implying that neurones are a source of trophic factors 
for these cells. Earlier studies showed that the factor or factors were sensitive to 
trypsin and heparin (Jessen et al., 1994) and that bFGF, a heparin-binding growth 
factor could support the survival of precursors in the presence of high concentrations 
of insulin (Jessen et at., 1994). Studies described in this chapter examine the ability of 
a large number of growth factors, including other members of the FGF family to 
rescue precursors in vitro (Gavrilovic et al., 1995). 
Nine members of the fibroblast growth factor family have been identified so far; acidic 
FGF (FGF-1) and basic FGF (FGF-2) being the first members of the family to be 
isolated (reviewed in Basilico and Moscatelli, 1992; Baird, 1994). All the members 
share a degree of homology, with aFGF and bFGF being 55% homologous at the 
protein level (Basilico and Moscatelli, 1992). These peptides have similar molecular 
weights of 15.5-17 kD, but higher molecular weight forms of bFGF have been 
reported in some tissues including the brain, (Basilico and Moscatelli, 1992). K-FGF 
(FGF-4) is 43% homologous to bFGF and is somewhat larger, with a molecular 
weight of 22-23 kD (Delli-Bovi et al., 1988). Non-glycosylation of K-FGF during its 
synthesis results in its immediate cleavage into two NH-2-terminally truncated 
fragments of 13 and 15 kD, the latter fragment, referred to as K140, possessing five- 
times the activity of the parent K-FGF molecule in mitogenic assays using 3T3 
fibroblasts (Bellosta et al., 1993). 
Both aFGF and bFGF, together with the latest addition to the FGF family, FGF-9, lack 
a conventional signal sequence, making their release from cells a matter for debate 
(Basilico and Moscatelli, 1992; Mason, 1994). It is thought that cells can release small 
amounts of the factors by an unknown novel secretory mechanism. The fact that 
aFGF and bFGF are found in serum and medium from cultured cells would support 
this idea (Mason, 1994). 
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FGFs are potent mitogens for many tissues and have angiogenic properties 
(Gospodarowicz et at., 1987; Basilico and Moscatelli, 1992). They have also been 
implicated in tissue patterning of the embryo especially during gastrulation and limb 
formation, and in tissue differentiation (reviewed in Yamaguchi and Rossant, 1995). 
During development, FGFs and their receptors are expressed in a cell-specific manner, 
some of the members such as bFGF and aFGF having a broad distribution, while other 
members are highly restricted (Basilico and Moscatelli, 1992; Givol and Yayon, 1992; 
Yamaguchi and Rossant, 1995). 
Four separate genes have been identified for the high affinity FGF receptors, 
designated FGFR1-4. These receptors are protein tyrosine kinases that share a 
common structure, with three extracellular Ig loops in the ligand-binding domain 
(reviewed in Givol and Yayon, 1992). On binding ligand, the receptors dimerize and 
the intracellular kinase domains are activated, producing autophosphorylation and 
phosphorylation of cytoplasmic substrates such as phospholipase Cy (Basilico and 
Moscatelli, 1992). Truncated isoforms of the receptors, lacking either the 
transmembrane or the intracellular kinase domain are also found, although it is not 
clear what function they perform (Givol and Yayon, 1992). The heparan sulfate 
proteoglycans (HSPGs) have been referred to as the low affinity FGF receptors 
(reviewed in Baird, 1994). The binding of the FGFs to their high affinity receptors is 
greatly enhanced by FGF binding to HSPGs on the cell surface or in the surrounding 
extracellular matrix (Mason, 1994); similarly, addition of exogenous heparin to cells 
in culture can facilitate the binding of FGFs to their receptors (Mason, 1994). Spivak- 
Kroizman et al. (1994) have reported that FGF molecules oligomerize in the presence 
of heparin, thus leading to FGF receptor dimerization and subsequent activation. 
The FGF family members bind with different affinities to the different FGFRs. 
Alternate splicing of the third Ig domain of all the receptors produces variants with 
altered ligand affinities and specificities, and these alternate forms are expressed in a 
tissue-specific manner (reviewed in Givol and Yayon, 1992; Eckenstein, 1994). The 
binding affinities of members of the FGF family for the full-length FGF receptors 
have been described as follows: aFGF and bFGF bind with equal high affinity to 
FGFRI (0.1-0.5 nM) but K-FGF exhibits 15-fold lower affinity for this receptor 
(Mansukhani et al., 1990); aFGF, bFGF and K-FGF bind to FGFR2 with equally high 
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affinities (Mansukhani et al., 1990); FGFR3 binds aFGF preferentially, bFGF exhibits 
approximately 20-fold lower affinity for this receptor; FGFR4 binds aFGF with 
similar affinity as that of FGFRI (Givol and Yayon, 1992). 
There is evidence that both aFGF and bFGF can translocate to the nucleus and affect 
gene transcription directly by an unknown mechanism (reviewed in Prochiantz and 
Theodore, 1995; Walicke and Baird, 1991). Alternately spliced variants of aFGF and 
bFGF contain putative nuclear localization sequences (Jans, 1994). This offers a 
potential intracrine pathway in cells that produce FGFs, and an alternative mechanism 
of action to the conventional signal transduction sequence when FGFs act in a 
paracrine manner. 
As described earlier, bFGF has been reported to affect cells of the neural crest, 
promoting the survival of nonneuronal cells derived from chick trunk neural crest 
(Kalcheim, 1989) and rat trunk neural crest cells (Bannerman and Pleasure, 1993); this 
factor enhances the development of melanocytes from chick neural crest cells in 
culture (Stocker et al., 1991). For Schwann cells, bFGF is a mitogen in the presence 
of forskolin (Stewart et at., 1991; Schumacher, 1993). 
In order to determine other potential survival factors for the Schwann cell precursors, 
an extensive list of growth factors were tested in the survival assay. The observations 
of the survival effects of aFGF, bFGF, and K-FGF were extended to determine the 
required combination of factors to promote the full survival of the precursors. The 
results of these studies are described in this Chapter. 
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RESULTS 
The effect of growth factors on precursor survival 
An extensive list of growth factors was screened for their ability to promote the 
survival of the Schwann cell precursors in the standard 20 hr survival assay (Table 
5.1). The factors were used in defined medium containing 5.7µg/ml (1µM) insulin or 
l00ng/ml (13nM) IGFs, some factors were combined with the cAMP elevating agent 
forskolin. The concentration ranges used were those shown to have biological activity 
in other systems. 
Most growth factors did not support survival under any of the conditions used, 
survival was less than 10% in these cases. Factors that supported significant survival 
were aFGF, bFGF and K-FGF, three members of the endothelin family, ET-1, ET-2 
and ET-3, and NDF02i a member of the neuregulin family of growth factors. All the 
growth factors except NDF02 required the presence of insulin and forskolin or IGFs 
for their effects. The results of studies with FGFs are described below, the neuregulin 
and endothelin results are described in Chapter 6. 
bFGF-mediated rescue of E14 precursors depends on IGF receptor activation 
It was observed in defined medium that 3ng/ml (0.182nM, MW 17 kD) bFGF, in the 
presence of 5.7pg/ml (1µM) insulin, promoted the survival of 50% of precursors at 20 
hr. Omission of insulin from this medium resulted in death of most of the cells (Fig 
5.1). 
In order to study the effects of insulin and IGFs on the action of bFGF, cells were 
plated out in a constant concentration (3ng/ml, 0.182nM) of bFGF without insulin or 
IGFs. At 3 hr, defined medium containing 3ng/ml (0.182nM) of bFGF and increasing 
concentrations of either insulin, IGF-1 or IGF-2 were added to the cells; dose response 
curves of survival at 20 hr were plotted (Fig 5.1). The survival effects of bFGF and 
IGF on precursors at 20 hr post-plating can be seen in Fig 5.2. 
All three insulin growth factors promoted precursor survival in a dose-dependent 
manner. However, insulin in the presence of bFGF promoted survival of only 50% of 
the cells, even at a concentration of 5.7µg/ml (1µM). This concentration is believed to 
be high enough to interact effectively with the type 1 IGF receptor (reviewed by 
Rechler and Nissley, 1985; Neely et al., 1991). Raising the concentration of insulin to 
141 
25µg/ml (4µM) in the presence of bFGF resulted in 10% fewer precursors surviving at 
20 hr (n=3, data not shown). 
IGF-2, in the presence of bFGF, maximally generated 80% survival at a concentration 
of 50ng/ml, whereas IGF-1 generated 100% survival at the same concentration. 
Half-maximally effective concentrations (EC50) were thus 20ng/ml, -'3.5nM for 
insulin, 8ng/ml, -1nM for IGF-2 and ing/ml, -0.13nM for IGF-1. 
In subsequent experiments, IGF-1 was used in preference to IGF-2 since IGF-1 
showed a stronger survival effect when combined with bFGF. 
IGF-1 requires bFGF to prevent Schwann cell precursor death 
To determine whether IGF-1 could promote Schwann cell precursor survival on its 
own, cells were plated and cultured in 100ng/ml (13nM) IGF-1 alone. Survival of less 
than 5% of the cells flattened at 3 hr was seen at 20 hr under these conditions. 
However, when IGF-1 was combined with increasing concentrations of bFGF survival 
increased in a dose-dependent manner (Fig 5.3). 100% survival was obtained at 
Ing/ml (0.06nM) bFGF and the EC50 was -0.07ng/ml, (0.004nM). 
Acidic FGF and K-FGF also support precursor survival in the presence of an 
insulin growth factor 
Two other members of the FGF family, aFGF and K-FGF were assayed for their 
ability to promote precursor survival in the standard assay. As with bFGF, both these 
factors were able to act as survival factors for the precursors in the presence of insulin 
growth factors. Dose-response curves for both these growth factors were generated in 
the presence of a constant IGF-1 concentration (100ng/ml, l3nM) (Fig 5.4 A) or 
constant insulin concentration (5.7µg/ml, 1µM) (Fig 5.4 B). The addition of heparin 
(20pg/ml) to the culture medium was necessary for the action of both aFGF and 
K-FGF but was not a requirement for the action of bFGF. 
Both aFGF and K-FGF were capable of promoting survival of 100% of cells when 
they were combined with IGF-1 (Fig 5.4 A). The EC50 for aFGF was 6ng/ml 
(-0.39nM, MW 15.5 kD) and for K-FGF 3 ng/ml (-0.14 nM, MW 22 kD). 
When a constant concentration of insulin was used, aFGF maximally generated 50% 
survival at a concentration of 30ng/ml (-1.95nM) (Fig 5.4B), similar to that seen with 
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bFGF in the presence of insulin (Fig 5.1). However, K-FGF in the presence of insulin 
maximally generated only 20% survival even at the highest concentration of 100ng/ml 
(-4.55 nM) (Fig 5.4 B). 
Elevation of cAMP promotes precursor survival in bFGF and insulin but does 
not affect survival in bFGF and IGF-1 or IGF-2 
Elevation of cAMP is known to synergize with several growth factors to promote 
DNA synthesis in Schwann cells. To determine whether cAMP would synergize with 
the growth factors that promoted precursor survival, the cAMP elevating agent 
forskolin was used in the survival assays at a concentration of 5µM. 
The addition of forskolin to precursors cultured in defined medium containing either 
5.7pg/m1 (1µM) insulin, l00ng/ml IGF-1 or IGF-2 alone did not promote survival of 
the cells. The dose-response curves of bFGF with IGF-1 or IGF-2 in the presence of 
forskolin showed similar maxima for cell survival (Fig 5.5 A, B, Q. The dose- 
response curves were only slightly altered to the left when increasing doses of IGF-1 
or IGF-2 were used in constant bFGF (Fig 5.5 A, B) as was that of bFGF in constant 
IGF-1 (Fig 5.5 Q. 
In contrast, the effect of insulin in the presence of constant bFGF, and the effect of 
bFGF in the presence of constant insulin both showed marked enhancement of survival 
when forskolin was present (Fig 5.6 A, B). In constant bFGF (3ng/ml), maximal 
survival was increased in 5.7pg/ml (1µM) insulin from -50% to 100% in the presence 
of 5µM forskolin (Fig 5.6 A). However, the EC50 value for insulin remained 
unchanged at -3.5nM (20ng/ml). In constant insulin (5.7µg/ml, 1µM), the maximal 
survival effect with bFGF was similarly increased in the presence of 5µM forskolin, 
but the concentration of bFGF required to promote maximal survival was reduced 
from 3ng/ml to 0.3ng/ml (Fig 5.6 B). The EC50 for bFGF was reduced by almost five- 
fold under these conditions, from -0.02nM to -0.004nM, similar to that seen with 
bFGF in the presence of IGF-1. When the cAMP analogues dibutyryl cAMP and 
8-bromo cAMP were used, similar increases in maximal survival were seen, 
confirming that these effects were due to the elevation of cAMP (data not shown). 
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Forskolin can synergize with aFGF, K-FGF and K140, in the presence of insulin, 
to promote survival 
Similar experiments were undertaken with aFGF, K-FGF and the truncated, 
non-glycosylated variant of K-FGF: K140. The effect of 5µM forskolin on the 
dose-response curves was determined in constant insulin (5.7pg/ml, 1µM) (Fig 5.7 A, 
B, Q. In all cases, the maximum survival of the precursors at 20 hr was increased and 
the FGF EC50 was decreased. In combination with insulin and forskolin, all three 
factors could support 100% survival at 20 hr; with insulin alone this was maximally 
40% with aFGF and only 20% with K-FGF and K140. The EC50 values decreased 
from -0.36nM to -0.03 nM for aFGF, from - 0.91 nM to -0.182nM for K-FGF and 
from -0.30nM to -0.10nM for K140 in the presence of forskolin. 
The action of forskolin with FGFs and insulin does not induce DNA synthesis 
Forskolin in combination with FGFs and insulin does not induce DNA synthesis in 
Schwarm cell precursors. Using BrdU incorporation for 8 hr at 12 hr post-plating and 
at 20 hr post-plating, the level of DNA synthesis in precursors and in newborn 
Schwann cells was determined. In the presence of bFGF (3ng/ml), insulin (5.7ng/ml) 
and forskolin 5µM, BrdU incorporation in precursors was 1.0% ± 0.1 (SD, n=2) at 12 
hr +8 hr and 0.4% ± 0.4 (SD, n=2) at 20 hr +8 hr. Experiments with aFGF and 
K-FGF under the same conditions gave similar results at 20 hr +8 hr. For newborn 
Schwann cells, BrdU incorporation was 22% ±6 (SD, n=2) at 20 hr +8 hr. 
Do any of the hormones present in the defined medium affect precursor survival? 
The defined medium used in all survival assays contained hormones shown to 
influence cell survival in other systems (Barres et al., 1993): namely dexamethasone, 
progesterone, thyroxine (T4) and triiodothyronine (T3). To determine whether any of 
these hormones were promoting survival of the precursors, each factor was omitted 
from the medium in turn, and also all four were omitted together. The standard assay 
with bFGF (3ng/ml) and IGF-1 (100ng/ml) was used and survival determined at 20 hr 
in two separate experiments (Fig 5.8). Using the Student's t test, there was no 
significant difference between survival in most of the different media, the exception 
being in the omission of triiodothyronine in the presence of bFGF and IGF-1. In this 
case, the lower survival was statistically significant, with P<0.01. However, when all 
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four hormones were omitted, the difference in survival was not statistically significant 
(P < 0.5). The effect of triiodothyronine omission on survival was not seen in one 
experiment when bFGF and insulin were present together (not shown). In the 
presence of forskolin, no significant difference in survival was seen in any of the 
media. 
Fibronectin can substitute for laminin as a plating substrate for precursors 
The effect of the substrate on precursor attachment and survival was studied by plating 
4000 cells in defined medium with 5.7µg/ml insulin on coverslips coated with PLL 
alone, rat tail collagen (10µg/ml) on PLL, fibronectin (25µg/ml) on PLL, and laminin 
(20µg/ml) on PLL. The cells were then cultured with bFGF (Ing/ml), in the presence 
of insulin (5.7µg/ml), with or without 5µM forskolin for 20 hr. 
On PLL alone, fewer cells attached and flattened at 3 hr compared to laminin: 1764 ± 
216 (SEM, n=3) in PLL compared to 2449 ± 248 (SEM, n=3). When cultured in 
bFGF (ing/ml), both in the presence and absence of forskolin, survival was never 
greater than 10% at 20 hr on PLL alone. Cells plated on collagen died before they 
could attach and flatten, this might be due to impurities in the collagen. 
In contrast, precursors attached to fibronectin in similar numbers to those seen on 
laminin at 3 hr. These cells, in the presence of 5.7µg/ml insulin, showed a similar 
dose-response to bFGF at lower concentrations of bFGF, both with and without 
forskolin, as precursors plated on laminin. At ing/ml bFGF, a dose producing 
maximal survival on laminin, there was lower survival on fibronectin at 20 hr. In the 
absence of forskolin, this difference was not significant (P < 0.1; Student's t test), but 
in the presence of forskolin the difference was just significant (P < 0.05; Student's t 
test). The average of two dose-response curves ± forskolin on fibronectin is shown in 
Fig 5.9, together with a dose-response curve for bFGF ± forskolin on laminin from 
five experiments (previously shown in Fig 5.6B) 
FGFs in the presence of IGFs or insulin do not promote the long term survival of 
precursors 
When Schwann cell precursors were cultured in bFGF (3ng/ml) in the presence of 
100ng/ml IGF-1,100% survival was seen at 20 hr. If the culture period was extended 
to 44 hr, this level of survival dropped to 28% of the population attached at 3 hr, even 
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if the culture medium was replaced with fresh defined medium containing newly 
thawed growth factors (Fig 5.10). 
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Table 5.1 Screen of candidate survival factors for E14 rat Schwann cell 
precursors 
The agents were tested in a 20 hr survival assay on LN-coated glass coverslips. The 
cells were stained for p75LNGFr. In all cases where survival is indicated as negative, 
no more than 10% of p75LNGFr+ cells found at 3 hr post-plating were alive at 20 hr. 
Comment: (A) Tested in the presence of I µM insulin in defined medium. (B) 
Tested as in (A), with and without 5µM forskolin. (C) Tested as in (A) but also in 
medium containing 50ng/ml IGF-1; both conditions were tested with and without 5µ. M 
forskolin. 
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Table 5.1 Screen of candidate survival factors for E14 rat Schwann 
cell precursors 
Agent Concentration Survival Comment 
........................................................................ IGF-1 ......... ......... .0.... ...................................... .................... 0.01-10 ng/ml - 
.................... ..................... C 
IGF-2 0.01-100 ng/ml - C 
Insulin 0.005-10,000 ng/ml - C 
PDGF-AA 0.3-30 ng/ml - C 
PDGF-BB 0.5-50 ng/ml - C 
NGF 20-2000 ng/ml - B 
BDNF 0.2-20 ng/ml - A 
NT-3 0.1-10 ng/ml - C 
CNTF 2-10 ng/ml - C 
LIF 10-100 ng/ml - B 
SCF (Steel factor) 1-100 ng/ml - B 
a-MSH 10-100 nM - A 
TPA 5-50 nM - A 
Cat+-ionophore, A23187 0.01-100 nM - A 
TGF- il 0.1-10 ng/ml - A 
TGF-02 0.1-10 ng/ml - A 
Basic FGF 0.01-10 ng/ml + C 
Acidic FGF 0.01-100 ng/ml + C 
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Table 5.1 Screen of candidate survival factors for E14 rat Schwann cell 
precursors 
Agent Concentration Survival Comment 
.............. ............... K-FGF 0.01-100 n ml ........................................ + .......................................... C 
K140 (K-FGF variant) 0.01-100 ng/ml + C 
ET-1 0.001-100 nM + C 
ET-2 0.001-100 nM + C 
ET-3 0.001-100 nM + C 
NDF-02 0.1-30 ng/ml + C 
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Figure 5.1 Insulin or IGFs are required for bFGF-mediated rescue of Schwann 
cell precursors 
Results of a 20 hr survival assay in the presence of a constant concentration (3ng/ml) 
of bFGF. Cell were stained for p75LNGFr at 20 hr and survival calculated as 
described in Chapter 2. All three insulin growth factors promote precursor survival in 
bFGF in a dose-dependent manner. The points represent an average of three 
experiments for IGF-1 and IGF-2, and five experiments for insulin, error bars indicate 
SEM. 
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Figure 5.2 Survival of Schwann cell precursors in the presence of I)FGF and IGF 
Phase micrographs of precursors after 20 hr in culture (A) 1)M denotes culture in 
defined medium alone. (B) FGF + IGF denotes culture in the presence of IOOng/ml 
IGF-1 and 3ng/ml bFGF. In defined medium alone. most cells are dead after 20 hr; in 






Figure 5.3 bFGF is required for IGF-1-mediated rescue of Schwann cell 
precursors 
Cells were cultured in a constant concentration (100ng/ml) IGF-1 with increasing 
concentrations of bFGF. The response to bFGF showed a dose-dependent increase. 
Culture and immunolabelling is as described in the legend to Fig 5.1. The points 
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Figure 5.4 Effects of aFGF and K-FGF on Schwann cell precursor survival 
Survival assays were performed as described in the legend to Fig 1, using increasing 
concentrations of aFGF or K-FGF in the presence of (A) a constant concentration of 
IGF-1 (100ng/ml), or (B) a constant concentration of insulin (1µM). (A) Both aFGF 
and K-FGF were capable of rescuing 100% of precursors in the presence of IGF-1. 
(B) High concentrations of insulin failed to mimic the survival effects of IGF-1. The 
points represent an average of three experiments, error bars indicate SEM. 
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Figure 5.5 Elevation of cAMP does not enhance survival of precursors in bFGF 
and IGF 
Survival assays were performed both with and without the addition of 5µM forskolin. 
Constant concentrations of bFGF (3ng/ml) were used in the presence of increasing 
concentrations of (A) IGF-1 and (B) IGF-2. In (C), a constant IGF-1 concentration of 
l00ng/ml was used with increasing concentrations of bFGF. No significant 
enhancement of survival or shift in the dose-response curves was produced by 
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Figure 5.6 Elevation of cAMP enhances survival of precursors in the presence of 
bFGF and insulin 
Survival assays were performed both with and without 5µM forskolin, in the presence 
of (A) a constant concentration (3ng/ml) of bFGF with increasing concentrations of 
insulin, and (B) a constant concentration (1µM) of insulin with increasing 
concentrations of bFGF. In (A), forskolin enhanced the maximal survival level to 
100% without altering the EC50 for insulin. In (B), in the presence of forskolin, the 
maximal survival level was increased to 100% and there was a 5-fold decrease in the 
EC50 value for bFGF. The points represent an average of four experiments in (A) and 
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Figure 5.7 Elevation of cAAMP promotes the survival effects of aFGF, K-FGF 
and K140 in the presence of insulin 
Survival assays were performed both with and without 5EtNM forskolin, in the presence 
of a constant concentration (1µM) of insulin and increasing concentrations of (A) 
aFGF, (B) K-FGF, and (C) K-140. (A) The survival promotion by forskolin in the 
case of insulin/aFGF is similar to that seen with insulin/bFGF, with the EC50 lowered 
-9-fold. (B) and (C) Forskolin produced a striking enhancement of survival, 
increasing the maximal survival in both factors from 20% to 100%. A decrease in the 
EC50 by -5 fold in the case of K-FGF and by -3-fold in the case of K-140 was also 
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Figure 5.8 The effect of hormone omission from defined medium on precursor 
survival 
The standard survival assay was performed in the presence of I uuný, nil IGF and 
3ng/ml bFGF. The defined medium was deficient in one or all of the hormones 
present in the standard medium as indicated in the graph. Omission of the hormones 
did not significantly affect precursor survival (Students I test; P -' 0.5), except for the 
omission of triiodothyronine (T3) where the difference was statistically significant 
(Students / test; P --- 0.01). NORM: standard defined medium, -DEX: without 
dexamethasone; -PROG: without progesterone; -T3: without triiodothyronine; -T4: 
without thyroxine, -ALL: without dexamethasone, progesterone, triiodothvronine and 
thyroxine. The points represent an average of two experiments, error bars indicate 
SD. 
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Figure 5.9 The effect of substrates on precursor survival 
A standard survival assay was performed in a constant concentration (1 µh1) of insulin 
with increasing concentrations of bFGF, both in the absence and presence (+ F) of 
5µM forskolin. The dose-response curve for bFGF with cells on tibronectin-coated 
coverslips (solid bars) represents the average of 2 experiments, error bars indicate SD. 
The dose-response curve for bFGF with cells on laminin-coated coverslips (hatched 
bars) (already shown as Fig 5.6B) represent an average of 5 experiments, error bars 
indicate SEM. The survival curves were similar when different substrates were used, 
although fibronectin was less effective at the highest bFGF concentration, both in the 
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Figure 5.10 bFGF does not promote the long term survival of precursors 
Cells were cultured in 3ng/ml bFGF and l00ng/ml IGF-1 and immunolabelled for 
p75LNGFr at 20 hr or 44 hr after plating. The culture medium was replaced at 20 hr 
in the 44 hr cultures. The survival of the cells in this growth factor combination drops 
rapidly after 20 hr in culture. 
error bars indicate SD. 
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DISCUSSION 
Schwann cell precursors die by apoptosis when cultured in defined medium but will 
survive if the same medium has been conditioned by DRG neurones. This observation 
suggested that these cells require the presence of neurone-derived growth factor(s) for 
their survival in culture. Many growth factors were tested for their ability to support 
precursor survival in culture; three members of the fibroblast growth factor family, 
aFGF, bFGF and K-FGF, endothelins 1,2 and 3, and neu differentiation factor (NDF) 
02 were identified as potential survival factors in combination with an insulin growth 
factor. This Chapter has described a detailed analysis of survival conditions with 
FGFs and IGFs for the precursors in vitro. 
Screening of candidate survival agents for E14 rat Schwann cell precursors 
All the factors described in Table 5.1 and screened in the survival assay have been 
shown to affect either CNS glia, cells of the neural crest, or their derivatives, including 
Schwann cells. Despite many of the growth factors exhibiting survival effects on cells 
of other lineages, only the growth factors mentioned above were able to promote the 
survival of Schwann cell precursors. 
Initial studies of all the factors were performed in medium that contained high levels 
(1µM) of insulin, a concentration that activates the type 1 IGF receptor (Rechler and 
Nissley, 1985). Later assays also included the addition of the cAMP-elevating agent 
forskolin, and the substitution of IGF-1 for insulin, as indicated in the table. Addition 
of forskolin or the presence of IGF did not enhance the effects of most of the factors 
that showed less than 10% survival in insulin alone. The addition of forskolin to high 
levels of insulin, and the substitution of IGF-1 for insulin, were effective at enhancing 
the survival effects of FGFs and will be discussed in detail below. 
As described in Chapter 1, PDGF-AA and -BB, BDNF, NT-3, SCF and TGFßs are all 
present in neurones during development (Ernfors and Persson, 1991; Flanders et at., 
1991; Hutchins and Jefferson, 1992; Schecterson and Bothwell, 1992; 
Langtimm-Sedlak et at., 1996). Similarly Schwann cells of perinatal and adult nerves 
have been shown to produce the above factors, with the exception of SCF (Scherer and 
Salzer, 1996). In addition, Schwann cells synthesize NGF, CNTF and LIF. Thus the 
growth factors are available in the nerve to act as paracrine or autocrine factors. 
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The lack of effect of all of the growth factors on the Schwann cell precursors was 
unexpected (Table 5.1). It is possible that, in some cases, these cells do not express 
functional receptors for the growth factor, or that the receptor number is low and 
occupancy cannot promote the survival of these cells. Weinmaster and Lemke (1990) 
have shown that elevation of cAMP in rat Schwarm cells increases the number of 
PDGF ß receptors. The time course of this increase is slow, however, with the 
increase in receptor mRNA first appearing after 24 hr. Even if elevating cAMP could 
increase receptor number in the precursors, the time course of death is so rapid that 
this could not promote the survival of these cells. Addition of forskolin to the 
precursor cultures with all the above growth factors showed no increase in survival. 
The lack of effect of NGF on precursor survival is important since this was present in 
the NCM that produced precursor survival (Chapter 3; Jessen et al., 1994). These 
T _^. 
results show that the survival produced by NCM is not due to NGF alone. 
a-melanocyte stimulating hormone has been shown to increase the number of 
melanocytes differentiating from quail neural crest (Satoh and Ide, 1987) and to 
induce melanogenesis from melanoblasts in newborn mouse skin (Hirobe and 
Takeuchi, 1977), via induction of adenyl cyclase (Abe et at., 1969; Hirobe and 
Takeuchi, 1977) but there is no evidence for survival factor activity in other systems. 
The phorbol ester TPA activates protein kinase C (PKC) and thus can mimic the 
ligand-receptor binding effects of growth factors such as PDGF, FGFs and heregulins 
(Van der Geer, et al., 1994; Mochly-Rosen, 1995), as well as neurotransmitters and 
hormones that are activators of this enzyme. TPA has been reported to promote the 
survival of DRG neurones in culture (Montz et al., 1985) and enhances differentiation 
of oligodendrocytes in culture (Yong et al., 1988). The lack of effect of this agent on 
precursors would suggest that activation of PKC is insufficient to promote survival of 
these cells. 
The Cat+-ionophore A23187 increases intracellular calcium by influx across the 
plasma membrane and by release of calcium from intracellular stores (McConkey and 
Orrenius, 1994). Ca 2+ is a second messenger for many intracellular pathways, 
including those that involve 1,2-diacylglycerol (DAG) and PKC (Van der Geer et al., 
1994), and has been implicated as an effector of apoptosis in thymocytes (Wyllie et 
al., 1984) and as an inhibitor of apoptosis as in the case of sympathetic neurones 
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(Edwards et al., 1991). Since in precursors, the developmental acquisition of survival 
in defined medium parallels the expression of the Cat+-binding protein, described in 
Chapter 3, the presence of nonphysiological concentrations of Ca 2+ would be predicted 
not to promote the survival of the Schwann cell precursors and this is indeed the case. 
These results indicate that survival of the precursors involves specific growth factor/ 
receptor interactions and that activation of PKC and increased intracellular Ca 2+ 
cannot mimic the effect of the survival factor(s). 
bFGF in combination with an insulin growth factor supports survival of E14 
Schwarm cell precursors 
In these experiments, bFGF supports survival of precursors when added in the 
presence of either insulin, IGF-1 or IGF-2. As described above, bFGF has been 
reported to be a survival factor for chick nonneuronal crest cell derivatives in vivo 
(Kalcheim, 1989) and for chick and rat neural crest cells in vitro (Kalcheim, 1989; 
Bannerman and Pleasure, 1993). In this respect, the Schwann cell precursors have 
retained the growth factor requirement shown by cells at an earlier stage in 
development. 
The level of survival observed with a given concentration of bFGF depends on the 
insulin growth factor present: the survival promoting effects of these factors are in the 
order IGF-1 > IGF-2 > insulin. These three factors are homologous, with IGF-1 and 
IGF-2 exhibiting an amino acid sequence homology of 62% to each other, and 43% 
and 41% homology, respectively, to proinsulin (Sara and Hall, 1990). Three receptors 
have been identified so far for these growth factors (reviewed in Neely et al., 1991). 
The insulin and the type 1 IGF receptors exhibit both structural and functional 
similarities. They are heterotetramers composed of disulphide-linked a and ß subunits 
(CC2132); the two a subunits form the extracellular ligand-binding domain, while the ß 
subunits are transmembrane proteins with tyrosine kinase activity. The type 2 IGF 
receptor is also the cation-independent mannose-6-phosphate receptor with no 
homology to either the insulin or the type 1 IGF receptor; this single chain 
transmembrane protein does not have kinase activity but is thought to act via G-protein 
linkage (Humbel, 1990; Neely et al., 1991). These receptors exhibit variable binding 
for the growth factors: the insulin receptor binds insulin with high affinity, IGF-2 with 
lower affinity and IGF-1 with lowest affinity; the type-1 IGF receptor binds IGF-l and 
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IGF-2 with high affinity and will also bind insulin at lower affinity, requiring the 
presence of high levels of insulin for activation (Rechler and Nissley, 1985; Sara and 
Carlsson-Skwirut, 1988); the type-2 IGF receptor binds IGF-2 with high affinity, IGF- 
1 with low affinity and does not bind insulin. 
On the basis of these receptor affinities, it would appear that the receptor present on 
the Schwann cell precursors is likely to be the type 1 IGF receptor, since it responds to 
IGF-1, IGF-2 and high concentrations of insulin (1µM) (Rechler and Nissley, 1985; 
Sara and Carlsson-Skwirut, 1988; Neely et al., 1991). The mRNA for this receptor has 
been detected in Schwann cells in vivo and in vitro (Cheng et at., 1996) and the 
receptor is expressed on neonatal rat Schwann cells in vitro (Schumacher et at., 1993; 
Stewart et at., 1996b). The requirement for high insulin concentrations suggests that 
the survival effect is not mediated by the insulin receptor since the combination of 
bFGF with concentrations of insulin in the 5-50ng/ml range (-0.1-1.0nM) produced 
low levels of survival (Fig 5.1). 
Both IGF and high concentrations of insulin can support the short-term survival of 
oligodendrocyte progenitors and oligodendrocytes in vitro without the presence of 
additional growth factors (Barres et al., 1992), and IGF-1 can support the survival of 
Purkinje neurones in culture (Torres-Aleman et al., 1992). IGF-1 and insulin block 
apoptosis induced by serum deprivation in Rat-1 fibroblasts and COS-1 cells 
transfected with ICE by preventing processing and subsequent activation of this 
protease (Jung et al., 1996). However, the presence of both an FGF and an IGF or 
insulin is required for Schwann cell precursor survival (Figs 5.1,5.3,5.4), suggesting 
either that the activation of IGF receptors is not sufficient to promote the survival of 
these cells, or that FGFs modulate the type-1 IGF receptors as has been shown in other 
cell types. Purified glial cells from hypothalamic cultures express increased numbers 
of type-1 IGF receptors in response to bFGF (Pons and Torres-Aleman, 1992); 
similarly, bFGF increases the number of IGF receptors expressed by cultured vascular 
smooth muscle cells (Ververis et al., 1993). It is possible, therefore, that the presence 
of bFGF upregulates the number of type-1 IGF receptors on the Schwann cell 
precursors and thus enhances the response to IGF-1, IGF-2 or insulin and thereby 
promotes survival. This action would have to be rapid, however, since the growth 
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factors are added to the precursor cultures at 3 hr post-plating and the precursors begin 
to die within 5 hr post-plating if the correct growth factors are not present. 
The actions of IGFs are modulated by binding proteins; six IGF binding proteins 
(IGFBP) have been described so far. These binding proteins can enhance or inhibit 
IGF activity, possibly by affecting the binding of IGF to receptors (Elgin et al., 1987; 
Sara and Hall, 1990; Lamson et al., 1991). Schwann cells have been shown to express 
IGFBP-5 and another IGFBP with a molecular weight consistent with either IGFBP- 4 
or -6 (Cheng et at., 1996). The level of IGFBP-5 is upregulated in these cells by the 
action of IGF-1 which appears to protect the binding protein from proteolysis. It has 
been shown that bFGF can modulate the synthesis of one of the IGFBPs in cultures of 
purified hypothalamic neural cell cultures (Ernst and Rodan, 1990; Pons and Torres- 
Aleman, 1992) and of IGFBPs 2 and 3 in cultures of rat astrocytes (Loret et al., 1991). 
This represents another mechanism by which FGFs could affect the response of the 
Schwann cell precursors to IGFs, but, as with the possible upregulation of IGF 
receptors, this effect would have to be rapid. 
As described earlier, high concentrations of insulin activate the type-1 IGF receptor 
(Sara and Hall, 1990) and in other systems such as cultured rat sympathetic 
neuroblasts (DiCicco-Bloom and Black, 1988) and rat oligodendrocytes (Barres et al., 
1992) both IGF-1 and high concentrations of insulin produce similar responses. In the 
system described here, however, the synergy of insulin and IGF with bFGF are not 
interchangeable (Fig 5.1). The presence of bFGF and IGF-1 promoted the survival of 
100% of precursors at 20 hr, but at I µM insulin the survival in bFGF was maximally 
50%. When the insulin concentration was increased to 4µM the survival in the 
presence of bFGF actually dropped by 10%, suggesting that the difference in effect 
was not due to a sub-optimal concentration of insulin. It is possible that the survival 
response may be enhanced by signalling via type 2 IGF receptors that do not bind 
insulin: these receptors are expressed by Schwann cells in culture (Stewart et al., 
1996b). However, it is not clear whether the type 2 receptor has a role in mediating 
effects of IGFs in other systems (Neely et al., 1991). The modulating actions of 
IGFBPs may also be involved in the IGF/insulin differences; these have been shown to 
bind and enhance the mitogenic effect of IGF-1 on fibroblasts, but do not affect the 
response of these cells to insulin (Elgin et al., 1987; Conover et al., 1990). 
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Alternatively, IGF-1 may protect the IGFBPs from rapid proteolysis (Cheng et al., 
1996), an effect that may not be mimicked by insulin if it does not bind efficiently to 
IGFBPs. 
Four hormones are present in the standard defined medium used in these experiments, 
dexamethasone, progesterone, thyroxine and triiodothyronine. Oligodendrocyte 
progenitors have been reported to respond to progesterone by increased survival 
(Barres et al., 1993) and both dexamethasone and triiodothyronine can influence the 
timing of oligodendrocyte differentiation from precursors (Barres et al., 1994b). In 
Schwann cells, progesterone has been reported to increase myelin sheath formation 
after lesion and can be synthesized by these cells (Koenig et al., 1995). Omission of 
the hormones from the precursor culture medium in the presence of bFGF and IGF, in 
turn or all together, did not result in a dramatic decrease in precursor survival. 
However, omission of triiodothyronine gave a statistically significant decrease in cell 
survival but this effect was lost when all four hormones were omitted (Fig 5.8). This 
may reflect the requirement for triiodothyronine in the presence of the other hormones, 
whose effects may be deleterious for precursor survival in its absence. 
Acidic FGF and K-FGF also synergize with an IGF to promote precursor 
survival 
Both aFGF and K-FGF were able to promote the survival of the precursors in 
combination with an insulin growth factor. The effect of K-FGF as a survival agent is 
important since this is a secreted form of FGF, while aFGF and bFGF do not possess 
conventional signal sequences (Delli-Bovi et al., 1988; Basilico and Moscatelli, 1992). 
As with bFGF, combination of these factors with IGF produced 100% survival, while 
combination with insulin rescued far fewer cells (Fig 5.4 B). Acidic FGF promoted 
similar survival to bFGF under these conditions (Figs 5.1,5.4 B) while K-FGF was 
able to rescue only 20% of the cells. The truncated K-FGF molecule, K140, that has 
been reported to have five times higher biological activity than K-FGF (Bellosta et al., 
1993), had a similar pattern of survival to K-FGF in insulin (Fig 5.7 C), and in line 
with higher biological activity, the EC50 in insulin showed a three-fold decrease in 
concentration compared to K-FGF. 
In other experiments, it has been shown that FGF-5, and in vitro translates of int-2 
(FGF-3) and KGF (FGF-7) do not have survival activity in this assay Q. Gavrilovic, 
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M. Mattieu and K. R. Jessen, unpublished data) suggesting a selective response to the 
FGF receptors present on the Schwann cell precursors. As mentioned above, the 
different members of the FGF family bind to the four mammalian high affinity FGF 
receptors with varying affinities. Since aFGF, bFGF, and K-FGF bind to FGFR-2 
with similar affinities, it is a good candidate for the receptor responsible for the 
survival signal in these cells. 
cAMP enhances the survival effects of FGFs in insulin 
The addition of forskolin to cultures of precursors in the presence of FGFs and insulin 
increased the total number of cells surviving at 20 hr and shifted the dose-response 
curves to the left, indicating an increase in receptor affinity (Figs 5.5,5.6,5.7). In the 
presence of IGF-1 or IGF-2, however, there was no significant change in either the 
cell survival or receptor affinity in the presence of bFGF. If forskolin increased the 
binding affinity of FGF for the receptor, there should be some difference in the EC50 
seen in bFGF/IGF. This was not the case, however, suggesting that the enhanced 
survival is a result of an increase in affinity of insulin for the IGF type-1 receptor (Fig 
5.6 A, B). The increase in the number of cells surviving in the presence of 
insulin/FGF and forskolin may be due to recruitment of cells previously unresponsive 
to insulin. This could occur either by upregulation of IGF receptor expression by 
cAMP, or by the enhancement of intracellular signals generated in response to 
insulin/type-1 receptor binding. Synergy between cAMP elevation and insulin action 
has been reported in fibroblasts, enhancing mitogenesis (Rozengurt et al., 1981), and 
forskolin has been reported to increase the number of type-1 IGF receptors on 
Schwann cells in culture (Schumacher et al., 1993). This increase in receptor number, 
however, was observed after 3 days exposure to the factors. Such an effect may be 
relevant in vivo, where cAMP-elevating signals and IGF may play a role in precursor 
survival, but, as described earlier, receptor synthesis de novo in this in vitro system 
would hardly be rapid enough to influence the survival of these cells. 
FGFs and IGFs are not mitogenic for precursors 
Both IGFs and FGFs are well known mitogens for many cell types (reviewed in Sara 
and Hall, 1990; Basilico and Moscatelli, 1992). This combination of growth factors, 
in the presence of elevated cAMP, is mitogenic for Schwann cells in culture (Stewart 
et al., 1991; Schumacher et al., 1993). The precursors, however, failed to divide in 
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response to these factors indicating that the regulation of DNA synthesis differs 
between these cells and Schwann cells. Thus the response of cells to this combination 
of growth factors is developmentally controlled. Work by Z. Dong (Dong et al., 1995) 
has shown that the cells develop the ability to proliferate in response to this growth 
factor combination with a time course that parallels the acquisition of survival in 
defined medium, and in Chapter 6, this response is used as one of the distinguishing 
features of the precursor to Schwann cell transition. 
The effect substrate on precursor survival 
The substrate used for the culture conditions appeared to play an important role in 
precursor survival. All the experiments described here were performed on laminin 
coated coverslips, but identical experiments on PLL coated coverslips resulted in the 
survival of no more than 10% of the starting population. In contrast, fibronectin 
coated coverslips promoted similar survival to laminin at low concentrations of bFGF 
(Fig 5.9). However, in both experiments on fibronectin, a concentration of bFGF 
(ing/ml) that produced maximal survival response on laminin, was slightly less 
effective on fibronectin; further experiments would reveal whether this is a real 
phenomenon. 
The solutions of both laminin and fibronectin used are relatively crude preparations 
which may contain other growth factors. It is possible that the survival effects 
observed with IGFs and FGFs require these additional factors for their affect. 
However, several batches of laminin were used during the course of these experiments 
and no differences in survival were observed. The lack of survival in PLL may be due 
to cytotoxic effects of this compound that are negated by coating these coverslips with 
laminin or fibronectin. Alternatively, it may be because the precursors require the 
presence of extracellular matrix molecules for survival, since the PLL coverslips do 
not kill neonatal Schwann cells. Both laminin and fibronectin are found along the path 
of migrating neural crest cells (reviewed in Bronner-Fraser, 1993) and laminin is 
associated with the earliest axons growing into the periphery in the chick (Rogers et 
al., 1986). Integrin receptors for extracellular matrix molecules have been described 
on both neural crest cells (reviewed in Bronner-Fraser, 1993) and on Schwann cells 
(Lefcort et at., 1992; Niessen et at., 1994). Addition of bFGF to cultures of chick 
neural tube cells promotes the adhesion of these cells to collagen, laminin or 
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fibronectin substrates by upregulating (31 integrins (Kinoshita et al., 1993). Moreover, 
clustering of integrins can induce intracellular changes such as protein phosphorylation 
(Kornberg et al., 1991). Embryonic chick ciliary ganglion neurones require the 
binding of laminin to the integrin receptor ßl for bFGF to promote the survival of 
these neurones (Schmidt and Kater, 1995). Therefore attachment of the precursors via 
integrins may be important in promoting their survival in conjunction with exogenous 
growth factors. 
FGFs and IGFs are present in the developing nerve 
For these factors to influence the development of the Schwann cell precursors they 
must be present in the PNS at an appropriate time. Acidic FGF has been reported to 
be absent from E15 DRG and is first detected at both the mRNA and protein levels in 
neurones of the E18 rat (Oellig et al., 1995), but in the same study 5100 protein is not 
found until E21, some 4-5 days after it is first detectable by immunocytochemistry as 
described in Chapter 3. The earliest available data for the expression of bFGF in vivo 
is that of the E18 rat where it is detectable by immunocytochemistry in DRG neurons 
(Gonzalez et al., 1990). Both aFGF and bFGF are present in DRG neurones isolated 
from E15 rat and maintained in culture (Neuberger and De Vries, 1993). In the chick, 
mRNAs for aFGF and bFGF protein are expressed from E6 onward (approximately 
equivalent to E14 rat) in spinal cord and DRG neurones (Kalcheim and Neufeld, 1990; 
Schnurch and Risau, 1991). Acidic FGF is found at high levels in the adult rat sciatic 
nerve, while bFGF is not detected (Eckenstein et al., 1991). The distribution of K- 
FGF in the developing peripheral nervous system has yet to be documented, but 
mRNA for K-FGF has been found at early stages in mouse development (Hebert et al., 
1990). 
As yet there is no direct localization of any of the FGF receptors to Schwann cells or 
their precursors. The mRNA for FGFRI has been detected in the rat DRG at E14 
(Wanaka et al., 1991). Oellig et al. (1995) report that mRNA for both FGFR1 and 
FGFR2 are associated with DRG neurones from E15 in the rat, but that the glial cells 
are negative; FGFR3 and FGFR4 are absent from the developing DRG. The 
radioactive detection method used in this study shows a diffuse signal throughout the 
early DRG and it is impossible to say with certainty that the glial cells do not possess 
FGFRs. 
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IGF-1 and IGF-2 mRNA are expressed throughout the developing rat embryo, and at 
E15 are found in undifferentiated mesenchyme of the developing limb, around the 
spinal ganglia and sympathetic trunk (Bondy et al., 1990). These studies also show 
IGF-1 mRNA in mesenchymal cells condensing around the developing nerve at E15. 
Strong IGF immunoreactivity has been detected within chick peripheral nerves 
(Ralphs et al., 1990) and immunoreactivity for IGF-1 has been found in Schwann cells 
of adult rat sciatic nerve (Cheng et al., 1996). 
The distribution of IGF receptors on cells of the developing nervous system have not 
been extensively studied. Bondy et al, (1990) have found type-1 IGF receptor mRNA 
throughout the embryonic nervous system and associated with the DRG. As described 
earlier, type-1 receptor mRNA has been detected in adult rat Schwann cells in vivo 
(Cheng et al., 1996). Schwann cells from neonatal nerves possess type-1 receptors as 
inferred from radiolabelled IGF-1 binding studies; non-radioactive IGF-1 was most 
effective at blocking radiolabelled IGF-1 binding, and 1µM insulin was only partially 
effective (Stewart et al., 1996b). Type-2 receptors are also present on these neonatal 
Schwann cells and in fact are expressed at higher levels in Schwann cell precursors 
(Stewart et al., 1996b; H. J. S. Stewart, personal communication). 
The distribution of FGFs and IGFs suggest that these factors are spatially and 
temporally available in the developing embryo for trophic support of the Schwann cell 
precursors. 
The effect of FGFs and IGFs on precursor survival is only short term 
Despite promoting the survival of 100% of the precursors in a 20 hr assay, bFGF and 
IGF or bFGF, insulin and forskolin cannot support long term survival of these cells. 
Only 28% of the cells that have attached at 3 hr survive culture under these conditions 
for 44 hr. The short-term survival effects of aFGF have been reported in PC12 cells, 
although `short-term' is relative, since the survival in this case is two weeks in culture, 
compared to survival produced by NGF of months (Claude et al., 1988). 
Oligodendrocytes require the presence of three growth factors, an IGF, a neurotrophin 
and a neurokine for their long term survival; the presence of a single factor from each 
of these families promotes only short-term (3d) survival (Barres et al., 1993). 
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Both FGF and IGF receptors are internalized and therefore downregulated after 
ligand-binding (Sara and Hall; 1990; Walicke and Baird, 1991). Such downregulation 
may make the cells unable to respond to the survival factors after prolonged exposure. 
The precursors have not lost the ability to survive in culture, since changing the 
medium at 20 hr from one containing IGF/bFGF to one containing NDFß-2 will allow 
all the cells alive at 20 hr to survive indefinitely (Dong et al., 1995). Since the 
evidence from the experiments described here suggest that IGF receptor binding is 
critical in promoting the survival of the precursors, down regulation of this receptor 
would render cells unable to respond to the factor. It is interesting to note that NDF{3- 
2 is able to promote precursor survival in the absence of insulin or IGF-1 (Dong et al., 
1995), and thus could effect a response even under conditions where IGF receptors are 
down regulated. 
In conclusion, three members of the FGF family, aFGF, bFGF and K-FGF, can 
synergize with a member of the IGF family of growth factors to promote the short- 
term survival of Schwann cell precursors. The presence of a member from both of the 
families is required for survival. The effects of an FGF and insulin are enhanced by 
elevation of cAMP, but the substitution of an IGF for insulin produces maximal 
survival that is not significantly altered by cAMP elevation. The addition of these 
factors does not result in DNA synthesis. 
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CHAPTER 6 




In the previous chapter, many factors were tested for their ability to promote the 
survival of the Schwann cell precursors. The effects of the FGFs have been described, 
but members of two other families of growth factors also supported survival in culture: 
NDFß-2, a member of the neuregulin family of growth factors, and endothelins 1,2 
and 3. 
Neu differentiation factor 
The neu differentiation factors (NDFs) are members of the neuregulin family of 
growth factors which are alternatively-spliced products of a single gene (Ben-Baruch 
and Yarden, 1994). Members of the family have been cloned from different species, 
hence the variety of names given to the factors in the group: NDF was cloned from rat 
(Wen et al., 1992), heregulin from human (Holmes et al., 1992), acetylcholine 
receptor-inducing activity (ARIA) from chick (Falls et al., 1993), and glial growth 
factor was cloned from bovine brain (Marchionni et al., 1993); at least 15 different 
variants are known, derived from mesenchymal and neuronal tissue (Peles and Yarden, 
1993; Burgess et al., 1995). 
The precursors of these factors are membrane-associated polypeptides with isoforms 
based around a structure comprising a variable N-terminal domain, an Ig motif, a 
spacer domain with glycosylation sites, an EGF-like domain, an hydrophobic 
transmembrane region and a variable cytoplasmic tail (Wen et al., 1992; Peles and 
Yarden, 1993; Ben-Baruch and Yarden, 1994). The isoforms are designated a or ß 
depending on the sequence of the third loop in the EGF-like domain. Variation in the 
extracellular juxtamembrane region produces the subtypes 1-5 (Ben-Baruch and 
Yarden, 1994). Most NDF isoforms can be secreted, being cleaved by proteolysis in 
the juxtamembrane domain, the exception being NDFß-3 which lacks the 
transmembrane domain (Ben-Baruch and Yarden, 1994; Burgess et al., 1995); the 
secreted rat NDFs have molecular weights of - 40-44kD. However, NDFs are also 
found in membrane-bound form which may be important in direct cell-cell signalling 
in vivo (Burgess et al., 1995). NDFs are produced by both mesenchymal and neuronal 
tissues, with pro-NDFa-2 as the predominant form in the mesenchyme and pro-NDF(3- 
1 as the major isoform in neuronal tissue (Wen et al., 1994). The presence of a 
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kringle-like domain at the N-terminus is found only in neuronally-expressed NDFs 
(Ben-Baruch and Yarden, 1994). 
Three receptors have so far been identified for NDF: Neu/ ER-2fErbB-2, HER- 
3/ErbB-3 and HER-4/ErbB-4 (Bargmann et al., 1986; Carraway et at., 1994; Tzahar et 
at., 1994; Wen et al., 1994). They are protein tyrosine kinases of the EGF-receptor 
family (Peles and Yarden, 1993) that on binding ligand form dimers (Marchionni, 
1995). The interaction of NDFs with these receptors and the subsequent intracellular 
signalling is complex. Constitutive expression of ErbB-2 by human ovary tumour cell 
lines or transfection of fibroblast cell lines with ErbB-2 cDNA does not confer high 
affinity binding for NDF on these cells and there is no phosphorylation of the receptor 
in the presence of ligand (Peles et al., 1993). Transfection of a bovine ErbB-3 cDNA 
into insect cells generated a receptor with a low affinity for NDF; in these cells and in 
fibroblasts transfected with ErbB-3 cDNA, the presence of ligand receptor resulted in 
tyrosine phosphorylation of the receptor (Carraway et al., 1994). ErbB-4 exhibits 
higher affinity for NDFs than ErbB -3 and ligand binding also produces receptor 
phosphorylation (Plowman et al., 1993a). The presence of ErbB-2 and ErbB-3 
together results in a high affinity binding site for NDFs with both receptor proteins 
being phosphorylated after binding ligand (Sliwkowski et at., 1994; Tzahar et al., 
1994) and similarly, co-expression of ErbB-2 and ErbB-4 results in phophorylation of 
both receptors in response to NDF (Plowman et at., 1993b). None of the NDF 
isoforms activate the EGF-RIErbB-1 receptor (Peles and Yarden, 1993) but NDF has 
been reported to inhibit EGF binding to its receptor by interference with 
heterodimerization of ErbB-1 with other ErbB proteins (Karunagaran et al., 1995). 
As described above, following ligand binding and receptor dimerization, the receptors 
undergo autophosphorylation on 5 tyrosine residues that are not part of the kinase 
domain. These residues act as docking sites for proteins that contain the src- 
homology-2 domain that include phospholipase Cy, phosphatidylinositol 3' kinase, and 
the GTPase activating protein of ras. Activation of the ErbB receptors by NDFs 
results in an increase in intracellular calcium, increased lipid turnover, increased 
glucose transport and rapid induction of c-fos and c-jun (Ben-Baruch and Yarden, 
1994). 
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The ß isoforms of NDF are active in both survival and mitogenesis of Schwann cells 
and Schwann cell precursors while the a isoforms are ineffective (Dong et al., 1995). 
NDFs are survival factors for other cells of neural origin, affecting cells of the cranial 
ganglia in vivo (Meyer and Birchmeier, 1995), astrocyte survival in vitro (Pinkas- 
Kramarski et al., 1994) and teloglia at developing neuromuscular junctions 
(Trachtenberg and Thompson, 1996). 
Endothelins 
The endothelins (ETs) were originally identified as factors released by endothelial 
cells causing prolonged vasoconstriction (Yanagisawa et al., 1988). They are small 
peptide growth factors of 21 amino acids, -MW 2.5 kD, with very similar amino acid 
sequences, ET-2 differs from ET-1 in 2 amino acids and ET-3 differs from ET-1 in 6 
amino acids (Ohlstein and Ruffolo, 1995). They form identical structures with two 
intrachain disulphide bonds, an identical 6 amino acid C-terminal sequence 
(Yanagisawa et al., 1988; Ohlstein and Ruffolo, 1995) and are structurally similar to 
the snake venom toxins - the sarafotoxins (Yanagisawa and Masaki, 1989). 
Each ET is encoded by a separate gene and is synthesized as a precursor protein of 
-200 amino acids (Yanagisawa et al., 1988; Simonson and Dunn, 1991). The 
precursor protein, prepro-ET, is cleaved by dibasic-pair-specific endopeptidases 
(Yanagisawa et al., 1988) to yield pro-ET, also known as big-ET (Yanagisawa et al., 
1988; Simonson and Dunn, 1991). This precursor peptide is then cleaved to give 
mature ET by a neutral metalloprotease, the endothelin converting enzyme, although 
other enzymes such as serine proteases may also be able to generate mature ET from 
the precursor protein (Ohlstein and Ruffolo, 1995). 
To date, two main subtypes of endothelin receptor have been described, ETA and ETB. 
ETA receptors bind ET-1 and ET-2 with high affinity and ET-3 with low affinity, 
while ETB receptors are non-isopeptide selective, binding all three peptides with equal 
affinity (reviewed in Miller et al., 1993). These receptors have been cloned and are 
encoded by separate genes (Arai et al., 1990; Sakurai et al., 1990). The ETB receptors 
have been tentatively classified into two groups, ETB1 and ETB2 depending on their 
response to receptor antagonists; how these relate to the cloned ETB receptor is not yet 
known (Douglas et al., 1994; Pollock et al., 1995). Both subtypes have been found in 
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brain (Sokolovsky et al., 1992). A third receptor that preferentially binds ET-3 has 
been reported in Xenopus dermal melanophores and named ETc but it is unclear 
whether this is a species homologue of ETA or ETB receptors (Karne et al., 1993). 
The receptors are all members of the G-protein-coupled seven transmembrane domain 
superfamily and can activate a number of signal transduction pathways (Nambi et al., 
1995). The effects of endothelin binding to the receptors include activation of 
phospholipases C, D and A2, generation of inositol-1,4,5-trisphosphate and DAG, 
influx of Ca2+ through opening of Ca2+ channels, activation and inhibtion of adenylate 
cyclase by ETA and ETB respectively, guanylate cyclase activation, and protein kinase 
C activation (Nambi et al., 1995) The pathway activated depends on the cell type and 
the receptor subtype. 
The receptor subtypes present can be distinguished by use of peptide antagonists or 
agonists that have receptor specificity. Two antagonists have been used in the present 
study: BQ-123 and IRL 1038. BQ-123 is a cyclic pentapeptide that is highly specific 
for ETA receptors and acts as a competitive antagonist (Ihara et al., 1992; Vigne et al., 
1993). IRL 1038 is an ETB receptor-selective antatgonist and is an 11 amino acid 
peptide corresponding to the C-terminal portion common to all ETs, with a single 
disulphide link between Cys11-Cys'5([Cysll-Cys15]-ET-1(11-21)) (Urade et al., 1992). 
ET-1, but not ET-2 or -3 is produced by endothelial cells (Ohlstein and Ruffolo, 1995) 
while ET-3 has been reported to be the major endothelin produced by neuronal tissue 
(Willette et al., 1995). Many cell types synthesize endothelins, including vascular 
smooth muscle, bronchial smooth muscle, mesangial cells, and fibroblasts (Ohlstein 
and Ruffolo, 1995). The initial studies of endothelin action were on the cardiovascular 
system where action of ET-1 via ETA receptors lead to potent vasoconstriction by 
stimulating smooth muscle contraction. Both ET-1 and ET-3 were equipotent for ETB 
receptor activation and lead to vasodilation. However, it is now clear that ETB 
receptors are also responsible for smooth muscle contraction including vascular 
smooth muscle (Bax and Saxena, 1994). ETs have also been implicated in renal 
function, pulmonary bronchoconstriction and tone of non-vascular smooth muscle; 
they also appear to function as endocrine hormones affecting the adrenal glands, 
thyroid and parathyroid glands and may play a role in smooth muscle contraction 
during pregnancy (Ohlstein and Ruffolo, 1995). 
185 
Endothelins have growth factor activity, acting as potent mitogens for many cell types 
including vascular smooth muscle cells (Komuro et al., 1988), 3T3 fibroblasts 
(Takuwa et al., 1989), mesangial cells (Simonson and Herman, 1993), melanocytes 
(Imokawa et al., 1992) and astrocytes (MacCumber et al., 1990). ET-1 stimulates c- 
fos and c-myc expression in vascular smooth muscle cells (Komura et al., 1988) and 
fibroblasts (Takuwa et al., 1989) and c-fos and c-jun expression in C6 glioma cells 
(Yin et al., 1992). As well as being mitogens for astrocytes, endothelins regulate gap 
junctions between the cells, causing gap junction closure (Giaume et al., 1992). 
In the CNS, endothelins are produced by neurones and endothelial cells in vivo 
(Willette et al., 1995) and can be produced by astrocytes in vitro (MacCumber et al., 
1990). ETs are widely distributed throughout the adult human brain, the major areas 
of ET production being the hypothalamus, the pituitary and the spinal cord (Takahashi 
et al., 1991). Northern blot analysis of adult rat brain has revealed that ET-3 is the 
predominant isoform (MacCumber et al., 1990). ETs have been localized by 
immunocytochemistry to neurones in the dorsal horn of the adult human spinal cord 
(Giaid et al., 1989) and produce depolarization of newborn rat spinal motorneurones 
(Yoshizawa et al., 1989) indicating that they can function as neuromodulators. In the 
PNS, ET immunoreactivity has been detected in adult human DRG neurones (Giaid et 
al., 1989) and in neonatal rat myenteric neurones (Eaker et al., 1995). 
Both main subtypes of receptor are expressed on neurones in the brain, the distribution 
of subtype depending on the type of neurone, while astrocytes appear to have 
predominantly the ETB receptor (Willette et al., 1995). Binding sites for ET-1 have 
been shown throughout the developing spinal cord, localizing to the grey matter in 
adult rat (Kar et al., 1991). ET-1 also localises to glial cells of the rat DRG, with no 
significant change in binding during postnatal development (Kar et al., 1991) but the 
exact receptor subtype present on these cells has not been determined. 
Mouse mutants have been made that are deficient in ET-1, ET-3 or the ETB receptor. 
Mice deficient in ET-1 have elevated blood pressure, and homozygotes have extensive 
craniofacial abnormalities, the latter effect is possibly a result of deficiencies in cranial 
neural crest migration or survival (Kurihara et al., 1994). Mice deficient in ET-3, 
have a similar phenotype to mice that have mutant ETB receptors (Greenstein Baynash 
et al., 1994; Hosoda et al., 1994). These mice lack myenteric ganglia in the colon and 
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have white-spotted coat colour as a result of an absence of melanocytes, seemingly due 
to loss of neural crest in the absence of ET signalling. Thus ETs play a role in 
development of some derivatives of the neural crest in vivo. 
This Chapter presents data on the survival effects of NDFß-2 and ETs on Schwann 
cell precursors. Both NDFß-2 and ET-1 can act as long term survival factors but only 
NDF(3-2 makes the precursors mature into cells with a Schwann cell phenotype. In the 
presence of ET-l, the precursors do not mature and ET-1 actively blocks the 
maturation effects of NDFß-2 in vitro. 
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RESULTS 
In Chapters 3-5, p75LNGFr was used as a marker for Schwann cell precursors. As 
described in Chapter 3, Z. Dong has shown that 3-5% of cells that express this antigen 
do not express the Ll antigen and are morphologically distinct (Z. Dong, personal 
communication). In this Chapter, L1 was used as the marker for cells of the Schwann 
cell lineage in the survival assays; p75LNGFr expression was used when double- 
labelling for S 100 expression, since both S 100 and Ll used biotin-conjugated second 
layers and were therefore incompatible (see Chapter 2). 
NDFß-2 promotes Schwann cell precursor survival 
NDFß-2 was used in the 20 hr survival assay in the presence of low levels of insulin 
(5.7 ng/ml, 1nM) and 100ng/ml IGF-1 (l3nM); at the end of this time surviving 
precursors were determined by staining with the L1 antibody (Fig 6.1). NDFß-2 
promoted the survival of the precursors in a dose dependent manner, with an EC50 of 
0.25ng/ml, - 10pM (Fig 6.2). Survival of 100% was obtained with concentrations of 
ing/ml and above, although at higher concentrations the survival was greater than 
100%, indicating that NDFß-2 was mitogenic for the cells. 
NDFß-2 is a long term survival factor for precursors 
To determine whether NDFß-2 could promote long term survival of these cells, 
precursors were cultured on coverslips in 1.5ng/ml (60pM) NDFß-2 and stained for L1 
at 20,44,68, and 92 hr after plating. The medium was replaced every day and 
contained freshly thawed growth factors. The survival of the cells after the extended 
period in culture was compared to the number of cells that had attached, flattened and 
were L1 positive at 3 hr post-plating. At 20 hr, 98% of cells survived (Fig 6.3); the 
cell numbers then proceeded to increase with time, and by 92 hr after plating, the 
starting population had increased by -20%. This increase in number is a further 
indication that not only is NDF(3-2 a long term survival factor but is also a mitogen for 
these cells. 
The survival effects of NDFf3-2 seemed to be specific for Schwann cell precursors. At 
20 hr, between 12 and 18% of cells in the cultures did not express L1 and therefore 
were not precursors. It was observed that the number of contaminating cells did not 
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increase with increased time in culture; after 4 days the number of Ll negative cells 
were less than 10% of the total starting population. 
NDF(3-2 promotes the maturation of Schwann cell precursors in vitro 
It had been shown previously that Schwann cell precursors cultured in the presence of 
bFGF and 1% serum or NCM would survive long term and mature into cells that could 
survive culture in defined medium and express the SlOO protein (Jessen et al., 1994). 
Since NDFß-2 could promote long term survival of the precursors, the effect of this 
growth factor on the maturation of the precursors was studied. Three parameters were 
used to determine the extent of the precursor maturation: S 100 expression, survival of 
the cells in defined medium after plating at moderate density, and their response to 
bFGF and forskolin; as described in Chapter 5, this latter combination is mitogenic for 
Schwann cells but does not promote DNA synthesis in precursors. 
S 100 expression and survival 
Nerves from E14, E15, E17, E18 and newborn rats, were dissociated and plated, as 
described in Chapter 2, in laminin coated tissue culture wells with defined medium 
containing 1nM insulin and l00ng/ml IGF-1, together with 1.5 ng/ml (60pM) NDFß- 
2. The medium was replaced every day with fresh medium containing newly thawed 
growth factors. The cells were cultured from 1-4 days before replating in defined 
medium containing insulin and IGF-1 only, thus removing any influence from growth 
factors that may have become associated with the original substrate. In order to 
compare the S100 expression and survival in defined medium to that seen in cells 
plated directly from the nerves, the data given in Chapter 3, Figs 3.3 and 3.6, has been 
reproduced here. 
When cells were replated after 1 day in vitro, those from E14 +1 (=E15) cultures 
showed very low levels of survival, comparable to the survival seen in cells from E15 
nerves (Table 6.1). Cells from E15 +1 (=E16) cultures showed somewhat higher 
survival, in line with the increased survival seen in cells directly from E16 nerves. By 
E18, cells taken directly from the nerve showed more than 90% survival in the assay 
and this was also seen in cells from E17 +1 (=E18). Newborn nerves when cultured 
for 1 day and then replated showed 80% survival, somewhat lower than that seen in 
cells taken directly from the nerves. 
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When E14 cells were cultured for 2 days before replating (=E16) survival was similar 
that seen in cells from E16 and E15 + 1, and was higher than that seen after I day in 
vitro. After 3 days in vitro (=E17), survival had increased to around 71%, although 
this was not quite as high as that seen in cells from E17 nerves. A further day in vitro, 
E14 +4 (E=18) increased the survival after replating to -85%, similar to the number 
surviving in cultures from newborn +1 day, and only slightly less than that observed 
in cells from E18 nerves and E17 +1 cells. 
The expression of S 100 immunoreactivity in the cytoplasm of the cells increased with 
time in culture in a similar manner: few cells were positive for S 100 at E14 +1 (=E15) 
but this had increased to almost half the cells at E14 +2 (=E 16) and E15 +1 (=E 16), 
paralleling the expression seen in the developing nerve (Table 6.1). After 3 days in 
vitro, E14 +3 (=E17) the number of cells expressing S100 had increased to 75%, 
slightly lower than that seen in the nerve at E17 (95%). The expression of S100 at 
E14 +4 (=E18) had increased further to 84%, but was again slightly lower than that 
seen in cells taken from the nerve at E18 (96%). An example of the type of S100 
staining is shown in Figure 6.4 C, with cells exhibiting varying levels of S 100 
expression (note cell indicated by double arrow). The S 100 expression started as a 
nuclear stain and rapidly spread to the surrounding cytoplasm. A cell not expressing 
p75LNGFr or S100, and likely to be a contaminating cell not of the Schwann cell 
lineage, is indicated by the asterisk. 
To determine whether the cells surviving at 20 hr after plating all expressed S100, 
cells that had been cultured in NDFß-2 for 4 days were replated and cultured in 
defined medium with 1nM insulin and 100ng/ml IGF-1 for 20 hr after replating before 
staining for p75LNGFr and S100 expression. Of the surviving cells, 90% ±1 (SD, 
n=2) expressed both p75LNGFr and S 100; however, the remaining 10% of cells 
expressed p75LNGFr but were S 100 negative. 
Response to bFGF and forskolin 
The mitogenic effects of bFGF and forskolin on cells taken directly from embryonic 
and neonatal nerves had previously been determined by Z. Dong (Dong et al., 1995). 
This work revealed that cells from E14 and E15 nerves initially showed levels of 
division that reflected proliferation found in vivo in the developing nerve ( Stewart et 
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al., 1993), but that these levels fell dramatically after 5 hr culture in the presence of 
bFGF and forskolin (Fig 6.5 A). However, by E17 this combination of growth factors 
could maintain initial levels of DNA synthesis, and induced higher levels of DNA 
synthesis in cells from E18 and newborn rats. 
To determine whether the precursors became responsive to the mitogenic effects of 
these factors after culture in NDFß-2, cells were replated in defined medium with 1nM 
insulin and 100ng/ml IGF-1 and were dosed with lOng/ml bFGF and 54M forskolin 
(in the presence of 100ng/ml IGF-1 and 1nM insulin) after 3 hr in culture. The cells 
were then pulsed with BrdU for 1.5 hr after 3.5,13.5 and 18.5 hr in culture and stained 
for BrdU incorporation and L1 expression at 5 hr, 15 hr and 20 hr in culture, repeating 
the method used for the measure of DNA synthesis in cells directly from the nerve 
(Dong et at., 1995). Cells from E14 nerves replated after 1 day (=E15) showed a 
decrease in DNA synthesis over the 20 hr experimental period (Fig 6.5 B). However, 
cells from E14 +3 (=E17) and E14 +4 (=E18) both showed an increase in DNA 
synthesis in the presence of bFGF and forskolin, indicating that these cells had 
acquired the ability to respond to these factors. 
Morphology 
The transition of precursors to Schwann cells involves a change in the morphology 
observed in vitro, from flattened groups of cells with extensive cell contacts at E14 
and E15 to bi- and tripolar cells observed in Schwann cells taken from E17 nerves and 
older (Fig 3.2). Cells from E14 nerves cultured in NDFß-2 initially formed groups 
similar to those seen at 3 hr post-plating (Fig 6.1). However, with extended time in 
culture in NDFß-2, the cells became greatly flattened with the limits of each cell being 
increasingly difficult to determine by phase microscopy (Fig 6.10 A). When E14 cells 
were cultured for 4 days in 1.5ng/ml NDFß-2,1nM insulin and 100ng/ml IGF-1 and 
then replated into medium containing 1nM insulin and 100ng/ml IGF-1, the cells 
initially adopted a flattened morphology with only a few cells at 3 hr extending 
processes. However, by 20 hr after replating, many cells had extended processes (Fig 
6.6). Many cells adopted bi-, tri- and multipolar morphologies, but the cytoplasm in 
the region of the nucleus continued to be flattened, unlike Schwann cells taken directly 
from E18 nerves (Fig 3.2). A few cells in the replated cultures failed to extend any 
processes, remaining flattened as they had been prior to replating. 
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Maturation of Schwann cell precursors does not require DNA synthesis 
DNA synthesis was examined in precursors cultured in 1.5ng/ml NDFß-2 using a 1.5 
hr pulse of BrdU on each of days 1-4 and was found to be between 10-20%, 
comparable to that seen in vivo during the developmental period E14-E18 (Stewart et 
al., 1993). To determine whether DNA synthesis is absolutely required for the 
precursors to acquire the Schwann cell phenotype, cells were cultured in a 
concentration of NDFß-2 (0.7 ng/ml, 28pM) that promoted survival but induced only 
low levels of division in the precursors. When division was measured in sister cultures 
in the 3 days prior to replating, using a 1.5 hr pulse of BrdU at the end of each culture 
period, this concentration of NDFß-2 produced DNA synthesis of 1% ± 0.4 (SD, n=2), 
2% ±1 (SD, n=2), and 2% ±1 (SD, n=2) on days 1,2 and 3 in vitro respectively. 
After replating on day 4, cytoplasmic S 100 was detected in 89% ±5 (SD, n=2) of the 
cells at 3 hr post-replating and 67% ±I (SD, n=2) of L1 positive cells survived at 20 
hr in defined medium. These cells also responded to bFGF and forskolin, with DNA 
synthesis increasing from 3% ±0 (SD, n=2) at 5 hr to 13% ± 0.4 (SD, n=2) at 20 hr. 
Thus, in conditions where DNA synthesis was low, the precursors could still generate 
Schwann cells. 
To confirm that Schwann cells could be generated without cell division, precursors 
were cultured in a lower concentration of NDFß-2 (0.4ng/ml, 16pM), in the 
continuous presence of BrdU for 3 days. At the end of this time they were replated 
and double labelled for BrdU and L1 at 3 hr and assayed for survival in defined 
medium at 20 hr. Only 41% ±2 (SEM, n=3) of the cells that survived at 20 hr were 
double labelled, indicating that more than half of the surviving cells had not undergone 
division during the 4 day culture period. The number of cells surviving, however, 
were similar to those seen in assays with higher concentrations of NDFß-2 (see Table 
6.1) with 78% ± 14 (SEM, n=3) surviving in defined medium at 20 hr. At 3 hr the 
number of cells expressing S 100 was 63% ± 10 (SEM, n=3). 
Endothelins block Schwann cell precursor death 
When used in the 20 hr survival assay endothelins (ET) 1,2 and 3 promoted precursor 
survival in defined medium in the presence of 100ng/ml IGF-1 (Fig 6.7 A, B, C). All 
three peptides acted in a similar dose-dependent mannner, maximally promoting 80% 
survival at the most optimal concentrations. The EC50 for ET-1 and ET-3 were 
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identical at -0.02nM, with ET-2 slightly higher at 0.05nM. The survival required the 
presence of IGF-1, no survival was observed in the absence of this growth factor (not 
shown). 
The morphology of E14 cells cultured for 20 hr with ETs in the presence of 1nM 
insulin and IOOng/ml IGF-1 (eg. ET-1; Fig 6.8) was similar to that seen in cultures of 
NDFß-2 (Fig 6.1). Flattened pavements of cells were observed with extensive cell 
contacts. 
The similar effects of all three ETs suggested that their actions were via the ETB 
receptor. Antagonists for both the ETA and ETB receptor were used to determine 
which type of receptor was present on the precursors. The antagonist for ETA 
receptors BQ-123 produced no decrease in survival when used in the concentration 
range 0.1nM - 10µM in the presence of 0.3nM ET-1. Surprisingly, when the ETB 
antagonist IRL 1038 was used in the concentration range 10pM - 1µM also in the 
presence of 0.3nM ET-1, there was no decrease in survival at any of the antagonist 
concentrations. 
Endothelin-1 promotes long term survival of precursors 
To determine whether ETs could promote long term survival of precursors, cells were 
cultured in 0.3nM ET-1 in the presence of 1nM insulin and 100ng/ml IGF-1 for 1-4 
days, as described for NDF(3-2. Medium containing fresh growth factors was replaced 
daily. The cells were stained for L1 at 20,44,68 and 92 hr after plating and the 
surviving cell number compared to the number of attached and flattened L1-positive 
cells at 3 hr post-plating. After 20 hr in culture, 72% of the cells were alive (Fig 6.9). 
The number of cells surviving decreased to 40% of the starting population over the 92 
hr culture period, suggesting that although ET-1 is a long term survival factor for 
some of these cells it is unable to promote survival of all cells and is not mitogenic 
(Fig 6.9). Pulsing the cells with BrdU for the last 1.5 hr in culture over 4 days showed 
a low level of DNA synthesis, between 1-3%, at each time point. 
ET-1, like NDFß-2, did not appear to support long term survival of contaminating L1- 
negative cells. At the start of the cultures, a higher proportion of contaminating cells 
were found in cultures with ET- 1; 20-23% of the cells after 20 hr in culture were LI- 
negative, compared with 12-18% of L1-negative cells in NDF(3-2 at the same 
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timepoint. However, this number decreased with time, so that by 4 days, similar 
numbers of these cells were present in ET-1 cultures compared to NDFß-2 cultures 
(less than 10% of the total starting population). 
Endothelin-1 does not promote precursor maturation 
Since NDFß-2 promoted the maturation of the precursors in culture the question arose 
whether the precursor / Schwann cell transition was a consequence of long term 
survival or whether the maturation of the cells was a response to a particular growth 
factor. 
Cells from E14 nerves were cultured for 4 days in 0.3nM ET-1 with 1nM insulin and 
100ng/ml IGF-l and then replated as previously described. S 100 expression was 
determined at 3 hr and survival in defined medium at 20 hr. It was observed that of 
the replated cells very few had matured to the Schwann cell phenotype. At 3 hr, only 
16% ±2 (SD, n=2) of the replated cells expressed cytoplasmic S 100 and the survival 
at 20 hr was 17% ±1 (SD, n=2). In parallel experiments in the presence of 1.5ng/ml 
NDFß-2,1nM insulin and 100ng/m1 IGF-1,87% ±1 (SD, n=2) of the replated cells 
expressed S 100 and 92% ±4 (SD, n=2) were alive at 20 hr in defined medium (Fig 
6.11). 
Unlike cells cultured in NDFß-2, the morphology of cells cultured with ET-1 did not 
change appreciably with time in culture (compare Fig 6.8 with Fig 6.10 C, D). After 4 
days in culture the cells were still in close groups, however the extensive flattening 
observed in NDFß-2 cultures did not occur in ET-1 (compare Fig 6.10 A, B with Fig 
6.10 C, D). In some cultures, particularly when high concentrations (>IOnM) of ET-1 
were used, the cells appeared to contract together after 3-4 days in culture, forming 
dense clumps of cells (not shown). 
Endothelin-1 can block the maturation effect of NDF(3-2 on precursors 
The lack of maturation of the precursors in ET-1 was unexpected. Suppression of cell 
death by ET-1 appeared to be insufficient to allow maturation of these cells in culture. 
To determine whether the lack of maturation observed in cultures with ET-1 was due 
to an inability of ET-1 to promote precursor maturation, or whether ET-1 actively 
prevented the transition of precursors to Schwann cells, cultures were prepared that 
contained both 0.3nM ET-1 and 1.5ng. ml (60nM) NDFß-2. After 4 days in vitro with 
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medium changed every day, the cells were replated. The expression of S 100 at 3 hr 
was 38% ± 10 (SD, n=2) and survival in defined medium was 50% ±8 (SD, n=2). 
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Table 6.1 Maturation of Schwann cell precursors cultured in NDFß-2 
Cells from different age nerves were cultured for various times in vitro: + 0, indicates 
experiments where the survival assays and S 100 expression were measured on cells 
taken directly from the nerves; the data here has been presented earlier as Figs 3.3 and 
3.6. These cells were cultured in defined medium containing 1µM insulin. 
+ 1-4 days in vitro indicates the time cells were cultured in defined medium with 
l00ng/ml IGF-1,1nM insulin and 1.5ng/ml (60pM) NDFß-2 prior to replating in this 
medium but without NDFß-2. The figures represent data from three experiments 
except for that of newborn cells which was from two experiments; the error for these 
latter experiments is the standard deviation. 
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Table 6.1 Maturation of Schwann cell precursors cultured in NDFß-2 
Cells - Age when removed Percentage of cells that Survival percentage ± 
from nerve + time in vitro express S 100 ± SEM SEM 
E14+0 4±3 1 ±2 
E15+0 4±4 3+2 
E14+1 15±2 12±2 
E16+0 42±6 16±5 
E14+2 41 ±4 30±3 
E15+1 47±7 18±3 
E17+0 95±2 87±5 
E14+3 75±3 71 f2 
E18+0 96±2 98±2 
E14+4 84±3 85±9 
E17+1 93±1 92±6 
Newborn +0 93 f6 100 t4 
Newborn +1 79 ±5 
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Figure 6.1 Precursor morphology and Ll expression after 20 hr culture in 
NDF 13-2. 
E14 precursors were cultured in defined medium containing 1.5no/ml (60pM) NDFß- 
2,1 nM insulin and 100ng/m) IGF-l for 20 hr and then stained for LI expression. (A) 
Phase contrast micrograph of the cells represented in (B). (B) LI expression on cells 
cultured in NDFß-2 for 20 hr. The morphology of the cells under these culture 
conditions closely resembled that of cells cultured for 20 hr with NCM (Fig 3.5 C) or 
bFGF (Fig 5.2). All precursors expressed L 1. Bar = 20ttm 
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Figure 6.2 NDFß-2 promotes precursor survival 
E14 precursors were cultured in the presence of increasing concentrations of NDFß-2, 
1nM insulin and l00ng/ml IGF-1. At 20 hr the cells were fixed and stained for L1, 
and the percentage survival determined as described previously. Survival of 
precursors increased in a dose-dependent manner. Each point represents the average 
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Figure 6.3 NDFß-2 promotes long term survival of precursors 
E14 cells cultured in 1.5ng/ml (60pM) NDFß-2,1nM insulin and 100ng/ml IGF-1 
were stained for L1 at 20,44,68 and 92 hr after plating. The percentage survival was 
calculated relative to L1 positive cells that had attached and flattened 3 hr post-plating. 
NDFß-2 is able to prevent precursor death in the long term and is mitogenic for these 
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Figure 6.4 Cells from E14 rats express SlOO after 4 days in culture with NDFI3-2 
E14 cells cultured on LN coated tissue culture wells in 1.5ng/ml NDFr-2,1nM insulin 
and IOOng/ml IGF-l for 4 days were replated onto LN coated glass coverslips and 
stained at 3 hr post-replating. (A) Phase contrast view of cultures represented in (B) 
and (C), (B) p75LNGFr staining with 1921g antibody; (C) S 100 expression. Most 
cells exhibit S100 labelling, the level of this varies between cells, double arrows 
indicate a cell expressing low levels of S 100. Asterisk indicates a non-precursor- 




Figure 6.5 A mitogenic response to bFGF plus forskolin distinguishes Schwann 
cells from precursors 
(A) The graphs show the percentage of L1-positive cells that incorporated BrdU when 
taken directly from the nerve and cultured in lOng/ml bFGF and 5µM forskolin, with 
BrdU pulsing for 1.5 hr at 5,15 and 20 hr after plating. A response to these Schwann 
cell mitogens is first apparent at E17, when cells with a Schwann cell phenotype are 
first seen in the nerve (Chapter 3). These data are from work by Z. Dong. 
(B) The same assay was performed on precursors cultured for various times in NDFß- 
2 and replated. The mitogenic effect of bFGF and forskolin is first apparent at E14 + 
3, a time equivalent to E17 in vivo and similar to that seen in cells taken directly from 
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Figure 6.6 Morphology of cells at 20 hr after replating following culture in 
NDFP-2 for 4 days. 
E14 cells cultured on LN coated tissue culture wells in l . 
5ng/ml NDFß-2, NM insulin 
and IOOng/ml IGF-1 for 4 days were replated and cultured for a further 20 hr in 
defined medium without NDF(3-2 but with lnM insulin and 100ng/ml IGF-l on LN 
coated glass coverslips. The cells were then stained for L1 expression. Some cells 
have a bipolar appearance but with flattened areas of cytoplasm around the nucleus. 
Other cells assume a mulitpolar morphology. (A) Phase contrast, (B) Ll expression. 
Bar 77 20µm 
20 
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Figure 6.7 Endothelins 1,2 and 3 promote survival of precursors in the presence 
of IGF-1 
E14 cells were cultured in the presence of 1nM insulin and 100ng/ml IGF-l with 
increasing concentrations of ET-1 (A), ET-2 (B) or ET-3 (C). At 20 hr the cultures 
were stained with L1 and survival calculated as described previously. All three ET 
isopeptides promote precursor survival in a dose-dependent manner and with similar 
affinities and effectivness. The points are an average of three experiments (A and B) 
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Figure 6.8 Morphology and Ll expression of E14 cells cultured in 0.3nM ET-l 
for 20 hr. 
E14 cells were cultured with 0.3nM ET-l, lnM insulin and 100ng/ml IGF-I for 20 hr 
and then stained for LI expression. The morphology of the precursors in ET-1 at this 
time point is similar to that seen in NDFO-2 after 20 hr in culture (Fig 6.1). (A) Phase 





Figure 6.9 ET-1 promotes long term survival of precursors 
E14 cells cultured in 0.3nM ET-1,1nM insulin and l00ng/ml IGF-l were stained for 
L1 at 20,44,68, and 92 hr after plating. The percentage survival was calculated 
relative to L1-positive cells that had attached and flattened 3 hr post-plating. ET-1 is 
able to prevent the death of 40% of the cells after 4 days in culture. Each point 
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Figure 6.10 Precursors cultured long term in NDFI3-2 or ET-1 with FGF-1 
E14 precursors were cultured for 4 days with 1 nM insulin and 100ng/ml IGF-1 and 
either Ing/ml (40pM) NDFß-2 (A, B), or 0.3nM ET-1 (C, D) and were then stained 
for LI expression. (A) Cells cultured in NDFß-2 have become extremely flattened 
during culture, the phase micrograph shows the nuclei of the cells depicted in (B). (B) 
Labelling the cells with LI shows the extensive flattening of the cell cytoplasm after 4 
days in culture with NDFß-2. The brightest L1 staining is seen where adjacent cells 
are apposed. (C) Phase micrograph of precursors cultured for 4 days in the presence 
of ET-1. (D) The same cells labelled with Ll. These cells have not flattened during 





Figure 6.11 Comparison of survival and S100 expression by cells cultured for 4 
days in NDFß-2, ET-1 or NDFß-2 with ET-1. 
E14 cells were cultured in LN coated tissue culture wells with 1nM insulin, 100ng/ml 
IGF-1 and either 1.5ng/ml NDFß-2,0.3nM ET-1 or both 1.5ng/ml NDFß-2 and 0.3nM 
ET-1. After 4 days the cells were replated onto LN coated glass coverslips and stained 
for L1 or S100 expression at 3 hr after plating, or cultured for a further 20 hr in 1nM 
insulin and 100ng/ml IGF-1 and assayed for survival by staining for L1 expression and 
comparing it to L1-positive cells adhered and flattened at 3 hr after replating. Cells 
replated from NDFß-2-treated cultures have similar levels of survival and S100 
expression to those of Schwann cells (Table 6.1); cells replated from ET-1-treated 
cultures have not matured towards the Schwann cell phenotype and have low levels of 
survival and 5100 expression; culture with both ET-1 and NDFß-2 produces cells with 
intermediate characteristics. The data represent the average of two experiments, error 
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DISCUSSION 
Schwann cell precursors are able to survive and mature in vivo, presumably in 
response to signals present in the developing nerve. These signals are most likely to 
be of axonal origin and neurone conditioned medium can mimic the effects of axons in 
supporting precursor survival. The previous Chapter described the short-term effects 
of FGFs and IGFs but other factors must be present in vivo to promote long term 
survival of these cells. NDFs are likely candidates for neuronal survival factors, being 
present in appropriate neurones at the right time (Meyer and Birchmeier, 1994) and 
affecting the survival in vivo of cells early in the Schwann cell lineage (Meyer and 
Birchmeier, 1995). Here, the NDFß-2 isoform has been used to investigate the long 
term survival and maturation of the Schwann cell precursors in vitro. Another growth 
factor family, the endothelins also support long term survival. Unlike NDFß-2, 
endothelins have not previously been reported as survival factors for any cell type and, 
as far as is known, this is the first description of a member of the endothelin family 
affecting cells of the Schwann cell lineage. 
NDFß-2 promotes Schwann cell precursor survival 
The NDFß-2 protein used in this study is a non-glycosylated recombinant protein that 
corresponds to the extracellular sequence of this isoform. This NDF(3-2, in the 
presence of 1nM insulin and 100ng/ml (l3nM) IGF-1, acts as a survival factor for 
precursors in a dose-dependent manner (Fig 6.2). The number of cells surviving at 20 
hr in the presence of the highest concentrations of NDFß-2 was higher than the 
number that had attached and flattened at 3 hr, indicating that this factor was 
mitogenic for these cells in short-term culture. This mitogenic effect has been studied 
further by Z. Dong (Dong et al., 1995) and is dose-dependent. 
The work here was performed with NDF(3-2 in the presence of 1nM insulin and 
l00ng/ml (13nM) IGF-1, but Z. Dong has shown that NDFß-2 will promote the 
survival of precursors in the absence of IGF-1, albeit at higher doses of NDF(3-2 
(Dong et al., 1995), unlike the surivival induced by FGFs where IGFs are essential for 
survival. This suggests that binding of NDFß-2 to its receptor(s) produces a response 
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in precursors that is sufficient to prevent death of these cells and does not require the 
activation of the IGF receptors. 
The presence of NDFß-2 promoted the long term survival of the precursors, with cells 
surviving 4 days in vitro (Fig 6.3). Again there was evidence for the mitogenic effect 
of this growth factor since the total number of precursors increased over the 4 day 
assay. It was notable, however, that this factor appeared to have survival and 
mitogenic properties that were specific for the precursors; the contaminating L1 
negative cells did not increase with time in culture. 
The ability of NDFß-2 to prevent death of the precursors in a long term assay is 
similar to that of NCM (Jessen et al., 1994). When NCM is incubated with a soluble 
protein containing the ligand binding domain of ErbB-4 and then used in a survival 
assay, precursor survival decreases with increasing concentrations of ErbB-4. The 
action of NDFß-2 can also be blocked in this manner but not the effect of FGF and 
forskolin, suggesting that ErbB-4 is blocking the action of NDFs present in the NCM 
(A. Brennan, data not shown; Dong et al., 1995). Even at the highest doses of ErbB-4, 
however, there is 20-25% survival, suggesting that other growth factors may be 
present in NCM that affect precursor survival (Dong et al., 1995). 
Both Schwann cell precursors and Schwann cells express ErbB-2, ErbB-3 and ErbB-4 
receptors (Cohen et al., 1992; Jin et al., 1993; Dong et al., 1995; Meyer and 
Birchmeier, 1995) and are able to respond to members of the NDF family. It has long 
been known that GGF, a member of this family, is mitogenic for Schwann cells in 
vitro (Lemke and Brockes, 1984, Marchionni et al., 1993; Minghetti et al., 1996). 
NDFs are produced by both sensory and motor neurones, and are detectable from early 
in development, from E10 in the mouse (-E11 rat) ( Marchionni et al., 1993; Orr- 
Urtreger et al., 1993; Meyer and Birchmeier, 1994; Dong et al., 1995; Ho et al., 1995). 
Thus cells early in the Schwann cell lineage are exposed to these factors and have 
receptors for them. In mutant mice, where the active EGF-like domain of NDF has 
been deleted, the number of Schwann cell precursors observed in the developing 
peripheral nerves is greatly decreased (Meyer and Birchmeier, 1995). This may be a 
direct result of loss of NDF as a survival factor for these cells, or it may be as a result 
of earlier influences of the NDFs on neural crest development. GGF has been shown 
to direct neural crest development towards a glial fate (Shah et al., 1994). Thus the 
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absence of this factor may decrease the number of neural crest cells adopting a glial 
fate. Furthermore, since some Schwann cell precursors are still detectable within the 
mutant mice it is likely that other factors can partially replace NDFs as survival factors 
at this early stage. 
NDF(3-2 generates Schwann cells from precursors in vitro 
In Chapter 3, the developmental regulation of S 100 expression and survival of 
precursors in defined medium was described. The transition from precursor to 
Schwann cell phenotype is rapid, taking place between E15 and E17 in vivo. Cells 
taken from E14 and E15 nerves and cultured in the presence of NDFß-2 acquired the 
ability to survive in defined medium and S 100 expression with a time course that 
paralleled that seen in vivo (Table 6.1). A rapid transition was seen between cells of 
E14 +1 (=E15) and E14 +3 (=E17) from low to high levels of survival and 5100 
expression. There is a slight discrepancy in the level of survival at E14 +2 compared 
to that seen in the nerve at E16: while only 16% of cells survived in defined medium 
when plated directly from the nerve, 30% of E14 cells exposed to NDFß-2 for 2 days 
survived. By E14 +4 (=E18) the majority of cells expressed 5100 and survived 
culture in defined medium at similar levels to that seen in cells directly from the 
nerves. When Schwann cells from newborn nerves are cultured for 1 day prior to 
replating it was found that 80% survived the procedure, while 100% of cells survived 
when plated directly after dissociation from the nerve. This is likely to be due to the 
nature of the replating procedure: when cells are dissociated from the nerve, the 
enzymatic and mechanical treatment is fairly harsh and cells that are not going to 
survive do not attach and flatten by 3 hr. However, the replating procedure is 
somewhat milder and could allow cells to attach that may be damaged in some way, 
thus producing a high 3 hr point which is then used to calculate survival of the cells. 
A pilot study on E14 cells cultured for 4 days with lOng/ml (400pM) NDF(3-2, in the 
presence of 1nM insulin but no IGF-l, produced similar levels of survival and SlO0 
expression as that described with IGF-1 present (data not shown) showing that NDFJ3- 
2 alone was capable of promoting the maturation of the cells. 
These results, although suggestive of the precursors acquiring some Schwann cell 
characteristics in culture, do not show that the cells generated by NDFß-2 can act like 
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Schwann cells. The test for this was the response of the cells to the Schwann cell 
mitogenic combination of bFGF and forskolin over 20 hr. Cells from E14 nerves 
cultured for 1 day in NDFß-2 did not respond to bFGF and forskolin, but after a 
further 2 days in vitro with NDFß-2 the cells showed an increase in DNA synthesis in 
response to these factors (Fig 6.5 B). 
These results show that NDFß-2 can promote the maturation of the precursors with a 
time course similar to that seen in vivo. That more than one developmental parameter 
is affected would suggest that NDFß-2 can act on different genes and coordinate at the 
molecular level the change from precursor to Schwann cell. 
One of the major differences between the precursors and Schwann cells is their 
morphology in vitro. Maturation of the precursors in vitro with NDF(3-2 did not 
produce this change in morphology without replating (not shown). After replating, 
many cells did adopt a morphology more closely resembling that of Schwann cells 
(Fig 6.6) but this transition was incomplete, with flattened sheets of cytoplasm 
extending from the cells in the region of the nucleus. It is possible that in the nerve, 
other factors are present that influence the morphology of the cells during this time of 
transition. 
Endothelins promote Schwann cell precursor survival 
The ETs used in this study are recombinant peptides corresponding to the mature ET 
sequences. All three ETs produced dose-dependent survival with maximal survival of 
80% of precursors at 20 hr (Fig 6.7 A, B, Q. The presence of 100ng/ml IGF-1 was 
required for the action of the endothelins suggesting that, like FGFs, the the activation 
of the type 1 IGF receptor was required for precursor survival and that activation of 
the ET receptors alone was insufficient to suppress precursor death. Other culture 
systems, particularly fibroblast cell lines, have shown that ETs require the presence of 
additional growth factors for mitogenic activity, and both high concentrations of 
insulin and IGF-1 are effective as co-mitogens (reviewed in Battistini et al, 1993). 
The ET receptor involved in precursor survival is likely to be the ETB receptor which, 
as described in the introduction, exhibits no selectivity for ETs 1-3. However, the 
antagonist studies failed to confirm this. BQ-123 produced no effect on the survival of 
precursors in ET-1 suggesting that the ETA receptor is not involved. The ETB 
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antagonist used, IRL 1038 has been reported to be highly selective for the ETB 
receptor (Urade et al., 1992) but also failed to reduce the level of survival seen in the 
presence of ET-1. Since this study was undertaken it has become apparent that the 
activity of this antagonist is highly batch-dependent and that results obtained with this 
compound should be treated with caution (Bax and Saxena, 1994). However, two 
batches of IRL 1038 from two different sources were tried in this study and exhibited 
a similar lack of effect. It is possible that this compound cannot inhibit the ETB 
receptors on the precursors, since an alternative transcript for ETB has been found in 
rat brain that has tissue specific expression (Cheng et al., 1993). As described in the 
introduction, the ETB receptors from different tissues display distinct responses to 
antagonists; for example, the compound RES701 inhibits ETB1 receptor-mediated 
vasorelaxation, while SB209670 inhibits ETB2 receptor-mediated vasoconstriction 
(Douglas et al., 1994). Further studies with the newer antagonists could clarify the 
receptor status of the precursors. 
Schwann cell precursor maturation in vitro 
The role of growth factors in cell differentiation and maturation appears to be 
complex, with some systems requiring a particular growth factor to direct cells 
towards a particular lineage, and other systems that require growth factors for survival 
and proliferation, with differentiation being cell autonomous (Shah et al., 1994). As 
described in Chapter 1, use of bcl-2 to prevent apoptosis in growth factor-deprived 
haemopoietic cells has shown that these haemopoietic cells will automatically 
differentiate into all cell types normally produced from the multipotent bone marrow 
(Fairbairn et al., 1993). In the haemopoietic system, therefore, it appears that the 
ability to differentiate is growth factor-independent and the presence of growth factors 
control the relative numbers of the cell types produced. Similarly, in the 
oligodendrocyte system, progenitor oligodendrocytes will differentiate into mature 
oligodendrocytes in vitro in the absence of growth factors (Raff et al., 1983). Thus it 
had been assumed that by preventing precursor death for several days the precursors 
would be able to mature into Schwann cells, as found in NDFt3-2. Therefore, the lack 
of maturation of the precursors after long term culture in ET-1 was surprising. 
GGF is implicated in directing neural crest differentiation towards the Schwann cell 
lineage by promoting gliogenesis and suppressing neurogenesis (Shah et al., 1994). In 
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this light, it may be that the transition of precursors into Schwann cells requires NDF. 
Combining ET-1 and NDFß-2 in long term cultures of precursors produced an 
intermediate population of cells, where -50% expressed SlOO and a similar number 
survived in vitro in defined medium for 20 hr (Fig 6.11). This result shows that ET 
acts to block the maturation effect of NDF(3-2. Similarly, NDFß-2 appears to be 
driving precursor maturation towards the Schwann cell; if it was merely providing 
favourable conditions for precursor survival then there would be no attenuation of the 
maturation-blocking effect of ET-1. 
As mentioned in the introduction, ETs are found in neurones of the spinal cord and 
DRG of adult human (Giaid et al., 1989) but as yet no description of their distribution 
in embryonic rats has been given. Thus it is not known whether precursors would be 
exposed to these growth factors in vivo. However, since some cell derivatives of the 
neural crest are directly influenced by ETs in vivo (Kurihara et al., 1994; Greenstein 
Baynash et al., 1994; Hosada et al., 1994) ETs must be present from early 
development onward, thus they could play a role in controlling development of the 
Schwann cell precursor lineage. 
Control of Schwann cell precursor maturation does not use the same timing 
mechanism as oligodendrocyte differentiation. 
The maturation of the precursors into Schwann cells does not exhibit the same 
elements of control as the maturation of oligodendrocyte progenitors. 
Oligodendrocyte differentiation it thought to be controlled by an intrinsic clock 
mechanism, where progenitors divide a set number of times before differentiating into 
oligodendrocytes regardless of whether mitogens are present (Raff et al., 1985). This 
clock can be controlled by thyroid hormones, glucocorticoids and retinoic acid (Barres 
et al., 1994). 
ET-1 can promote survival of the precursors in long term cultures (Fig 6.9) but unlike 
NDFß-2, the survival was not accompanied by appreciable DNA synthesis. If the 
Schwann cell precursors used the same mechanism of counting cell divisions prior to 
differentiation then the low cell division could account for the lack of effect of this 
growth factor on precursor maturation. However, long term culture in the presence of 
NDFß-2 at low concentrations that generated DNA synthesis in only 40% of cells, 
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resulted in 78% survival at 20 hr in defined medium after replating, indicating that cell 
division is not a prerequisite for precursor maturation. Thus a clock mechanism that 
counts cell divisions does not determine the precursor to Schwann cell transition. 
In summary, both NDFß-2 and ET-1 can support long term survival of Schwann cell 
precursors in vitro in the presence of IGF-1, but only NDFß-2 promotes the maturation 
of precursors to Schwann cells. ET-1 blocks precursor maturation, but this can be 
partially overcome by NDFß-2, showing that NDF(3-2 actively drives precursors to the 
Schwann cell phenotype. The maturation does not require the cells to undergo 
division, suggesting that the mechanism for the timing of maturation is not the same as 





The aim of this work was to study in detail the glial cells of the peripheral nerves in 
the rat embryo. This has been approached in three ways: firstly, a study has been 
made of some of the phenotypic differences between glial cells of early embryonic 
nerves, the Schwann cell precursors, and the cells found earlier and later in 
development, namely the neural crest and Schwann cells; secondly, the nature of 
precursor death in vitro and the survival requirements of these cells, has been 
explored; and thirdly, the maturation of these cells into Schwann cells in vitro has been 
investigated. 
The early development of nerves has previously been studied with regard to axonal 
outgrowth and innervation of targets but, prior to this work, the glial cells associated 
with these nerves had not been studied in any depth. This study has shown that these 
cells are not neural crest cells although they are morphologically similar in vitro, but, 
like cultured neural crest cells, retain the survival response to members of the FGF 
family of growth factors in the presence of a member of the insulin growth factor 
family (Bannerman and Pleasure, 1993). However, the precursors exhibit an altered 
response to other factors, with NDFs or ETs together with IGF-1 also being able to 
promote survival in precursors but not in neural crest cells. NDFs have been reported 
not to be mitogens for neural crest cells, adding to the differences between the two cell 
types (Shah et al., 1994). In addition, a change is seen in the expression of the 
phosphoprotein GAP-43, which is absent in neural crest but expressed by all 
precursors. 
This study has also established that the Schwann cell precursors express many proteins 
found on Schwann cells of the perinatal and adult nerve, with the phenotype more 
closely resembling that of the non-myelin-forming Schwann cells than that of myelin- 
forming Schwann cells (Table 3.3). However, the precursors exhibit four major 
differences from Schwann cells, namely morphology, lack of expression of the Cat+- 
binding protein S 100, an inability to survive culture in defined medium and an 
inability to increase DNA synthesis in response to the Schwann cell mitogenic 
combination of FGF, IGF and forskolin. Thus the glial cells found in E14 and E15 
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nerves are not Schwann cells, and can be considered a distinct cell type in the 
Schwann cell lineage. 
The transition of precursors into cells with the Schwann cell phenotype is rapid, 
occuring essentially over one developmental day at E16. Expression of S100 
correlates with survival in defined conditions suggesting that these two features may 
be linked. Exogenous S 100, however, does not act as a survival factor for precursors, 
and in studies where cells were stained for SIN at 20 hr after replating, some 
surviving cells did not express this protein (data not shown). Although the exact 
nature of the S 100 protein function is unknown, the ubiquitous expression in all PNS 
glia of perinatal and adult rats would suggest that it has an important role in glial 
function. It is possible that precursor S 100 can function as trophic support for 
neurones; exogenous 5100 as has been reported to increase the survival of motor 
neurones in the developing chick (Bhattacharyya et al., 1992). The onset of S 100 
expression coincides with the end of the period of motor neurone death, since the rate 
of neuronal loss starts to decrease at E16 in mouse (equivalent of E17 rat) 
(Lance-Jones, 1982). Schwann cell precursors are believed to be a source of GDNF 
that is trophic for developing motor neurones (Henderson et al., 1994). Thus, a mutual 
support system may function in the developing nerve. 
The ability of NCM (Chapter 3 and Jessen et al., 1994) and neurones in co-culture 
systems (Roufa et al., 1986; Smith-Thomas et al., 1990; Dong et al., 1995) to promote 
precursor survival and maturation strongly suggests that neurones are the source of 
factors necessary for precursor survival. These cells are in intimate association with 
neuronal membranes from the earliest times of axonal outgrowth (Dahm and 
Landmesser, 1988; Carpenter and Hollyday, 1992a, b; Jessen et al., 1994) and a 
reliance on neuronally-derived factors for survival and mitogenesis provides a 
mechanism for controlling the final Schwann cell numbers within the nerve. These 
studies have provided the first evidence that cells of the Schwann cell lineage can 
undergo apoptosis in the absence of survival factors. 
A recent paper, describing studies of cell death in vivo during nerve development in 
the chick, has shown that glial cells in the nerve undergo two waves of cell death 
(Ciutat et al., 1996). Studying the glial cells of the ventral root, the first wave occurs 
at E5-6 with a second peak of death occuring at E8-9 coinciding with the peak time of 
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motor neurone death. Ciutat and collegues suggest that the first wave of glial cell 
death occurs at a time when the axons are grouped into fascicles and some Schwann 
cells may be unable to obtain sufficient survival factors because of their location on 
the outside of the nerve bundles. The work reported in this thesis suggests that the 
first period of natural cell death may correlate with a transition from neural crest cells 
to Schwann cell precursors. The transition of crest cells to precursors is accompanied 
by a change in growth factor requirement and, as described in Ciutat et al. (1996), the 
newly formed precursors may now be unable to survive without axonal contact where 
previously the neural crest cells were viable. Alternatively, the first wave of cell death 
may represent neural crest cells that have failed to make the transition to Schwann 
cells, and therefore cannot be supported by axonal growth factors at this stage. 
Ciutat et al. (1996) also show that neuronally-derived factors are required to prevent 
the apoptosis of glial cells in the developing nerve. In the E7.5 chick embryo, 
Schwann cell precursors are seen to die in increased numbers when axonal 
degeneration is induced by killing motor neurones with high levels of N-methyl-D- 
aspartate (NMDA), or by killing motor and sensory neurones with ß-bungarotoxin. 
This embryonic age in chick is developmentally equivalent to E14 in rat (Ciutat et al., 
1996), suggesting that the death observed in vitro in rat Schwann cell precursors in the 
absence of neurones or NCM is not an artifact due to culturing the cells, and is likely 
to reflect the behaviour of precursors in the rat developing nerve in vivo. 
The Schwann cell precursors are highly motile (Jessen et al., 1994) and apoptosis 
could be an important mechanism in controlling survival of these cells in inappropriate 
locations away from axonal contact. The timing of susceptibility of precursors to 
apoptosis in the absence of survival factors coincides with the period of natural cell 
death of neurones: from -E12 to E19 in rat lumbar motor neurones (projecting data 
available from mouse) (Lance-Jones, 1982), and from E15 to birth in rat lumbar 
sensory neurones (Coggeshali et al., 1994). 
Prior to the transition to Schwann cells, the precursors exhibit survival factor 
requirements that are quite specific. Three members of the FGF family can promote 
short-term survival in the presence of an IGF or high levels of insulin. In most cell 
systems, high levels (1µM) insulin can substitute for IGF-1 in activating the type-1 
IGF receptor (Rechler and Nissley, 1985; Sara and Carlsson Skwirut, 1988). 
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However, the present study shows that insulin cannot elicit the same survival effects as 
IGF-1 unless there is elevation of cAMP. This may be due to a difference in affinity 
for insulin by the IGFBPs, but it may be that a novel form of the type 1 IGF receptor 
exists in the early embryonic nerve, as is suggested from the studies of mice deficient 
in IGFs and their receptors. These mutation studies suggest that an alternative IGF 
receptor exists during development, but the evidence points to this receptor 
preferentially binding IGF-2. However, without isolation of the protein no definite 
comment on binding properties can be made (Baker et al., 1993; Liu et al., 1993). 
The short-term effect of the FGFs on blocking apoptosis in precursors suggests that 
they are unlikely to play the main role in precursor survival in vivo. The discovery 
that NDF(3-2 not only promotes long-term survival but also stimulates DNA synthesis, 
makes this factor, or one of the members of the NDF family, a likely candidate for an 
in vivo survival factor and neuronally-produced mitogen (Dong et al., 1995; Morrisey 
et al., 1995). NDFs are present in the developing nerves at appropriate ages to support 
survival, and both neural crest and cells of the Schwann cell lineage express receptors 
for these factors making it highly probable that they play a vital role in Schwann cell 
development (see above, and Chapter 6 for references). As described earlier, 
precursors are not entirely absent from early nerves of mice lacking the active domain 
of NDF (Meyer and Birchmeier, 1995), indicating that other growth factors may be 
present in the nerve that can act as survival factors in the absence of NDF. The 
discovery that ET-1 also has long-term survival effects on the precursors raises the 
possibility that this could act as such a factor. As yet the embryonic distribution of the 
ETs is not known and work is underway to determine whether they are present in the 
developing PNS. 
Perhaps the most surprising data from this study is that NDFß-2 can promote the 
maturation of precursors to cells of a Schwann cell phenotype with a time course not 
unlike that seen in vivo. The presence of this single growth factor appears to be 
sufficient to elicit the multiplicity of changes that occur during this transition from 
precursor to Schwann cell. Some of the changes have been described here, but it is 
certain that many others have yet to be elucidated. For example, the timing of 
transition coincides with strong elevation of expression of the zinc-finger transcription 
factor Krox 20. Expression of the factor appears along the entire length of peripheral 
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nerve at around E15 in the mouse (equivalent to rat E16-17) (Topilko et al., 1994). 
The function of Krox 20 at this age is unknown, but ablation of the gene blocks PNS 
myelination at an early stage, suggesting that its expression in the nerve determines 
full maturation of the myelin-forming Schwann cells. 
How NDF acts to promote the maturation of precursors to Schwann cells is not 
known. It may be that it acts purely to suppress apoptosis. In this case, differentiation 
of Schwann cells would be due to an intrinsic programme that requires no additional 
signals for its completion. If such a programme exists in Schwann cells, then blocking 
cell death would be sufficient to allow differentiation of precursors; such an event may 
be considered a default pathway. Alternatively, NDF may not only block cell death 
but also drive the differentiation programme. At present, it is not clear which of these 
explanations best describes the role of NDF in Schwann cell maturation. 
It is of interest that the entire population of Schwann cell precursors in the nerve 
apparently undergo transition to Schwann cells in an approximately synchronous 
fashion. As mentioned in Chapter 6, the control of this developmental change is not 
due to a clock counting cell division, as is the case for oligodendrocytes. The control 
of maturation exerted on the precursors by NDF does not require cell division, a factor 
that might permit the change to Schwann cells to occur over a relatively short 
developmental period. When the transition occurs in vivo, it would be possible to look 
to other events in nerve development, such as the initiation of electrical activity, for a 
signal to coordinate the change. However, in vitro there is no such change of external 
signals, which raises the question of the nature of the switch that controls maturation. 
The cultures used in these experiments have two drawbacks i) they are not 100% pure, 
and ii) precursor cell numbers and density increase during the course of the 
experiment, both raising the possibility that cell-cell signalling might take place in 
these cultures. Factors produced by a small number of cells that have attained 
maturation to Schwann cells may act in a paracrine manner on surrounding cells to 
produce an apparently synchronous switch of phenotype. To determine whether the 
survival and maturation of Schwann cell precursors requires endogenously produced 
autocrine factors as well as NDFs, experiments with cultures at clonal density (50 cells 
per 13mm diameter coverslip) are planned. 
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The NDFs seem to act as truly multifunctional growth factors in PNS glial 
development from the very earliest stages of neural crest development to the 
maturation of Schwann cells in the nerve. As mentioned in Chapter 1, the models 
proposed for growth factor effects on cell fate determination are that i) growth factors 
present in the environment determine the developmental choice of the cell, or ii) that 
the cell makes a choice stochastically, with growth factors acting to amplify this 
decision, selectively promoting survival and/or proliferation of a differentiated cell 
type. It is difficult to say with certainty which model represents the generation of glia 
in the PNS. Among the first known actions of NDF on neural crest is suppression of 
the neuronal transcription factor MASH 1 (Shah et al., 1994) and in this way NDF 
may direct crest cells towards a glial fate. It is not known whether neurones arise by 
stochastic events in the neural crest. However, the first neuroblasts can act as a source 
of NDFs to direct differentiation of other neural crest cells away from the neuronal 
fate. As desribed in Chapter 1, the earliest neuroblasts and glia in the developing 
sympathetic ganglia appear to have complex cell-cell interactions, with NDF 
production from the neuroblasts enhancing NT-3 production by the glia, which in turn 
promotes survival of the neuroblasts, followed by trkA expression and their 
subsequent transition from NT-3-dependent cells to NGF dependent cells (Verdi et al., 
1996). 
Other growth factors are likely to be produced by the developing neuroblasts that act 
as survival and proliferation factors for the glial-determined neural crest cells since 
NDF alone does not seem to promote survival of these cells (Chapter 3) and is not a 
mitogen for them (Shah et al., 1994). Once cells have started to develop as glia, the 
NDFs act as trophic and mitogenic factors as shown in the present work, eventually 
controlling the timing of maturation of glial cells in the nerve into Schwann cells. It 
will be interesting to determine the mechanisms behind this sequence of events. 
A role for endothelins in peripheral nerve development remains hypothetical at this 
stage. That they are present in neurones of the adult DRG suggests that the glial cells 
are exposed to them, but whether they are available to influence cells in the developing 
nerve is not known. Similarly, it is not clear whether precursors cultured in ET-1 and 
IGF-1 would eventually acquire the Schwann cell phenotype, a few cells do seem to 
mature in the four day cultures, and it could be that this factor combination severely 
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delays maturation. It will be interesting to see whether cultures of precursors exposed 
for longer than four days to this growth factor combination have increased numbers of 
cells maturing. Other work planned is to look for other growth factors, such as FGFs, 
that can influence not only ET-1 effects but also those of NDF. 
It is possible that ET-1 is altering the fate of the precursors; little work has been done 
to determine whether these cells can differentiate along other paths of neural crest 
development. In preliminary studies on precursors from pigmented rats, conditions 
reported to induce melanogenesis in avian neural crest cells and Schwann cells in 
culture (addition of bFGF, TPA and forskolin) (Stocker et at., 1991) failed to produce 
any cells that resemble melanocytes (A. Brennan, A. Sinanan and K. R. Jessen, 
unpublished data). This may be a species difference in the point of commitment to a 
particular lineage or a requirement for additional growth factors in rat melanogenesis, 
for example ETs. It is interesting to note that absence of ET-3 or the ETB receptor 
results in an absence of melanocytes from the trunk region of mutant mice (Greenstein 
Baynash et al., 1994). 
Future studies are planned to investigate PNS glial development in ETB mutant mice. 
While overt differences in peripheral nerve development of these mice have not been 
reported, the effects of ETs implied from the current work may influence timing rather 
than any gross change in phenotype. 
In summary, this study shows that the Schwann cell precursor is a distinct intermediate 
in the Schwann cell lineage, with transition to a Schwann cell phenotype occuring 
rapidly over one developmental day. NDFs can promote not only survival and 
proliferation of the precursor, but also maturation in vitro with a time course that is 
quite similar to that in vivo. Other growth factors, namely FGFs and ETs, may affect 
precursor differentiation, suggesting that a complex growth factor interplay might 
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